Comparison	O	NOUN	B
with	O	ADP	O
alkaline	B-GENE	NOUN	B
phosphatases	I-GENE	NOUN	I
and	O	CCONJ	O
5	B-GENE	NUM	B
-	I-GENE	PUNCT	O
nucleotidase	I-GENE	NOUN	B


The	O	DET	O
variable	O	ADJ	B
HMG	B-GENE	NOUN	B
dosage	O	NOUN	I
regimen	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
offer	O	VERB	O
no	O	DET	O
advantages	O	NOUN	O
when	O	SCONJ	O
compared	O	VERB	B
with	O	ADP	O
our	O	PRON	O
standard	O	ADJ	O
daily	O	ADJ	O
dosage	O	NOUN	B
regimen	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
secretory	B-GENE	ADJ	B
HI	I-GENE	NOUN	I
antibodies	I-GENE	NOUN	I
were	O	AUX	O
not	O	PART	O
demonstrated	O	VERB	O
at	O	ADP	O
the	O	DET	O
onset	O	NOUN	B
of	O	ADP	I
illness	O	NOUN	B
in	O	ADP	O
any	O	DET	O
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
their	O	PRON	O
formation	O	NOUN	B
started	O	VERB	O
early	O	ADV	B
and	O	CCONJ	O
the	O	DET	O
antibodies	O	NOUN	B
reached	O	VERB	O
maximal	O	ADJ	B
levels	O	NOUN	B
about	O	ADP	O
10	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
onset	O	NOUN	B
of	O	ADP	I
illness	O	NOUN	I
.	O	PUNCT	O


SGPT	B-GENE	NOUN	B
,	O	PUNCT	O
SGOT	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
alkaline	B-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
concentrations	O	NOUN	B
were	O	AUX	O
essentially	O	ADV	O
normal	O	ADJ	O
in	O	ADP	O
all	O	DET	O
subjects	O	NOUN	B
.	O	PUNCT	O


Gamma	B-GENE	NOUN	B
glutamyl	I-GENE	NOUN	I
transpeptidase	I-GENE	NOUN	I
(	O	PUNCT	O
GGTP	B-GENE	NOUN	B
)	O	PUNCT	O
activity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
seminal	O	ADJ	B
fluid	O	NOUN	I


An	O	DET	O
IgG	B-GENE	NOUN	B
monoclonal	O	ADJ	B
gammopathy	O	NOUN	I
was	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
serum	O	NOUN	B
of	O	ADP	O
4	O	NUM	O
patients	O	NOUN	B
and	O	CCONJ	O
Bence	O	NOUN	B
-	O	PUNCT	O
Joanes	O	PROPN	B
proteinuria	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
in	O	ADP	O
1	O	NUM	O
patient	O	NOUN	B
.	O	PUNCT	O


Peroxydase	B-GENE	NOUN	B
reaction	O	NOUN	I
stains	O	NOUN	O
were	O	AUX	O
negative	O	ADJ	B
,	O	PUNCT	O
chloroacetate	B-GENE	NOUN	B
esterase	I-GENE	NOUN	I
were	O	AUX	O
strongly	O	ADV	O
positive	O	ADJ	B
.	O	PUNCT	O


A	O	DET	O
mixture	O	NOUN	O
of	O	ADP	O
human	B-GENE	ADJ	B
albumin	I-GENE	NOUN	O
5	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
hydroxy	O	ADJ	B
-	O	PUNCT	O
ethyl	O	NOUN	B
-	O	PUNCT	O
starch	O	NOUN	B
was	O	AUX	O
used	O	VERB	O
as	O	ADP	O
a	O	DET	O
solution	O	NOUN	B
for	O	ADP	O
dilution	O	NOUN	B
.	O	PUNCT	O


Albumin	B-GENE	NOUN	B
and	O	CCONJ	O
cyclic	O	ADJ	B
AMP	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
peritoneal	O	ADJ	B
fluids	O	NOUN	I
in	O	ADP	O
the	O	DET	O
child	O	NOUN	B


The	O	DET	O
concentration	O	NOUN	B
of	O	ADP	O
alpha	B-GENE	NOUN	B
2	I-GENE	NUM	I
-	I-GENE	PUNCT	O
macroglobulin	I-GENE	NOUN	B
,	O	PUNCT	O
alpha	B-GENE	NOUN	B
1	I-GENE	NUM	I
-	I-GENE	PUNCT	O
antitrypsin	I-GENE	NOUN	B
,	O	PUNCT	O
plasminogen	B-GENE	NOUN	B
,	O	PUNCT	O
C3	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
complement	I-GENE	NOUN	B
,	O	PUNCT	O
fibrinogen	B-GENE	NOUN	B
degradation	I-GENE	NOUN	I
products	I-GENE	NOUN	I
(	O	PUNCT	O
FDP	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
fibrinolytic	O	ADJ	B
activity	O	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
the	O	DET	O
aqueous	O	ADJ	B
humour	O	NOUN	B
and	O	CCONJ	O
serum	O	NOUN	B
from	O	ADP	O
nine	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
Fuchs	O	NOUN	B
'	O	PART	O
endothelial	O	ADJ	B
dystrophy	O	NOUN	I
,	O	PUNCT	O
17	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
uncomplicated	O	ADJ	B
senile	O	ADJ	B
cataract	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
secondary	O	ADJ	B
aqueous	O	ADJ	B
from	O	ADP	O
six	O	NUM	O
cataract	O	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
CBZ	O	NOUN	B
and	O	CCONJ	O
DPH	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
explained	O	VERB	O
by	O	ADP	O
interference	O	NOUN	B
with	O	ADP	O
thyroid	O	NOUN	B
hormone	O	NOUN	I
binding	O	NOUN	I
to	O	PART	O
TBG	B-GENE	NOUN	B
combined	O	VERB	O
with	O	ADP	O
enzyme	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
increased	O	VERB	B
metabolic	O	ADJ	B
clearance	O	NOUN	O
rate	O	NOUN	B
of	O	ADP	O
thyroid	O	NOUN	B
hormones	O	NOUN	I
without	O	ADP	O
homeostatic	O	ADJ	B
maintenance	O	NOUN	B
of	O	ADP	O
premedication	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
FT4	O	NOUN	B
and	O	CCONJ	O
FT3	O	NOUN	B
.	O	PUNCT	O


Native	O	ADJ	B
human	B-GENE	ADJ	B
fibrinogen	I-GENE	NOUN	O
was	O	AUX	O
brought	O	VERB	O
to	O	PART	O
coagulation	O	NOUN	B
by	O	ADP	O
adding	O	VERB	O
thrombin	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Southern	O	ADJ	B
technique	O	NOUN	I
allowed	O	VERB	O
a	O	DET	O
further	O	ADJ	O
localization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
region	O	NOUN	B
of	O	ADP	O
most	O	ADV	O
extensive	O	ADJ	B
transcription	O	NOUN	B
to	O	PART	O
a	O	DET	O
1	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
kb	O	NOUN	O
HindIII	B-GENE	NOUN	B
-	O	PUNCT	O
EcoRI	B-GENE	NOUN	B
fragment	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
no	O	DET	O
correlation	O	NOUN	B
between	O	ADP	O
serum	B-GENE	NOUN	B
LH	I-GENE	NOUN	B
and	O	CCONJ	O
chronological	O	ADJ	B
or	O	CCONJ	O
bone	O	NOUN	B
age	O	NOUN	I
in	O	ADP	O
this	O	DET	O
age	O	NOUN	B
group	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
correlation	O	NOUN	B
found	O	VERB	O
is	O	AUX	O
not	O	PART	O
due	O	ADJ	O
to	O	ADP	O
age	O	NOUN	B
-	O	PUNCT	O
related	O	ADJ	B
parallel	O	ADJ	O
phenomena	O	NOUN	B
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
succimer	O	NOUN	B
on	O	ADP	O
the	O	DET	O
intensity	O	NOUN	B
of	O	ADP	O
tricarboxylic	B-GENE	ADJ	B
acid	I-GENE	NOUN	I
dehydrogenase	I-GENE	NOUN	I
reactions	O	NOUN	I
in	O	ADP	O
the	O	DET	O
brain	O	NOUN	B
of	O	ADP	O
rats	O	NOUN	B
poisoned	O	VERB	B
with	O	ADP	O
mercuric	O	ADJ	B
chloride	O	NOUN	I


Total	O	ADJ	B
VO2	O	NOUN	B
was	O	AUX	O
decreased	O	VERB	B
in	O	ADP	O
both	O	DET	O
groups	O	NOUN	B
during	O	ADP	O
severe	O	ADJ	B
hypoxia	O	NOUN	B
but	O	CCONJ	O
limb	O	NOUN	B
VO2	O	NOUN	B
was	O	AUX	O
maintained	O	VERB	B
in	O	ADP	O
the	O	DET	O
beta	O	NOUN	B
-	O	PUNCT	O
block	O	NOUN	B
group	O	NOUN	B
.	O	PUNCT	O
beta	O	NOUN	B
-	O	PUNCT	O
Block	O	PROPN	B
prevented	O	VERB	B
the	O	DET	O
fall	O	NOUN	B
in	O	ADP	O
total	O	NOUN	O
and	O	CCONJ	O
limb	O	ADJ	B
peripheral	O	ADJ	I
resistance	O	NOUN	I
seen	O	VERB	O
in	O	ADP	O
severe	O	ADJ	B
hypoxia	O	NOUN	B
but	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
consistently	O	ADV	O
more	O	ADV	O
efficient	O	ADJ	B
utilization	O	NOUN	B
of	O	ADP	O
total	O	ADJ	O
O2	O	NOUN	B
delivery	O	NOUN	B
shown	O	VERB	O
by	O	ADP	O
the	O	DET	O
limb	O	NOUN	B
in	O	ADP	O
comparison	O	NOUN	B
to	O	ADP	O
the	O	DET	O
whole	O	ADJ	B
body	O	NOUN	I
by	O	ADP	O
higher	O	ADJ	B
O2	O	NOUN	B
extraction	O	NOUN	I
ratios	O	NOUN	B
and	O	CCONJ	O
lower	O	ADJ	O
venous	O	ADJ	B
O2	O	NOUN	I
pressure	O	NOUN	I
.	O	PUNCT	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Vasodilator	I-GENE	NOUN	B
receptors	I-GENE	NOUN	I
evidently	O	ADV	O
played	O	VERB	O
an	O	DET	O
active	O	ADJ	B
part	O	NOUN	O
in	O	ADP	O
the	O	DET	O
vasodilatation	O	NOUN	B
seen	O	VERB	O
during	O	ADP	O
severe	O	ADJ	B
hypoxia	O	NOUN	B
.	O	PUNCT	O


Modulation	O	NOUN	B
of	O	ADP	O
25	B-GENE	NUM	O
-	I-GENE	PUNCT	O
hydroxyvitamin	I-GENE	NOUN	B
D3	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
24	I-GENE	NUM	B
-	I-GENE	PUNCT	O
hydroxylase	I-GENE	NOUN	B
by	O	ADP	O
aminophylline	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
cytochrome	B-GENE	NOUN	B
P	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
450	I-GENE	NUM	O
monooxygenase	I-GENE	NOUN	B
system	O	NOUN	I
.	O	PUNCT	O


Serum	B-GENE	NOUN	B
ACTH	I-GENE	NOUN	I
did	O	AUX	O
not	O	PART	O
respond	O	VERB	O
to	O	PART	O
insulin	B-GENE	NOUN	B
and	O	CCONJ	O
metyrapone	O	NOUN	B
.	O	PUNCT	O


Dopamine	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
blockade	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
neuroleptics	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
crystallographic	O	ADJ	B
study	O	NOUN	I
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
maternal	B-GENE	ADJ	B
serum	I-GENE	NOUN	B
somatomedin	I-GENE	NOUN	B
A	I-GENE	NOUN	I
was	O	AUX	O
significantly	O	ADV	O
reduced	O	VERB	B
in	O	ADP	O
rats	O	NOUN	B
nursing	O	NOUN	B
large	O	ADJ	O
litters	O	NOUN	B
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
calcitonin	B-GENE	NOUN	I
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
renal	O	ADJ	I
failure	O	NOUN	I
.	O	PUNCT	O


Detection	O	NOUN	B
of	O	ADP	O
anti	O	ADJ	B
-	O	PUNCT	O
lymphocyte	O	NOUN	B
antibodies	O	NOUN	O
using	O	VERB	O
the	O	DET	O
immunoperoxidase	B-GENE	NOUN	B
antiglobulin	B-GENE	NOUN	I
technic	O	NOUN	I
.	O	PUNCT	O


Disrupted	O	ADJ	B
vaccines	O	NOUN	B
and	O	CCONJ	O
whole	O	ADJ	B
-	O	PUNCT	O
virus	O	NOUN	B
vaccines	O	NOUN	B
containing	O	VERB	O
type	B-GENE	NOUN	B
B	I-GENE	NOUN	I
antigen	I-GENE	NOUN	I
only	O	ADV	O
did	O	AUX	O
not	O	PART	O
cause	O	VERB	O
significant	O	ADJ	O
reactivity	O	NOUN	B
.	O	PUNCT	O


Follow	O	PROPN	B
-	O	PUNCT	O
up	O	ADP	O
controls	O	NOUN	B
of	O	ADP	O
luteinizing	B-GENE	NOUN	B
hormone	I-GENE	NOUN	I
(	O	PUNCT	O
LH	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
follicle	B-GENE	NOUN	B
stimulating	I-GENE	NOUN	O
hormone	I-GENE	NOUN	O
(	O	PUNCT	O
FSH	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
prolactin	B-GENE	NOUN	B
(	O	PUNCT	O
HPRL	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
oestradiol	O	NOUN	B
(	O	PUNCT	O
E2	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
progesterone	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
)	O	PUNCT	O
and	O	CCONJ	O
testosterone	O	NOUN	B
(	O	PUNCT	O
T	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
catabolic	O	ADJ	B
and	O	CCONJ	O
healing	O	NOUN	B
phase	O	NOUN	O
of	O	ADP	O
burn	O	NOUN	B
disease	O	NOUN	I
.	O	PUNCT	O


Renin	B-GENE	NOUN	B
studies	O	NOUN	B
performed	O	VERB	O
in	O	ADP	O
34	O	NUM	O
hypertensive	O	ADJ	B
patients	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
a	O	DET	O
control	O	ADJ	B
group	O	NOUN	I
of	O	ADP	O
11	O	NUM	O
recipients	O	NOUN	B
showed	O	VERB	O
that	O	SCONJ	O
elevation	O	NOUN	B
of	O	ADP	O
plasma	B-GENE	NOUN	B
renin	I-GENE	NOUN	B
activity	O	NOUN	B
and	O	CCONJ	O
of	O	ADP	O
plasma	O	NOUN	B
aldosterone	O	NOUN	B
level	O	NOUN	B
is	O	AUX	O
frequent	O	ADJ	B
but	O	CCONJ	O
difficult	O	ADJ	O
to	O	PART	O
interpret	O	VERB	O
,	O	PUNCT	O
particularly	O	ADV	O
when	O	SCONJ	O
a	O	DET	O
renal	O	ADJ	B
artery	O	NOUN	I
stenosis	O	NOUN	I
is	O	AUX	O
observed	O	VERB	O
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
pepsin	B-GENE	NOUN	B
in	O	ADP	O
human	O	ADJ	B
gastric	O	ADJ	B
juice	O	NOUN	I
does	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
have	O	AUX	O
a	O	DET	O
major	O	ADJ	O
influence	O	NOUN	B
on	O	ADP	O
the	O	DET	O
healing	O	NOUN	B
of	O	ADP	O
duodenal	O	ADJ	B
ulcer	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
authorized	O	VERB	O
by	O	ADP	O
the	O	DET	O
World	O	PROPN	B
Health	O	PROPN	I
Organization	O	PROPN	I
29th	O	PROPN	I
Expert	O	PROPN	I
Committee	O	PROPN	I
on	O	ADP	O
Biological	O	PROPN	B
Standardization	O	PROPN	B
,	O	PUNCT	O
the	O	DET	O
preparation	O	NOUN	B
of	O	ADP	O
human	B-GENE	ADJ	B
prolactin	I-GENE	NOUN	B
in	O	ADP	O
ampoules	O	NOUN	B
coded	O	VERB	O
75	O	NUM	O
/	O	SYM	O
504	O	NUM	O
has	O	AUX	O
been	O	AUX	O
established	O	VERB	O
as	O	ADP	O
the	O	DET	O
International	O	PROPN	B
Reference	O	PROPN	I
Preparation	O	PROPN	I
(	O	PUNCT	O
IRP	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
human	B-GENE	ADJ	B
prolactin	I-GENE	NOUN	B
for	O	ADP	O
immunoassay	O	NOUN	B
.	O	PUNCT	O


Such	O	ADJ	O
marked	O	ADJ	O
differences	O	NOUN	B
are	O	AUX	O
found	O	VERB	O
occasionally	O	ADV	O
in	O	ADP	O
the	O	DET	O
literature	O	NOUN	B
:	O	PUNCT	O
heterophile	O	NOUN	B
antibodies	O	NOUN	I
against	O	ADP	O
bovine	B-GENE	ADJ	B
gammaglobulin	I-GENE	NOUN	I
are	O	AUX	O
regarded	O	VERB	O
as	O	ADP	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
interference	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Sephadex	O	NOUN	B
system	O	NOUN	I
of	O	ADP	O
RIST	O	NOUN	B
.	O	PUNCT	O


Serial	O	ADJ	O
measurements	O	NOUN	B
of	O	ADP	O
total	O	ADJ	O
serum	O	NOUN	O
IgE	B-GENE	NOUN	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
useful	O	ADJ	O
index	O	NOUN	O
of	O	ADP	O
disease	O	NOUN	B
activity	O	NOUN	I
in	O	ADP	O
ABPA	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
rise	O	NOUN	O
of	O	ADP	O
hemoglobin	B-GENE	NOUN	B
concentration	O	NOUN	I
accompanied	O	VERB	O
by	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
the	O	DET	O
total	O	ADJ	O
iron	O	NOUN	B
in	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
serum	O	NOUN	I
of	O	ADP	O
white	O	ADJ	B
mice	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
under	O	ADP	O
oxygen	O	NOUN	B
pressure	O	NOUN	I
of	O	ADP	O
4	O	NUM	O
atm	O	NOUN	O
for	O	ADP	O
an	O	DET	O
hour	O	NOUN	B
(	O	PUNCT	O
preconvulsive	O	ADJ	B
state	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
6	O	NUM	O
atm	O	NOUN	O
(	O	PUNCT	O
convulsive	O	ADJ	B
state	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
concluded	O	VERB	O
that	O	SCONJ	O
opiate	B-GENE	ADJ	B
receptors	I-GENE	NOUN	I
bordering	O	VERB	O
the	O	DET	O
fourth	O	ADJ	O
cerebral	O	ADJ	B
ventricle	O	NOUN	I
mediate	O	VERB	O
the	O	DET	O
cardiovascular	O	ADJ	B
and	O	CCONJ	O
hypnotic	O	ADJ	B
action	O	NOUN	I
of	O	ADP	O
fentanyl	O	NOUN	B
.	O	PUNCT	O


Urinary	O	ADJ	B
excretion	O	NOUN	B
of	O	ADP	O
oestrone	O	NOUN	B
,	O	PUNCT	O
oestradiol	O	NOUN	B
-	O	PUNCT	O
17	O	NUM	O
beta	O	NOUN	B
and	O	CCONJ	O
oestriol	O	NOUN	B
in	O	ADP	O
pregnancies	O	NOUN	B
complicated	O	VERB	O
by	O	ADP	O
steroid	B-GENE	NOUN	B
sulphatase	I-GENE	NOUN	I
deficiency	O	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
transferrin	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
uptake	O	NOUN	B
of	O	ADP	O
gallium	O	NOUN	B
by	O	ADP	O
tumor	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Screening	O	NOUN	B
of	O	ADP	O
asthma	O	NOUN	B
patients	O	NOUN	B
by	O	ADP	O
determination	O	NOUN	B
of	O	ADP	O
IgE	B-GENE	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
comprehension	O	NOUN	B
of	O	ADP	O
spectrum	O	NOUN	B
of	O	ADP	O
allergospecific	B-GENE	ADJ	B
IgE	I-GENE	NOUN	B
antibodies	I-GENE	NOUN	O


A	O	DET	O
highly	O	ADV	O
significant	O	ADJ	O
correlation	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
between	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
fibrinolytic	O	ADJ	B
degradation	O	NOUN	I
products	O	NOUN	I
(	O	PUNCT	O
FDP	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
incidence	O	NOUN	B
of	O	ADP	O
nephropathy	O	NOUN	B
and	O	CCONJ	O
renal	O	ADJ	B
insufficiency	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
between	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
fibrin	B-GENE	NOUN	B
monomers	I-GENE	NOUN	I
(	O	PUNCT	O
Godal	O	PROPN	B
'	O	PART	I
s	O	PROPN	I
ethanol	O	NOUN	B
-	O	PUNCT	O
gelification	O	NOUN	B
test	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
evolutive	O	ADJ	B
signs	O	NOUN	B
of	O	ADP	O
the	O	DET	O
primary	O	ADJ	B
disease	O	NOUN	I
(	O	PUNCT	O
fever	O	NOUN	B
,	O	PUNCT	O
accelerated	O	VERB	O
ESR	O	PROPN	B
)	O	PUNCT	O
.	O	PUNCT	O


Serum	O	NOUN	B
levels	O	NOUN	O
of	O	ADP	O
IgG	B-GENE	NOUN	B
and	O	CCONJ	O
IgM	B-GENE	NOUN	B
were	O	AUX	O
also	O	ADV	O
raised	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
contrary	O	ADJ	O
to	O	ADP	O
the	O	DET	O
findings	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
observers	O	NOUN	B
IgA	B-GENE	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
normal	O	ADJ	O
.	O	PUNCT	O


A	O	DET	O
decrease	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lysozyme	B-GENE	NOUN	B
activity	O	NOUN	B
coincided	O	VERB	O
with	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
improvement	O	NOUN	I
of	O	ADP	O
the	O	DET	O
bacterial	O	ADJ	B
meningitis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
multiple	O	ADJ	B
factors	O	NOUN	B
affecting	O	VERB	O
plasma	O	NOUN	B
renin	B-GENE	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
essential	O	ADJ	B
hypertension	O	NOUN	I
.	O	PUNCT	O


Prevention	O	NOUN	B
of	O	ADP	O
acute	O	ADJ	B
paraquat	O	NOUN	B
toxicity	O	NOUN	B
in	O	ADP	O
rats	O	NOUN	B
by	O	ADP	O
superoxide	B-GENE	NOUN	B
dismutase	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
pure	O	ADJ	O
natural	O	ADJ	B
porcine	B-GENE	NOUN	O
secretin	I-GENE	NOUN	B
on	O	ADP	O
endocrine	O	ADJ	B
and	O	CCONJ	O
exocrine	O	ADJ	B
pancreatic	O	ADJ	I
secretion	O	NOUN	I
was	O	AUX	O
studied	O	VERB	O
in	O	ADP	O
the	O	DET	O
totally	O	ADV	O
isolated	O	VERB	B
perfused	O	ADJ	B
porcine	O	NOUN	O
pancreas	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
biopsies	O	NOUN	B
CK	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
MB	I-GENE	NOUN	B
fraction	O	NOUN	B
of	O	ADP	O
total	O	ADJ	O
myocardial	O	ADJ	O
CPK	B-GENE	NOUN	B
was	O	AUX	O
37	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
total	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CPK	I-GENE	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
skeletal	O	ADJ	B
muscles	O	NOUN	I
still	O	ADV	O
shows	O	VERB	O
a	O	DET	O
5	O	NUM	O
%	O	NOUN	O
fraction	O	NOUN	B
of	O	ADP	O
CK	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
MB	I-GENE	PROPN	B
.	O	PUNCT	O


It	O	PRON	O
was	O	AUX	O
postulated	O	VERB	O
that	O	SCONJ	O
persistent	O	ADJ	B
challenge	O	NOUN	O
by	O	ADP	O
M	O	NOUN	B
.	O	PUNCT	O
leprae	O	NOUN	B
or	O	CCONJ	O
its	O	PRON	O
antigens	O	NOUN	B
to	O	PART	O
the	O	DET	O
IgA	B-GENE	NOUN	B
immunocytes	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intestinal	O	ADJ	B
epithelium	O	NOUN	I
might	O	AUX	O
have	O	AUX	O
induced	O	VERB	B
tolerance	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
IgA	B-GENE	NOUN	B
deficiency	O	NOUN	I
and	O	CCONJ	O
subsequent	O	ADJ	O
subtotal	O	ADJ	B
atrophy	O	NOUN	I
of	O	ADP	O
the	O	DET	O
intestinal	O	ADJ	B
villi	O	NOUN	I
in	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
with	O	ADP	O
lepromatous	O	ADJ	B
leprosy	O	NOUN	I
.	O	PUNCT	O


Platelet	O	NOUN	B
serotonin	O	NOUN	I
(	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
HT	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
5	B-GENE	NUM	B
-	I-GENE	PUNCT	O
HT	I-GENE	NOUN	B
releasing	I-GENE	NOUN	O
factor	I-GENE	NOUN	O
in	O	ADP	O
plasma	O	NOUN	B
of	O	ADP	O
migrainous	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O


Carcinoembryonic	B-GENE	NOUN	B
antigen	I-GENE	NOUN	I
(	O	PUNCT	O
CEA	B-GENE	NOUN	B
)	O	PUNCT	O
procedures	O	NOUN	B
and	O	CCONJ	O
clinical	O	ADJ	B
evaluation	O	NOUN	I
.	O	PUNCT	O


Rheumatoid	B-GENE	ADJ	B
factor	I-GENE	NOUN	I
and	O	CCONJ	O
antinuclear	O	ADJ	B
antibody	O	NOUN	I
tests	O	NOUN	I
were	O	AUX	O
frequently	O	ADV	O
positive	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
reactions	O	NOUN	B
to	O	ADP	O
gold	O	NOUN	B
therapy	O	NOUN	I
were	O	AUX	O
more	O	ADV	O
frequent	O	ADJ	B
than	O	ADP	O
in	O	ADP	O
other	O	ADJ	O
rheumatoid	O	ADJ	B
populations	O	NOUN	I
.	O	PUNCT	O


Recurrence	O	NOUN	B
of	O	ADP	O
bladder	O	NOUN	B
tumors	O	NOUN	I
among	O	ADP	O
the	O	DET	O
original	O	ADJ	B
9	O	NUM	O
cases	O	NOUN	B
has	O	AUX	O
occurred	O	VERB	O
only	O	ADV	O
among	O	ADP	O
the	O	DET	O
5	O	NUM	O
whose	O	DET	O
properdin	B-GENE	NOUN	B
levels	O	NOUN	O
remained	O	VERB	O
below	O	ADP	O
the	O	DET	O
median	O	NOUN	B
.	O	PUNCT	O


Serum	B-GENE	NOUN	B
amylase	I-GENE	NOUN	I
became	O	VERB	O
markedly	O	ADV	O
elevated	O	ADJ	B
(	O	PUNCT	O
2	O	NUM	O
,	O	PUNCT	O
624	O	NUM	O
CU	O	PROPN	B
/	O	SYM	O
100	O	NUM	O
ml	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADP	O
did	O	AUX	O
the	O	DET	O
serum	O	NOUN	B
FFA	O	NOUN	B
(	O	PUNCT	O
29	O	NUM	O
.	O	PUNCT	O
19	O	NUM	O
mEq	O	NOUN	B
/	O	SYM	O
liter	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
sera	O	NOUN	B
and	O	CCONJ	O
nasal	O	ADJ	B
secretions	O	NOUN	I
of	O	ADP	O
142	O	NUM	O
patients	O	NOUN	B
,	O	PUNCT	O
who	O	PRON	O
were	O	AUX	O
positive	O	ADJ	B
in	O	ADP	O
HD	O	NOUN	B
or	O	CCONJ	O
mites	O	NOUN	B
skin	O	NOUN	B
test	O	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
subjected	O	VERB	O
to	O	PART	O
a	O	DET	O
radioallergosorbent	O	ADJ	B
test	O	NOUN	I
(	O	PUNCT	O
RAST	O	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
estimating	O	VERB	B
the	O	DET	O
specific	O	ADJ	O
IgE	B-GENE	NOUN	B
antibody	I-GENE	NOUN	B
activity	O	NOUN	I
to	O	PART	O
mites	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
hepatitis	B-GENE	NOUN	B
B	I-GENE	NOUN	I
surface	I-GENE	NOUN	I
antigen	I-GENE	NOUN	I
(	O	PUNCT	O
HBsAg	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
HBs	I-GENE	NOUN	B
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
a	O	DET	O
sensitive	O	ADJ	B
double	O	ADJ	B
-	O	PUNCT	O
antibody	O	NOUN	B
radio	O	NOUN	B
-	O	PUNCT	O
immunoassay	O	NOUN	B
technique	O	NOUN	B
in	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
liver	O	NOUN	I
diseases	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
spontaneous	O	ADJ	B
recovery	O	NOUN	B
of	O	ADP	O
central	O	ADJ	B
respiratory	O	ADJ	I
function	O	NOUN	I
after	O	ADP	O
intoxication	O	NOUN	B
with	O	ADP	O
Soman	O	PROPN	B
or	O	CCONJ	O
Sarin	O	PROPN	B
may	O	AUX	O
not	O	PART	O
be	O	AUX	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
return	O	NOUN	O
of	O	ADP	O
AChE	B-GENE	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


Pregnant	O	ADJ	B
women	O	NOUN	I
at	O	ADP	O
term	O	NOUN	O
had	O	AUX	O
the	O	DET	O
lowest	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
antithrombin	B-GENE	NOUN	B
III	I-GENE	NUM	I
.	O	PUNCT	O


Mean	O	VERB	B
corpuscular	B-GENE	ADJ	I
hemoglobin	I-GENE	NOUN	I
concentrations	O	NOUN	I
remained	O	VERB	O
normal	O	ADJ	O
for	O	ADP	O
48	O	NUM	O
h	O	NOUN	O
and	O	CCONJ	O
then	O	ADV	O
decreased	O	VERB	B
in	O	ADP	O
both	O	DET	O
groups	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
CO2	O	NOUN	B
group	O	NOUN	B
showing	O	VERB	O
the	O	DET	O
larger	O	ADJ	O
decrease	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
calcitonin	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
large	O	ADJ	O
amount	O	NOUN	O
of	O	ADP	O
calcium	O	NOUN	B
given	O	VERB	O
orally	O	ADV	B
,	O	PUNCT	O
pentagastrin	O	NOUN	B
and	O	CCONJ	O
glucagon	B-GENE	NOUN	B
on	O	ADP	O
plasma	O	NOUN	B
47Ca	O	NOUN	O
radioactivity	O	NOUN	B
curves	O	NOUN	I
in	O	ADP	O
subjects	O	NOUN	B
pretreated	O	VERB	B
with	O	ADP	O
47Ca	O	NOUN	B
was	O	AUX	O
examined	O	VERB	B
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
trauma	O	NOUN	B
on	O	ADP	O
plasma	B-GENE	NOUN	B
glucagon	I-GENE	NOUN	B
and	O	CCONJ	O
insulin	B-GENE	NOUN	B
concentrations	O	NOUN	B
in	O	ADP	O
sheep	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
influence	O	NOUN	B
of	O	ADP	O
adrenergic	O	ADJ	B
nerves	O	NOUN	I
of	O	ADP	O
the	O	DET	O
response	O	NOUN	B
of	O	ADP	O
blood	O	NOUN	B
vessels	O	NOUN	I
in	O	ADP	O
the	O	DET	O
rabbit	O	NOUN	B
ear	O	NOUN	B
to	O	PART	O
2	B-GENE	NUM	O
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
phenylalanine	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
8	I-GENE	NUM	B
-	I-GENE	PUNCT	O
lysine	I-GENE	NOUN	B
vasopressin	I-GENE	NOUN	I
(	O	PUNCT	O
Octapressin	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
second	O	ADJ	O
and	O	CCONJ	O
third	O	NOUN	O
responded	O	VERB	O
similarly	O	ADV	O
to	O	PART	O
either	O	CCONJ	O
a	O	DET	O
combined	O	ADJ	O
cyclophosphamide	O	NOUN	B
+	O	CCONJ	O
antilymphocyte	B-GENE	NOUN	B
globulin	I-GENE	NOUN	I
(	O	PUNCT	O
ALG	B-GENE	NOUN	B
)	O	PUNCT	O
treatment	O	NOUN	B
or	O	CCONJ	O
to	O	PART	O
ALG	B-GENE	NOUN	B
administration	O	NOUN	B
preceded	O	VERB	O
by	O	ADP	O
a	O	DET	O
small	O	ADJ	O
dosage	O	NOUN	B
of	O	ADP	O
cyclophosphamide	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
had	O	AUX	O
proved	O	VERB	O
ineffective	O	ADJ	B
when	O	SCONJ	O
administered	O	VERB	B
alone	O	ADV	O
.	O	PUNCT	O


Alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
antitrypsin	I-GENE	NOUN	B
and	O	CCONJ	O
Indian	O	ADJ	B
childhood	O	NOUN	O
cirrhosis	O	NOUN	O
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
a	O	DET	O
slight	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
total	O	ADJ	O
transferrin	B-GENE	NOUN	O
2	O	NUM	O
hr	O	NOUN	O
after	O	ADP	O
1	O	NUM	O
tablet	O	NOUN	B
and	O	CCONJ	O
values	O	NOUN	B
remained	O	VERB	O
high	O	ADJ	O
throughout	O	ADP	O
the	O	DET	O
experiment	O	NOUN	B
.	O	PUNCT	O


Thromboplastin	B-GENE	ADJ	B
time	O	NOUN	I
,	O	PUNCT	O
partial	O	ADJ	B
thromboplastin	B-GENE	NOUN	I
time	O	NOUN	I
,	O	PUNCT	O
thrombin	B-GENE	NOUN	B
time	O	NOUN	I
,	O	PUNCT	O
heat	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
fibrin	B-GENE	NOUN	B
,	O	PUNCT	O
clot	O	NOUN	B
retraction	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
clotting	B-GENE	NOUN	B
factors	I-GENE	NOUN	I
II	I-GENE	NUM	I
,	I-GENE	PUNCT	O
V	I-GENE	PROPN	B
,	I-GENE	PUNCT	O
VIII	I-GENE	NOUN	B
,	I-GENE	PUNCT	O
IX	I-GENE	NUM	B
,	I-GENE	PUNCT	O
X	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
platelet	O	NOUN	B
count	O	NOUN	I
were	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


Glucose	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
(	O	PUNCT	O
G	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	B
-	I-GENE	PUNCT	O
PD	I-GENE	NOUN	B
)	O	PUNCT	O
deficiency	O	NOUN	B
in	O	ADP	O
the	O	DET	O
newborn	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
appearance	O	NOUN	B
of	O	ADP	O
dyskinetic	O	ADJ	B
movement	O	NOUN	O
disorders	O	NOUN	O
in	O	ADP	O
humans	O	NOUN	B
following	O	VERB	O
the	O	DET	O
chronic	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
levodopa	O	NOUN	B
or	O	CCONJ	O
amphetamine	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
a	O	DET	O
manifestation	O	NOUN	B
of	O	ADP	O
similarly	O	ADV	O
increased	O	VERB	B
dopamine	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
site	I-GENE	NOUN	O
sensitivity	O	NOUN	B
within	O	ADP	O
the	O	DET	O
striatum	O	NOUN	B
.	O	PUNCT	O


Three	O	NUM	O
groups	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
who	O	PRON	O
had	O	AUX	O
undergone	O	VERB	O
subtotal	O	ADJ	B
thyroidectomy	O	NOUN	I
for	O	ADP	O
Graves	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
disease	O	NOUN	I
,	O	PUNCT	O
toxic	O	ADJ	B
multinodular	O	ADJ	B
goitre	O	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
euthyroid	O	ADJ	B
multinodular	O	ADJ	B
goitre	O	NOUN	I
12	O	NUM	O
to	O	PART	O
15	O	NUM	O
years	O	NOUN	B
before	O	ADP	O
and	O	CCONJ	O
in	O	ADP	O
whom	O	PRON	O
a	O	DET	O
normal	O	ADJ	O
serum	O	NOUN	O
thyroxine	O	NOUN	O
(	O	PUNCT	O
T	O	NOUN	B
-	O	PUNCT	O
4	O	NUM	O
)	O	PUNCT	O
level	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
were	O	AUX	O
each	O	DET	O
divided	O	VERB	O
into	O	ADP	O
two	O	NUM	O
subgroups	O	NOUN	B
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
a	O	DET	O
normal	O	ADJ	B
or	O	CCONJ	O
a	O	DET	O
raised	O	VERB	O
serum	O	NOUN	B
thyrotrophin	B-GENE	NOUN	O
concentration	O	NOUN	B
.	O	PUNCT	O


Generally	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
correlation	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
between	O	ADP	O
highest	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
CSF	B-GENE	NOUN	B
immunoglobulins	I-GENE	NOUN	B
and	O	CCONJ	O
degree	O	NOUN	B
of	O	ADP	O
meningeal	O	ADJ	B
inflammatory	O	ADJ	O
response	O	NOUN	O
,	O	PUNCT	O
even	O	ADV	O
if	O	SCONJ	O
this	O	DET	O
was	O	AUX	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
neurological	O	ADJ	B
diseases	O	NOUN	I
.	O	PUNCT	O


3	O	NUM	O
activities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
factor	B-GENE	NOUN	B
II	I-GENE	NUM	I
molecule	O	NOUN	I
in	O	ADP	O
the	O	DET	O
newborn	O	ADJ	B
infant	O	NOUN	I
at	O	ADP	O
term	O	NOUN	O


One	O	NUM	O
site	O	NOUN	B
,	O	PUNCT	O
PAL	B-GENE	NOUN	B
,	O	PUNCT	O
occurs	O	VERB	O
within	O	ADP	O
the	O	DET	O
10	O	NUM	O
bp	O	NOUN	O
sequence	O	NOUN	O
GGGGAGGAGG	O	NOUN	O
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
if	O	SCONJ	O
the	O	DET	O
NF	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
H	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
promoter	I-GENE	NOUN	B
can	O	AUX	O
be	O	AUX	O
activated	O	VERB	B
in	O	ADP	O
a	O	DET	O
tissue	O	NOUN	B
specific	O	ADJ	B
manner	O	NOUN	O
during	O	ADP	O
development	O	NOUN	B
transgenic	O	ADJ	B
mice	O	NOUN	I
containing	O	VERB	O
the	O	DET	O
promoter	O	NOUN	B
region	O	NOUN	I
linked	O	VERB	O
to	O	PART	O
a	O	DET	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
galactosidase	I-GENE	NOUN	B
reporter	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
were	O	AUX	O
generated	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
apparent	O	ADJ	B
Kd	O	NOUN	O
of	O	ADP	O
the	O	DET	O
MetRS	B-GENE	PROPN	B
/	I-GENE	PUNCT	O
CAU	I-GENE	PROPN	B
operator	I-GENE	NOUN	B
complex	I-GENE	NOUN	I
is	O	AUX	O
one	O	NUM	O
order	O	NOUN	O
magnitude	O	NOUN	B
higher	O	ADJ	B
than	O	ADP	O
that	O	DET	O
of	O	ADP	O
the	O	DET	O
ThrRS	B-GENE	NOUN	B
/	I-GENE	SYM	O
CGU	I-GENE	NOUN	B
operator	I-GENE	NOUN	O
complex	I-GENE	NOUN	O
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
gene	I-GENE	NOUN	I
encoding	I-GENE	VERB	O
cytokeratin	I-GENE	NOUN	B
17	I-GENE	NUM	I
and	O	CCONJ	O
its	O	PRON	O
expression	O	NOUN	B
pattern	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
statistically	O	ADV	B
significant	O	ADJ	I
improvement	O	NOUN	B
due	O	ADJ	O
to	O	ADP	O
the	O	DET	O
administration	O	NOUN	B
of	O	ADP	O
Bromergon	O	PROPN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
symptoms	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
overreactiveness	O	NOUN	B
to	O	PART	O
normal	O	ADJ	O
prolactin	B-GENE	NOUN	B
levels	O	NOUN	I
,	O	PUNCT	O
i	O	X	O
.	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
abdominal	O	ADJ	B
tension	O	NOUN	I
,	O	PUNCT	O
edema	O	NOUN	B
,	O	PUNCT	O
weight	O	NOUN	B
gain	O	NOUN	I
and	O	CCONJ	O
breast	O	NOUN	B
tenderness	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
7	O	NUM	O
of	O	ADP	O
9	O	NUM	O
cases	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
enhancer	O	NOUN	B
is	O	AUX	O
fused	O	VERB	B
to	O	PART	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
bearing	I-GENE	VERB	O
sequences	I-GENE	NOUN	O
of	O	ADP	O
chromosome	O	NOUN	O
8	O	NUM	O
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
UCRBP	B-GENE	NOUN	B
binds	O	VERB	B
to	O	PART	O
various	O	ADJ	O
target	O	NOUN	B
motifs	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
distinct	O	ADJ	O
from	O	ADP	O
the	O	DET	O
UCR	O	NOUN	B
motif	O	NOUN	B
:	O	PUNCT	O
the	O	DET	O
adeno	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
associated	I-GENE	VERB	B
virus	I-GENE	NOUN	B
P5	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
and	O	CCONJ	O
elements	O	NOUN	B
in	O	ADP	O
the	O	DET	O
immunoglobulin	B-GENE	NOUN	B
light	I-GENE	ADJ	I
-	I-GENE	PUNCT	O
and	I-GENE	CCONJ	O
heavy	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
chain	I-GENE	NOUN	B
genes	O	NOUN	I
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
elements	O	NOUN	B
in	O	ADP	O
ribosomal	B-GENE	ADJ	B
protein	I-GENE	NOUN	I
genes	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
both	O	CCONJ	O
N	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
mutations	O	NOUN	B
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
transrepression	O	NOUN	B
by	O	ADP	O
FBR	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
and	O	CCONJ	O
that	O	SCONJ	O
multiple	O	ADJ	O
structural	O	ADJ	B
mutations	O	NOUN	I
accompanied	O	VERB	O
by	O	ADP	O
posttranslational	O	ADJ	B
protein	O	NOUN	I
modification	O	NOUN	O
alter	O	VERB	O
gene	O	NOUN	B
regulation	O	NOUN	I
by	O	ADP	O
FBR	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	O
receptor	O	NOUN	B
structure	O	NOUN	I
includes	O	VERB	O
a	O	DET	O
cysteine	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
extracellular	O	ADJ	O
domain	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
single	O	ADJ	O
hydrophobic	O	ADJ	B
transmembrane	O	ADJ	O
domain	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
predicted	O	VERB	O
cytoplasmic	B-GENE	ADJ	B
serine	I-GENE	NOUN	B
/	I-GENE	PUNCT	O
threonine	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
domain	I-GENE	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
entire	O	ADJ	O
16	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
mt	O	X	B
genome	O	NOUN	I
determined	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
MDP1	B-GENE	NOUN	B
mediates	O	VERB	O
cleavage	O	NOUN	B
of	O	ADP	O
chick	O	NOUN	B
mtDNA	O	NOUN	B
in	O	X	B
vitro	O	X	I
at	O	ADP	O
three	O	NUM	O
H	O	PROPN	B
-	O	PUNCT	O
and	O	CCONJ	O
two	O	NUM	O
L	O	PROPN	B
-	O	PUNCT	O
strand	O	NOUN	B
sequence	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
target	O	NOUN	B
sites	O	NOUN	O
located	O	ADJ	O
within	O	ADP	O
a	O	DET	O
90	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
A	O	NOUN	O
+	O	CCONJ	O
T	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
genomic	O	ADJ	B
tract	O	NOUN	I
,	O	PUNCT	O
theoretically	O	ADV	O
capable	O	ADJ	O
of	O	ADP	O
forming	O	VERB	O
stable	O	ADJ	B
secondary	O	ADJ	B
structures	O	NOUN	I
,	O	PUNCT	O
approximately	O	ADV	O
200	O	NUM	O
bases	O	NOUN	B
upstream	O	ADJ	O
from	O	ADP	O
the	O	DET	O
H	O	NOUN	B
-	O	PUNCT	O
strand	O	NOUN	B
origin	O	NOUN	B
(	O	PUNCT	O
OH	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
replication	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
rather	O	ADV	O
similar	O	ADJ	O
pattern	O	NOUN	B
of	O	ADP	O
results	O	NOUN	B
was	O	AUX	O
obtained	O	VERB	O
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
LMP2B	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
transcripts	O	NOUN	B
being	O	AUX	O
detectable	O	ADJ	B
only	O	ADV	O
in	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
tumors	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
then	O	ADV	O
at	O	ADP	O
apparently	O	ADV	O
low	O	ADJ	B
levels	O	NOUN	B
.	O	PUNCT	O


Myogenic	O	ADJ	B
differentiation	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
the	O	DET	O
adenovirus	O	NOUN	B
E1a	B-GENE	NOUN	I
protein	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
L6	O	NOUN	B
muscle	O	NOUN	I
cell	O	NOUN	I
line	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
DNA	O	NOUN	B
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
sulfate	B-GENE	NOUN	B
activation	I-GENE	NOUN	I
locus	I-GENE	NOUN	I
from	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
K	O	PROPN	I
-	O	PUNCT	O
12	O	NUM	O
has	O	AUX	O
been	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
internal	O	ADJ	B
short	O	ADJ	I
element	O	NOUN	I
located	O	ADJ	O
at	O	ADP	O
the	O	DET	O
very	O	ADV	O
5	O	NUM	O
'	O	PART	O
terminal	O	NOUN	B
of	O	ADP	O
L1	B-GENE	NOUN	O
sequence	I-GENE	NOUN	O
and	O	CCONJ	O
the	O	DET	O
nuclear	O	ADJ	B
factor	O	NOUN	I
binding	O	VERB	I
to	O	PART	O
the	O	DET	O
element	O	NOUN	B
play	O	VERB	O
a	O	DET	O
crucial	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
human	B-GENE	ADJ	B
L1	I-GENE	NOUN	O
.	O	PUNCT	O


Tumor	O	NOUN	B
cells	O	NOUN	I
were	O	AUX	O
focally	O	ADV	B
immunoreactive	O	ADJ	I
for	O	ADP	O
neuron	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
enolase	I-GENE	NOUN	B
,	O	PUNCT	O
insulin	B-GENE	NOUN	B
,	O	PUNCT	O
glucagon	B-GENE	NOUN	B
and	O	CCONJ	O
VIP	B-GENE	NOUN	B
.	O	PUNCT	O


To	O	PART	O
define	O	VERB	O
the	O	DET	O
number	O	NOUN	O
and	O	CCONJ	O
nature	O	NOUN	B
of	O	ADP	O
the	O	DET	O
E6	B-GENE	NOUN	B
and	O	CCONJ	O
E7	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
products	O	NOUN	I
expressed	O	VERB	B
in	O	ADP	O
BPV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
-	O	PUNCT	O
transformed	O	VERB	B
cells	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
performed	O	VERB	O
immunoprecipitation	O	NOUN	B
experiments	O	NOUN	B
with	O	ADP	O
antisera	O	NOUN	B
raised	O	VERB	O
to	O	PART	O
bacterially	O	ADV	B
expressed	O	VERB	B
BPV	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
E6	I-GENE	NOUN	B
and	O	CCONJ	O
E7	B-GENE	NOUN	B
fusion	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
third	O	ADJ	O
prominent	O	ADJ	O
component	O	NOUN	O
of	O	ADP	O
apparent	O	ADJ	B
molecular	O	ADJ	B
mass	O	NOUN	I
16	O	NUM	O
kDa	O	NOUN	O
displayed	O	VERB	O
several	O	ADJ	O
properties	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
ability	O	NOUN	O
to	O	PART	O
bind	O	VERB	B
45Ca2	O	NOUN	B
+	O	CCONJ	O
,	O	PUNCT	O
that	O	PRON	O
are	O	AUX	O
characteristic	O	ADJ	O
of	O	ADP	O
the	O	DET	O
regulatory	O	ADJ	B
(	O	PUNCT	O
B	O	NOUN	O
)	O	PUNCT	O
subunit	O	NOUN	O
of	O	ADP	O
mammalian	B-GENE	ADJ	B
calcineurin	I-GENE	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
an	O	DET	O
antiserum	O	NOUN	B
raised	O	VERB	B
against	O	ADP	O
bovine	B-GENE	ADJ	B
calcineurin	I-GENE	NOUN	O
.	O	PUNCT	O


As	O	ADP	O
was	O	AUX	O
observed	O	VERB	O
previously	O	ADV	O
for	O	ADP	O
MATa	B-GENE	X	B
cna1	B-GENE	NOUN	B
cna2	B-GENE	NOUN	B
double	O	ADJ	B
mutants	O	NOUN	I
,	O	PUNCT	O
MATa	B-GENE	AUX	B
cnb1	B-GENE	NOUN	B
mutants	I-GENE	NOUN	B
were	O	AUX	O
defective	O	ADJ	B
in	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
recover	O	VERB	O
from	O	ADP	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
factor	I-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
growth	O	NOUN	B
arrest	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
position	O	NOUN	B
-	O	PUNCT	O
independent	O	ADJ	B
activation	O	NOUN	B
domain	O	NOUN	I
which	O	DET	O
contained	O	VERB	O
conserved	O	VERB	B
regions	O	NOUN	I
II	O	NUM	I
and	O	CCONJ	O
III	O	NUM	B
was	O	AUX	O
identified	O	VERB	B
at	O	ADP	O
the	O	DET	O
carboxyl	O	NOUN	B
terminus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
beta	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
(	O	PUNCT	O
amino	O	NOUN	B
acids	O	NOUN	I
361	O	NUM	O
to	O	PART	O
458	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
beta	I-GENE	NOUN	B
amino	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
terminal	I-GENE	ADJ	B
sequences	I-GENE	NOUN	B
defined	O	VERB	O
by	O	ADP	O
conserved	O	VERB	B
region	O	NOUN	I
IV	O	NUM	I
also	O	ADV	O
contributed	O	VERB	O
to	O	PART	O
transactivation	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
region	O	NOUN	B
IV	O	NUM	I
activity	O	NOUN	B
required	O	VERB	O
the	O	DET	O
participation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
region	O	NOUN	B
II	O	NUM	I
-	O	PUNCT	O
III	O	NUM	B
domain	O	NOUN	I
.	O	PUNCT	O


Nocodazole	O	NOUN	B
arrest	O	NOUN	B
of	O	ADP	O
DU249	O	NOUN	B
cells	O	NOUN	I
was	O	AUX	O
exploited	O	VERB	O
for	O	ADP	O
the	O	DET	O
detection	O	NOUN	B
of	O	ADP	O
an	O	DET	O
M	O	NOUN	B
-	O	PUNCT	O
phase	O	NOUN	B
-	O	PUNCT	O
activated	O	VERB	B
MBP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
that	O	PRON	O
was	O	AUX	O
resolved	O	VERB	O
from	O	ADP	O
p41	B-GENE	NOUN	B
MAP	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
by	O	ADP	O
phenyl	O	NOUN	B
-	O	PUNCT	O
Superose	O	NOUN	B
chromatography	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
319	O	NUM	O
base	O	NOUN	B
pair	O	NOUN	I
region	O	NOUN	I
immediately	O	ADV	O
upstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
CAP	O	NOUN	B
site	O	NOUN	B
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
a	O	DET	O
proximal	O	ADJ	B
TATA	O	NOUN	O
box	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
sequences	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
GC	O	NOUN	B
boxes	O	NOUN	I
,	O	PUNCT	O
CACCC	O	NOUN	B
boxes	O	NOUN	I
,	O	PUNCT	O
CCAAT	O	NOUN	B
boxes	O	NOUN	I
,	O	PUNCT	O
activator	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
2	I-GENE	NUM	I
(	O	PUNCT	O
Ap	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
sites	O	NOUN	B
,	O	PUNCT	O
partial	O	ADJ	B
glucocorticoid	O	NOUN	B
response	O	NOUN	I
elements	O	NOUN	I
(	O	PUNCT	O
GREs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
partial	O	ADJ	B
cyclic	O	ADJ	B
AMP	O	NOUN	O
response	O	NOUN	O
elements	O	NOUN	O
(	O	PUNCT	O
CREs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Insertional	O	ADJ	B
inactivation	O	NOUN	B
of	O	ADP	O
sms	B-GENE	NOUN	B
led	O	VERB	O
to	O	PART	O
increased	O	VERB	B
sensitivity	O	NOUN	B
to	O	PART	O
the	O	DET	O
alkylating	O	NOUN	B
agent	O	NOUN	I
methylmethane	O	NOUN	B
sulfonate	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
to	O	PART	O
a	O	DET	O
requirement	O	NOUN	B
for	O	ADP	O
serine	O	NOUN	B
or	O	CCONJ	O
other	O	ADJ	O
metabolites	O	NOUN	B
.	O	PUNCT	O


NSCL	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
larger	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
these	O	DET	O
cell	O	NOUN	B
lines	O	NOUN	I
.	O	PUNCT	O


Truncation	O	NOUN	B
variants	O	NOUN	B
of	O	ADP	O
peptides	O	NOUN	B
isolated	O	VERB	B
from	O	ADP	O
MHC	B-GENE	NOUN	B
class	I-GENE	NOUN	I
II	I-GENE	NUM	I
molecules	I-GENE	NOUN	I
suggest	O	VERB	O
sequence	O	NOUN	B
motifs	O	NOUN	B
.	O	PUNCT	O


Intermediate	O	ADJ	B
levels	O	NOUN	O
of	O	ADP	O
gene	O	NOUN	B
activity	O	NOUN	I
were	O	AUX	O
observed	O	VERB	O
for	O	ADP	O
TnI	B-GENE	NOUN	B
enhancers	I-GENE	NOUN	B
containing	O	VERB	O
E	O	NOUN	B
-	O	PUNCT	O
boxes	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
MCK	B-GENE	NOUN	B
left	I-GENE	VERB	B
E	I-GENE	PROPN	I
-	I-GENE	PUNCT	O
box	I-GENE	NOUN	B
site	I-GENE	NOUN	I
or	O	CCONJ	O
from	O	ADP	O
the	O	DET	O
Ig	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
E2	I-GENE	NOUN	I
E	I-GENE	PROPN	I
-	I-GENE	PUNCT	O
box	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
CANNTG	O	NOUN	B
motifs	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
bind	O	VERB	B
MyoD	B-GENE	NOUN	B
and	O	CCONJ	O
myogenin	B-GENE	NOUN	B
fusion	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
and	O	CCONJ	O
to	O	PART	O
interact	O	VERB	B
with	O	ADP	O
proteins	O	NOUN	B
in	O	ADP	O
nuclear	O	ADJ	B
extracts	O	NOUN	I
from	O	ADP	O
cultured	O	VERB	B
myotubes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
the	O	DET	O
calcineurin	B-GENE	NOUN	B
A	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
was	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
comparison	O	NOUN	B
of	O	ADP	O
the	O	DET	O
genomic	O	ADJ	B
and	O	CCONJ	O
cDNA	O	NOUN	B
sequences	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
basal	O	ADJ	B
promoter	O	NOUN	O
elements	O	NOUN	O
of	O	ADP	O
murine	B-GENE	ADJ	B
cytochrome	I-GENE	NOUN	B
c	I-GENE	NOUN	I
oxidase	I-GENE	NOUN	I
subunit	I-GENE	NOUN	I
IV	I-GENE	NUM	I
gene	I-GENE	NOUN	O
consist	O	VERB	O
of	O	ADP	O
tandemly	O	ADJ	B
duplicated	O	ADJ	O
ets	B-GENE	NOUN	B
motifs	O	NOUN	I
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
GABP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
transcription	I-GENE	NOUN	B
factors	I-GENE	NOUN	I
.	O	PUNCT	O


Mapping	O	VERB	B
the	O	DET	O
cAMP	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
contact	I-GENE	NOUN	B
site	I-GENE	NOUN	I
on	O	ADP	O
the	O	DET	O
alpha	O	NOUN	B
subunit	O	NOUN	I
of	O	ADP	O
Escherichia	B-GENE	X	B
coli	I-GENE	X	I
RNA	I-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
major	O	ADJ	O
mechanism	O	NOUN	B
whereby	O	SCONJ	O
steroid	B-GENE	NOUN	B
hydroxylase	I-GENE	NOUN	I
gene	I-GENE	NOUN	B
transcription	O	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
in	O	ADP	O
the	O	DET	O
adrenal	O	ADJ	B
cortex	O	NOUN	I
requires	O	VERB	O
the	O	DET	O
pituitary	O	ADJ	B
peptide	O	NOUN	I
hormone	O	NOUN	I
,	O	PUNCT	O
ACTH	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
acts	O	VERB	O
via	O	ADP	O
cAMP	O	NOUN	B
.	O	PUNCT	O


Km	O	NOUN	B
and	O	CCONJ	O
Vmax	O	NOUN	B
for	O	ADP	O
two	O	NUM	O
substrates	O	NOUN	B
,	O	PUNCT	O
src	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
peptide	I-GENE	NOUN	B
and	O	CCONJ	O
poly	O	NOUN	B
(	O	PUNCT	I
Glu	O	NOUN	B
,	O	PUNCT	O
Tyr	O	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
4	O	NUM	O
:	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
were	O	AUX	O
2	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
mM	O	NOUN	O
and	O	CCONJ	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
mumol	O	NOUN	O
min	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
mg	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
26	O	NUM	O
mM	O	NOUN	O
and	O	CCONJ	O
1	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
mumol	O	NOUN	O
min	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
mg	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
characterized	O	VERB	B
a	O	DET	O
55	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
DNA	O	NOUN	B
surrounding	O	VERB	O
HRAS1	B-GENE	NOUN	B
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
regulon	O	NOUN	B
controlled	O	VERB	B
by	O	ADP	O
the	O	DET	O
leucine	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
responsive	I-GENE	ADJ	B
regulatory	I-GENE	ADJ	B
protein	I-GENE	NOUN	I
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
.	O	PUNCT	O


This	O	DET	O
mutation	O	NOUN	B
also	O	ADV	O
results	O	VERB	B
in	O	ADP	O
markedly	O	ADV	O
decreased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
CAD	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
in	O	ADP	O
the	O	DET	O
mutant	O	NOUN	B
.	O	PUNCT	O


Mutational	O	ADJ	B
studies	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
was	O	AUX	O
the	O	DET	O
homeodomain	B-GENE	NOUN	B
binding	I-GENE	NOUN	I
site	I-GENE	NOUN	I
II	I-GENE	NUM	I
sequence	I-GENE	NOUN	O
that	O	PRON	O
was	O	AUX	O
required	O	VERB	O
for	O	ADP	O
this	O	DET	O
regulation	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
retrospective	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
data	O	NOUN	B
from	O	ADP	O
35	O	NUM	O
cases	O	NOUN	B
with	O	ADP	O
malignant	O	ADJ	B
lymphoma	O	NOUN	I
from	O	ADP	O
a	O	DET	O
cohort	O	NOUN	B
of	O	ADP	O
2017	O	NUM	O
HIV	O	NOUN	B
-	O	PUNCT	O
infected	O	VERB	B
patients	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
stage	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
-	O	PUNCT	O
disease	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
CD4	B-GENE	NOUN	B
counts	O	VERB	I
at	O	ADP	O
the	O	DET	O
time	O	NOUN	B
of	O	ADP	O
diagnosis	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
antineoplastic	O	ADJ	B
agents	O	NOUN	I
or	O	CCONJ	O
radiotherapy	O	NOUN	B
were	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
outcome	O	NOUN	B
.	O	PUNCT	O


Interaction	O	NOUN	B
of	O	ADP	O
H	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2Eb	I-GENE	NOUN	B
with	O	ADP	O
an	O	DET	O
IAP	B-GENE	NOUN	B
retrotransposon	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
A20	O	NOUN	B
/	O	SYM	O
2J	O	NOUN	B
B	O	NOUN	I
cell	O	NOUN	I
lymphoma	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
subunit	O	NOUN	B
protein	O	NOUN	I
of	O	ADP	O
curli	B-GENE	NOUN	B
was	O	AUX	O
highly	O	ADV	O
homologous	O	ADJ	B
at	O	ADP	O
its	O	PRON	O
amino	O	NOUN	B
terminus	O	NOUN	I
to	O	PART	O
SEF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
17	I-GENE	NUM	O
,	O	PUNCT	O
the	O	DET	O
subunit	O	NOUN	B
protein	O	NOUN	I
of	O	ADP	I
thin	O	ADJ	I
,	O	PUNCT	O
aggregative	O	ADJ	B
fimbriae	O	NOUN	B
of	O	ADP	O
Salmonella	O	X	B
enteritidis	O	X	I
27655	O	NUM	I
strain	O	NOUN	B
3b	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
fibres	O	NOUN	B
form	O	VERB	O
a	O	DET	O
novel	O	ADJ	B
class	O	NOUN	O
of	O	ADP	O
surface	O	NOUN	B
organelles	O	NOUN	B
on	O	ADP	O
enterobacteria	O	NOUN	B
.	O	PUNCT	O


Substitution	O	NOUN	B
of	O	ADP	O
the	O	DET	O
DR1	B-GENE	NOUN	B
beta	I-GENE	NOUN	I
chain	I-GENE	NOUN	I
with	O	ADP	I
H	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2E	I-GENE	NOUN	B
beta	I-GENE	NOUN	B
k	I-GENE	NOUN	I
led	O	VERB	O
to	O	PART	O
a	O	DET	O
dramatic	O	ADJ	O
loss	O	NOUN	O
of	O	ADP	O
recognition	O	NOUN	O
;	O	PUNCT	O
alpha	O	NOUN	B
chain	O	NOUN	I
substitution	O	NOUN	I
had	O	AUX	O
a	O	DET	O
less	O	ADV	O
marked	O	ADJ	O
effect	O	NOUN	B
.	O	PUNCT	O


From	O	ADP	O
August	O	PROPN	O
1989	O	NUM	O
to	O	ADP	O
October	O	PROPN	O
1990	O	NUM	O
,	O	PUNCT	O
83	O	NUM	O
pregnant	O	ADJ	B
Chinese	O	ADJ	I
women	O	NOUN	B
were	O	AUX	O
the	O	DET	O
subjects	O	NOUN	B
for	O	ADP	O
measuring	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
plasma	O	NOUN	B
functional	O	ADJ	O
antithrombin	B-GENE	NOUN	O
III	I-GENE	NUM	O
(	O	PUNCT	O
AT	B-GENE	NOUN	O
III	I-GENE	NUM	O
)	O	PUNCT	O
activity	O	NOUN	B
.	O	PUNCT	O


Currents	O	NOUN	B
aspects	O	NOUN	O
of	O	ADP	O
H2	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
antagonists	O	NOUN	B
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
ulcers	O	NOUN	B


Differential	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
"	O	PUNCT	O
B	O	NOUN	O
"	O	PUNCT	O
subunit	O	NOUN	O
of	O	ADP	O
the	O	DET	O
vacuolar	B-GENE	NOUN	B
H	I-GENE	NOUN	I
(	I-GENE	PUNCT	I
+	I-GENE	CCONJ	O
)	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
ATPase	I-GENE	NOUN	B
in	O	ADP	O
bovine	O	ADJ	B
tissues	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
hGCSFR	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
chromosomally	O	ADV	B
localized	O	VERB	I
by	O	ADP	O
Southern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
its	O	PRON	O
segregation	O	NOUN	B
pattern	O	NOUN	B
in	O	ADP	O
a	O	DET	O
panel	O	NOUN	O
of	O	ADP	O
rodent	O	ADJ	B
-	O	PUNCT	O
human	O	ADJ	B
hybrid	O	NOUN	B
DNAs	O	NOUN	I
using	O	VERB	O
the	O	DET	O
radiolabeled	O	VERB	B
cDNA	O	NOUN	B
probe	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
exons	O	NOUN	B
,	O	PUNCT	O
further	O	ADV	O
identified	O	VERB	O
as	O	ADP	O
exons	O	NOUN	B
9	O	NUM	O
,	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
11	O	NUM	O
,	O	PUNCT	O
together	O	ADV	O
encode	O	VERB	B
the	O	DET	O
37	O	NUM	O
amino	O	NOUN	B
acid	O	NOUN	I
residues	O	NOUN	I
present	O	ADJ	O
in	O	ADP	O
alpha	B-GENE	NOUN	B
s1	I-GENE	ADJ	I
-	I-GENE	PUNCT	O
casein	I-GENE	NOUN	B
variant	I-GENE	NOUN	B
A	I-GENE	NOUN	I
but	O	CCONJ	O
missing	O	VERB	O
in	O	ADP	O
variant	O	ADJ	B
F	O	PROPN	I
.	O	PUNCT	O


Homodimers	O	NOUN	B
of	O	ADP	O
the	O	DET	O
three	O	NUM	O
proteins	O	NOUN	B
specifically	O	ADV	O
recognize	O	VERB	O
the	O	DET	O
G	O	NOUN	B
-	O	PUNCT	O
box	O	NOUN	B
motif	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
GBF1	B-GENE	NOUN	B
and	O	CCONJ	O
GBF3	B-GENE	NOUN	B
binding	O	NOUN	B
symmetrically	O	ADV	O
to	O	PART	O
this	O	DET	O
palindromic	O	ADJ	B
sequence	O	NOUN	I
.	O	PUNCT	O


Genetic	O	ADJ	B
and	O	CCONJ	O
biochemical	O	ADJ	B
evidence	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
v	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Crk	I-GENE	NOUN	B
can	O	AUX	O
induce	O	VERB	B
transformation	O	NOUN	B
of	O	ADP	O
chicken	O	NOUN	B
embryo	O	NOUN	B
fibroblasts	O	NOUN	B
by	O	ADP	O
influencing	O	VERB	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
cellular	O	ADJ	B
proteins	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
growth	O	NOUN	B
regulation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
beta	I-GENE	NOUN	B
and	O	CCONJ	O
C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
gamma	I-GENE	NOUN	B
readily	O	ADV	O
heterodimerize	O	VERB	B
with	O	ADP	O
each	O	DET	O
other	O	ADJ	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
with	O	ADP	O
C	B-GENE	NOUN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
alpha	I-GENE	NOUN	I
.	O	PUNCT	O


Between	O	ADP	O
acoR	B-GENE	NOUN	B
and	O	CCONJ	O
acoXABC	B-GENE	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
different	O	ADJ	O
types	O	NOUN	O
of	O	ADP	O
sequences	O	NOUN	B
with	O	ADP	O
dual	O	ADJ	B
rotational	O	ADJ	I
symmetry	O	NOUN	I
[	O	PUNCT	O
CAC	O	PROPN	B
-	O	PUNCT	O
(	O	PUNCT	O
N11	O	NOUN	O
to	O	PART	O
N18	O	NOUN	O
)	O	PUNCT	O
-	O	PUNCT	O
GTG	O	NOUN	B
and	O	CCONJ	O
TGT	O	PROPN	B
-	O	PUNCT	O
(	O	PUNCT	O
N10	O	NOUN	O
to	O	PART	O
N14	O	NOUN	O
)	O	PUNCT	O
-	O	PUNCT	O
ACA	O	NOUN	B
]	O	PUNCT	O
were	O	AUX	O
found	O	VERB	O
;	O	PUNCT	O
these	O	DET	O
sequences	O	NOUN	B
are	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
NtrC	B-GENE	NOUN	B
and	O	CCONJ	O
NifA	B-GENE	NOUN	B
upstream	I-GENE	ADJ	I
activator	I-GENE	NOUN	I
sequences	I-GENE	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
protein	O	NOUN	B
product	O	NOUN	I
of	O	ADP	O
the	O	DET	O
ref	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
gene	I-GENE	NOUN	B
stimulates	O	VERB	B
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
Fos	B-GENE	NOUN	B
-	O	PUNCT	O
Jun	B-GENE	NOUN	B
heterodimers	O	NOUN	I
,	O	PUNCT	O
Jun	B-GENE	NOUN	B
-	O	PUNCT	O
Jun	B-GENE	NOUN	B
homodimers	O	NOUN	I
and	O	CCONJ	O
Hela	O	NOUN	B
cell	O	NOUN	I
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
proteins	I-GENE	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
that	O	DET	O
of	O	ADP	O
several	O	ADJ	O
other	O	ADJ	O
transcription	O	NOUN	B
factors	O	NOUN	I
including	O	VERB	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
,	O	PUNCT	O
Myb	B-GENE	NOUN	B
and	O	CCONJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ATF	B-GENE	NOUN	B
/	O	SYM	O
CREB	B-GENE	NOUN	B
family	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
analyzed	O	VERB	B
an	O	DET	O
EBV	O	NOUN	B
B	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
clone	O	NOUN	I
,	O	PUNCT	O
E29	O	NOUN	B
.	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
an	O	DET	O
11	O	NUM	O
week	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
embryo	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
secreting	O	VERB	B
both	O	CCONJ	O
IgM	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
and	O	CCONJ	O
IgM	B-GENE	NOUN	B
lambda	I-GENE	NOUN	I
.	O	PUNCT	O


Through	O	ADP	O
Southern	O	NOUN	B
blot	O	NOUN	I
analyses	O	NOUN	I
of	O	ADP	O
DNA	O	NOUN	B
from	O	ADP	O
backcross	O	NOUN	B
and	O	CCONJ	O
cogenic	O	ADJ	B
mice	O	NOUN	I
,	O	PUNCT	O
recombinant	O	ADJ	B
inbred	O	ADJ	I
strains	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
somatic	O	ADJ	B
cell	O	NOUN	I
hybrids	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
genetic	O	ADJ	B
loci	O	NOUN	I
that	O	PRON	O
produce	O	VERB	O
the	O	DET	O
cyclin	B-GENE	NOUN	B
B1	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
sequences	I-GENE	NOUN	B
(	O	PUNCT	O
designated	O	VERB	O
loci	B-GENE	NOUN	B
Cycb1	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
rs1	I-GENE	PROPN	B
to	O	PART	O
Cycb1	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
rs9	I-GENE	NUM	B
)	O	PUNCT	O
were	O	AUX	O
mapped	O	VERB	B
on	O	ADP	O
mouse	O	NOUN	B
chromosomes	O	NOUN	I
5	O	NUM	I
,	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
17	O	NUM	O
,	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
14	O	NUM	O
,	O	PUNCT	O
13	O	NUM	O
,	O	PUNCT	O
7	O	NUM	O
,	O	PUNCT	O
X	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
8	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
neurohypophysial	O	ADJ	B
vasopressin	B-GENE	NOUN	I
and	O	CCONJ	O
oxytocin	B-GENE	NOUN	B
content	O	NOUN	B
was	O	AUX	O
bioassayed	O	VERB	B
by	O	ADP	O
pressor	O	ADJ	B
effect	O	NOUN	O
following	O	VERB	O
Dekanski	O	PROPN	B
or	O	CCONJ	O
milk	O	NOUN	B
-	O	PUNCT	O
ejection	O	NOUN	B
activity	O	NOUN	I
in	O	X	B
vitro	O	X	I
following	O	VERB	O
van	O	NOUN	B
Dongen	O	PROPN	I
and	O	CCONJ	I
Hays	O	PROPN	I
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Urease	B-GENE	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
judged	O	VERB	O
as	O	ADP	O
the	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
ammonia	O	NOUN	B
production	O	NOUN	I
from	O	ADP	O
urea	O	NOUN	B
,	O	PUNCT	O
could	O	AUX	O
be	O	AUX	O
measured	O	VERB	B
at	O	ADP	O
25	O	NUM	O
ng	O	NOUN	O
per	O	ADP	B
tube	O	NOUN	I
(	O	PUNCT	O
S	O	PROPN	B
/	O	SYM	O
N	O	NOUN	B
=	O	ADJ	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
)	O	PUNCT	O
with	O	ADP	O
Jack	B-GENE	PROPN	B
bean	I-GENE	NOUN	I
meal	I-GENE	NOUN	B
urease	I-GENE	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
experiments	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
SCL	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
can	O	AUX	O
be	O	AUX	O
a	O	DET	O
target	O	NOUN	B
for	O	ADP	O
the	O	DET	O
erythroid	B-GENE	ADJ	B
transcription	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
GATA	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
SCL	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	O
serves	O	VERB	O
as	O	ADP	O
a	O	DET	O
positive	O	ADJ	B
regulator	O	NOUN	B
of	O	ADP	O
erythroid	O	ADJ	B
differentiation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
lead	O	VERB	O
us	O	PRON	O
to	O	PART	O
hypothesize	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
single	O	ADJ	O
multisubunit	B-GENE	ADJ	B
TFIID	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
supports	O	VERB	O
transcriptional	O	ADJ	B
stimulation	O	NOUN	I
by	O	ADP	O
diverse	O	ADJ	O
activation	O	NOUN	B
domains	O	NOUN	I
and	O	CCONJ	O
from	O	ADP	O
a	O	DET	O
TATA	O	NOUN	B
-	O	PUNCT	O
less	O	ADJ	B
promoter	O	NOUN	B
.	O	PUNCT	O


Cleavage	O	NOUN	B
by	O	ADP	O
the	O	DET	O
intron	O	NOUN	B
-	O	PUNCT	O
encoded	O	VERB	B
enzyme	O	NOUN	B
(	O	PUNCT	O
I	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CreI	I-GENE	NOUN	B
)	O	PUNCT	O
occurs	O	VERB	O
5	O	NUM	O
bp	O	NOUN	O
and	O	CCONJ	O
1	O	NUM	O
bp	O	NOUN	O
3	O	NUM	O
'	O	PUNCT	O
to	O	PART	O
the	O	DET	O
intron	O	NOUN	B
insertion	O	NOUN	O
site	O	NOUN	O
(	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
exon	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
top	O	NOUN	B
(	O	PUNCT	B
/	O	SYM	O
)	O	PUNCT	B
and	O	CCONJ	O
bottom	O	NOUN	B
(	O	PUNCT	O
,	O	PUNCT	O
)	O	PUNCT	O
strands	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
4	O	NUM	O
-	O	PUNCT	O
nt	O	NOUN	B
single	O	ADJ	B
-	O	PUNCT	O
stranded	O	VERB	B
overhangs	O	NOUN	B
with	O	ADP	O
3	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
OH	O	NOUN	B
termini	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
support	O	VERB	O
earlier	O	ADV	O
reports	O	VERB	B
that	O	SCONJ	O
collagenase	B-GENE	NOUN	B
inhibitors	O	NOUN	I
are	O	AUX	O
useful	O	ADJ	O
in	O	ADP	O
controlling	O	VERB	B
blister	O	NOUN	B
formation	O	NOUN	B
in	O	ADP	O
recessive	O	ADJ	B
dystrophic	O	ADJ	I
epidermolysis	O	NOUN	I
bullosa	O	NOUN	I
.	O	PUNCT	O


Western	O	NOUN	B
blot	O	NOUN	I
analyses	O	NOUN	I
detect	O	VERB	B
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
E	I-GENE	PROPN	B
-	O	PUNCT	O
specific	O	ADJ	B
immunoreactivity	O	NOUN	B
in	O	ADP	O
affinity	O	NOUN	B
-	O	PUNCT	O
purified	O	VERB	B
extracts	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
bacterial	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
truncated	B-GENE	VERB	B
AMPD3	I-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
.	O	PUNCT	O


Behind	O	VERB	B
the	O	DET	O
ATPase	B-GENE	NOUN	B
cluster	I-GENE	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
open	O	ADJ	O
reading	O	NOUN	O
frames	O	NOUN	O
were	O	AUX	O
detected	O	VERB	B
that	O	PRON	O
are	O	AUX	O
not	O	PART	O
homologous	O	ADJ	O
to	O	PART	O
any	O	DET	O
known	O	ADJ	O
chloroplast	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
either	O	CCONJ	O
a	O	DET	O
p50	B-GENE	NOUN	B
-	O	PUNCT	O
or	O	CCONJ	O
p65	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
selected	I-GENE	VERB	B
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
motif	I-GENE	NOUN	I
,	O	PUNCT	O
which	O	DET	O
displayed	O	VERB	O
differential	O	ADJ	O
binding	O	NOUN	O
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
the	O	DET	O
other	O	ADJ	O
protein	O	NOUN	B
,	O	PUNCT	O
little	O	ADJ	O
to	O	PART	O
no	O	DET	O
binding	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
with	O	ADP	O
the	O	DET	O
heterodimeric	B-GENE	ADJ	B
NF	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
complex	I-GENE	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
cosmid	O	NOUN	B
clone	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
entire	O	ADJ	O
mouse	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	I-GENE	PUNCT	O
I	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
gene	I-GENE	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
3	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
kb	O	NOUN	O
of	O	ADP	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
and	O	CCONJ	O
4	O	NUM	O
kb	O	NOUN	O
of	O	ADP	O
3	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
flanking	O	ADJ	B
DNA	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
expressed	O	VERB	B
at	O	ADP	O
reduced	O	VERB	B
levels	O	NOUN	B
in	O	ADP	O
fibroblasts	O	NOUN	B
overexpressing	O	VERB	B
oncogenic	B-GENE	ADJ	B
ras	I-GENE	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
screening	O	VERB	B
a	O	DET	O
Y1	O	NOUN	B
cell	O	NOUN	I
cDNA	O	NOUN	O
library	O	NOUN	O
with	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
H	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2RIIBP	I-GENE	NUM	B
nuclear	I-GENE	ADJ	B
hormone	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
cDNA	I-GENE	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
a	O	DET	O
cDNA	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
selectively	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
steroidogenic	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
using	O	VERB	O
lambda	O	NOUN	B
gt11	O	NOUN	I
expression	O	NOUN	B
cloning	O	VERB	I
with	O	ADP	O
oligonucleotides	O	NOUN	B
corresponding	O	VERB	O
to	O	PART	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
1	O	NUM	I
TATA	O	NOUN	B
element	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cellular	O	ADJ	B
protein	O	NOUN	I
with	O	ADP	O
a	O	DET	O
calculated	O	VERB	O
molecular	O	ADJ	B
mass	O	NOUN	I
of	O	ADP	O
123	O	NUM	O
kDa	O	NOUN	O
that	O	PRON	O
we	O	PRON	O
designate	O	VERB	O
TATA	B-GENE	NOUN	B
element	I-GENE	NOUN	O
modulatory	I-GENE	ADJ	B
factor	I-GENE	NOUN	I
(	O	PUNCT	O
TMF	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Blood	O	NOUN	B
levels	O	NOUN	I
of	O	ADP	O
melatonin	O	NOUN	B
,	O	PUNCT	O
serotonin	O	NOUN	B
,	O	PUNCT	O
cortisol	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
prolactin	B-GENE	NOUN	B
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
the	O	DET	O
circadian	O	ADJ	B
rhythm	O	NOUN	I
of	O	ADP	O
platelet	O	NOUN	B
serotonin	O	NOUN	I
uptake	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
TIMP	B-GENE	NOUN	B
(	O	PUNCT	O
-	O	PUNCT	O
59	O	NUM	B
/	O	SYM	O
-	O	PUNCT	O
53	O	NUM	O
)	O	PUNCT	O
AP1	B-GENE	NOUN	B
site	O	NOUN	O
is	O	AUX	O
a	O	DET	O
promiscuous	O	ADJ	B
motif	O	NOUN	B
that	O	PRON	O
binds	O	VERB	B
c	B-GENE	X	O
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
/	O	SYM	O
c	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
Jun	I-GENE	NOUN	B
AP1	B-GENE	NOUN	I
translated	O	VERB	B
in	O	X	B
vitro	O	X	I
and	O	CCONJ	O
is	O	AUX	O
an	O	DET	O
effective	O	ADJ	B
competitor	O	NOUN	B
for	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
nuclear	B-GENE	ADJ	B
AP1	I-GENE	NOUN	I
factors	I-GENE	NOUN	I
to	O	PART	O
the	O	DET	O
consensus	O	NOUN	B
TRE	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
in	O	ADP	O
addition	O	NOUN	O
it	O	PRON	O
binds	O	VERB	B
factors	O	NOUN	O
that	O	PRON	O
do	O	AUX	O
not	O	PART	O
associate	O	VERB	B
with	O	ADP	I
the	O	DET	O
consensus	O	NOUN	B
TRE	O	NOUN	I
.	O	PUNCT	O


Involvement	O	NOUN	B
of	O	ADP	O
AP1	B-GENE	NOUN	B
and	O	CCONJ	O
PEA3	B-GENE	NOUN	B
binding	I-GENE	NOUN	B
sites	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
murine	B-GENE	ADJ	B
tissue	I-GENE	NOUN	B
inhibitor	I-GENE	NOUN	I
of	I-GENE	ADP	O
metalloproteinases	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
(	O	PUNCT	O
TIMP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	O	PUNCT	O
transcription	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
controlled	O	ADJ	B
trial	O	NOUN	I
of	O	ADP	O
recombinant	B-GENE	ADJ	B
human	I-GENE	ADJ	O
granulocyte	I-GENE	NOUN	O
-	I-GENE	PUNCT	O
macrophage	I-GENE	NOUN	B
colony	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
stimulating	I-GENE	VERB	B
factor	I-GENE	NOUN	B
after	O	ADP	O
total	O	ADJ	B
body	O	NOUN	I
irradiation	O	NOUN	I
,	O	PUNCT	O
high	O	ADJ	B
-	O	PUNCT	O
dose	O	NOUN	B
chemotherapy	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
autologous	O	ADJ	B
bone	O	NOUN	I
marrow	O	NOUN	I
transplantation	O	NOUN	I
for	O	ADP	O
acute	O	ADJ	B
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
or	O	CCONJ	O
malignant	O	ADJ	B
lymphoma	O	NOUN	I
.	O	PUNCT	O


Examination	O	NOUN	B
of	O	ADP	O
ANCA	B-GENE	NOUN	B
is	O	AUX	O
not	O	PART	O
only	O	ADV	O
a	O	DET	O
significant	O	ADJ	O
contribution	O	NOUN	B
towards	O	ADP	O
a	O	DET	O
more	O	ADV	O
accurate	O	ADJ	B
diagnosis	O	NOUN	B
of	O	ADP	O
renal	O	ADJ	B
vasculitis	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
also	O	ADV	O
an	O	DET	O
indicator	O	NOUN	B
of	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
and	O	CCONJ	O
thus	O	ADV	O
of	O	ADP	O
the	O	DET	O
effectiveness	O	NOUN	B
of	O	ADP	O
immunosuppressive	O	ADJ	B
treatment	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
distinguishing	O	ADJ	O
features	O	NOUN	B
involved	O	VERB	O
eight	O	NUM	O
amino	O	NOUN	B
acid	O	NOUN	I
changes	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
a	O	DET	O
single	O	ADJ	O
lysine	O	NOUN	O
deletion	O	NOUN	O
relative	O	ADJ	O
to	O	PART	O
a	O	DET	O
primate	O	ADJ	B
consensus	O	NOUN	B
sequence	O	NOUN	I
in	O	ADP	O
the	O	DET	O
first	O	ADJ	O
complementary	O	ADJ	B
-	O	PUNCT	O
determing	O	VERB	B
region	O	NOUN	I
of	O	ADP	O
V1J1	B-GENE	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
these	O	DET	O
unique	O	ADJ	B
properties	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
newly	O	ADV	O
characterized	O	VERB	B
hemagglutinin	B-GENE	NOUN	B
has	O	AUX	O
been	O	AUX	O
termed	O	VERB	O
Limulus	B-GENE	ADJ	B
18K	I-GENE	NOUN	I
agglutination	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
aggregation	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
(	O	PUNCT	O
18K	B-GENE	NUM	B
-	I-GENE	PUNCT	O
LAF	I-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
shift	O	NOUN	B
to	O	PART	O
the	O	DET	O
nonpermissive	O	ADJ	B
temperature	O	NOUN	B
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
guanyl	O	NOUN	B
nucleotide	O	NOUN	I
-	O	PUNCT	O
dependent	O	ADJ	B
activity	O	NOUN	B
of	O	ADP	O
adenylylcyclase	B-GENE	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


It	O	PRON	O
corresponds	O	VERB	O
to	O	ADP	O
the	O	DET	O
complete	O	ADJ	O
mitochondrial	O	ADJ	B
presequence	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
lipoyl	O	NOUN	B
-	O	PUNCT	O
bearing	O	VERB	B
domain	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
encoded	O	VERB	B
by	O	ADP	O
exons	O	NOUN	B
I	O	NUM	I
through	O	ADP	O
IV	O	NUM	B
of	O	ADP	O
the	O	DET	O
functional	O	ADJ	B
E2	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


According	O	VERB	O
to	O	ADP	O
out	O	ADP	O
field	O	NOUN	B
research	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
tick	O	NOUN	B
fauna	O	NOUN	B
was	O	AUX	O
very	O	ADV	O
rich	O	ADJ	O
throughout	O	ADP	O
that	O	DET	O
area	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
it	O	PRON	O
was	O	AUX	O
permissible	O	ADJ	O
enough	O	ADV	O
to	O	PART	O
determine	O	VERB	O
ticks	O	NOUN	B
as	O	ADP	O
the	O	DET	O
vectors	O	NOUN	B
,	O	PUNCT	O
based	O	VERB	O
on	O	ADP	O
arising	O	VERB	O
of	O	ADP	O
anti	B-GENE	X	B
-	I-GENE	PUNCT	O
SF	I-GENE	NOUN	B
group	I-GENE	NOUN	B
rickettsiae	I-GENE	NOUN	I
(	O	PUNCT	O
SFGR	B-GENE	NOUN	B
)	O	PUNCT	O
antibody	O	NOUN	B
in	O	ADP	O
mice	O	NOUN	B
inoculated	O	VERB	B
with	O	ADP	O
some	O	DET	O
tick	O	NOUN	B
emulsions	O	NOUN	B
,	O	PUNCT	O
findings	O	NOUN	B
of	O	ADP	O
rickettsiae	O	NOUN	B
reactive	O	ADJ	B
to	O	PART	O
patient	O	NOUN	B
sera	O	NOUN	B
or	O	CCONJ	O
a	O	DET	O
species	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
monoclonal	O	ADJ	B
antibody	O	NOUN	I
to	O	PART	O
JSFR	B-GENE	PROPN	B
in	O	ADP	O
the	O	DET	O
hemolymph	O	NOUN	B
cells	O	NOUN	I
of	O	ADP	O
some	O	DET	O
ticks	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
electron	O	NOUN	B
microscopical	O	ADJ	I
observations	O	NOUN	I
of	O	ADP	O
SFGR	B-GENE	NOUN	B
in	O	ADP	O
various	O	ADJ	O
internal	O	ADJ	B
organs	O	NOUN	I
including	O	VERB	O
the	O	DET	O
salivary	O	ADJ	B
gland	O	NOUN	I
of	O	ADP	O
ticks	O	NOUN	B
.	O	PUNCT	O


Nucleotide	O	NOUN	B
sequence	O	NOUN	I
and	O	CCONJ	O
transcriptional	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
polyhedrin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
of	O	ADP	O
Spodoptera	O	NOUN	B
exigua	O	X	I
nuclear	O	ADJ	B
polyhedrosis	O	NOUN	I
virus	O	NOUN	I
.	O	PUNCT	O


Subcutaneous	O	ADJ	B
administration	O	NOUN	I
of	O	ADP	O
the	O	DET	O
somatostatin	B-GENE	NOUN	B
analogue	O	NOUN	B
,	O	PUNCT	O
octreotide	O	NOUN	B
,	O	PUNCT	O
100	O	NUM	O
micrograms	O	NOUN	O
thrice	O	ADV	O
daily	O	ADV	B
,	O	PUNCT	O
resulted	O	VERB	O
in	O	ADP	O
a	O	DET	O
sustained	O	ADJ	B
improvement	O	NOUN	B
in	O	ADP	O
diarrhoea	O	NOUN	B
and	O	CCONJ	O
disappearance	O	NOUN	B
of	O	ADP	O
faecal	O	ADJ	B
incontinence	O	NOUN	O
without	O	ADP	O
reducing	O	VERB	B
calcitonin	B-GENE	NOUN	B
levels	O	NOUN	B
.	O	PUNCT	O


No	O	DET	O
other	O	ADJ	O
changes	O	NOUN	B
in	O	ADP	O
hematopoietic	O	ADJ	B
differentiation	O	NOUN	I
status	O	NOUN	I
were	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	O
Id	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
SCL	I-GENE	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Purification	O	NOUN	B
and	O	CCONJ	O
cloning	O	NOUN	B
of	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
serine	B-GENE	NOUN	B
protease	I-GENE	NOUN	I
,	O	PUNCT	O
RNK	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Met	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
,	O	PUNCT	O
from	O	ADP	O
the	O	DET	O
granules	O	NOUN	B
of	O	ADP	O
a	O	DET	O
rat	O	NOUN	B
natural	O	ADJ	B
killer	O	NOUN	I
cell	O	NOUN	I
leukemia	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
here	O	ADV	O
17	O	NUM	O
dominant	B-GENE	ADJ	B
GCN2	I-GENE	NOUN	B
mutations	I-GENE	NOUN	B
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
derepression	O	NOUN	B
of	O	ADP	O
GCN4	B-GENE	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
amino	O	NOUN	B
acid	O	NOUN	I
starvation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
utility	O	NOUN	O
of	O	ADP	O
beta	B-GENE	NOUN	B
2	I-GENE	NUM	I
transferrin	I-GENE	NOUN	I
assay	O	NOUN	I
in	O	ADP	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
cerebrospinal	O	ADJ	B
fluid	O	ADJ	I
otorrhea	O	NOUN	O
is	O	AUX	O
presented	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
structural	O	ADJ	B
genes	O	NOUN	I
encoding	O	VERB	B
glyceraldehyde	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
(	O	PUNCT	O
GAPDH	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
3	B-GENE	NUM	O
-	I-GENE	PUNCT	O
phosphoglycerate	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
(	O	PUNCT	O
PGK	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
part	O	NOUN	O
of	O	ADP	O
triosephosphate	B-GENE	ADJ	B
isomerase	I-GENE	NOUN	I
(	O	PUNCT	O
TIM	B-GENE	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
mesophilic	O	ADJ	B
Bacillus	O	X	B
megaterium	O	X	I
DSM319	O	X	I
have	O	AUX	O
been	O	AUX	O
cloned	O	VERB	B
as	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
cluster	O	NOUN	I
(	O	PUNCT	O
gap	B-GENE	NOUN	B
operon	I-GENE	NOUN	I
)	O	PUNCT	O
by	O	ADP	O
complementation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
Escherichia	O	X	B
coli	O	X	I
gap	B-GENE	NOUN	B
amber	I-GENE	NOUN	B
mutant	I-GENE	NOUN	I
.	O	PUNCT	O


To	O	PART	O
study	O	VERB	B
the	O	DET	O
significance	O	NOUN	B
of	O	ADP	O
these	O	DET	O
domains	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
overall	O	ADJ	O
evolutionary	O	ADJ	B
conservation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
homolog	O	NOUN	B
from	O	ADP	O
Drosophila	O	X	B
melanogaster	O	NOUN	B
was	O	AUX	O
isolated	O	VERB	B
by	O	ADP	O
low	O	ADJ	O
stringency	O	NOUN	O
hybridizations	O	NOUN	O
using	O	VERB	O
two	O	NUM	O
flanking	O	ADJ	B
probes	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
ERCC3	I-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
tramtrack	B-GENE	NOUN	B
(	O	PUNCT	O
ttk	B-GENE	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	O
of	O	ADP	O
Drosophila	O	X	B
encodes	O	VERB	B
69	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
and	O	CCONJ	O
88	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
proteins	O	NOUN	I
through	O	ADP	O
alternative	O	ADJ	B
splicing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
primary	O	ADJ	B
ttk	B-GENE	NOUN	B
transcript	I-GENE	NOUN	I
.	O	PUNCT	O


Removal	O	NOUN	B
of	O	ADP	O
beta	B-GENE	NOUN	B
2	I-GENE	NUM	I
-	I-GENE	PUNCT	O
microglobulin	I-GENE	NOUN	B
by	O	ADP	O
hemodialysis	O	NOUN	B
and	O	CCONJ	O
hemofiltration	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
four	O	NUM	O
year	O	NOUN	B
follow	O	VERB	B
up	O	ADP	I
.	O	PUNCT	O


GAL4	B-GENE	NOUN	B
-	O	PUNCT	O
VP16	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
antirepression	O	NOUN	B
required	O	VERB	O
an	O	DET	O
auxiliary	O	ADJ	B
factor	O	NOUN	I
,	O	PUNCT	O
denoted	O	VERB	O
as	O	ADP	O
a	O	DET	O
co	O	X	B
-	O	PUNCT	O
antirepressor	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
partially	O	ADV	O
purified	O	VERB	B
from	O	ADP	O
Drosophila	O	X	B
embryos	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
ICSBP	B-GENE	NOUN	B
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
maintaining	O	VERB	O
submaximal	O	ADJ	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
IFN	B-GENE	NOUN	B
-	O	PUNCT	O
inducible	O	ADJ	B
genes	O	NOUN	B
in	O	ADP	O
hematopoietic	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
a	O	DET	O
possible	O	ADJ	O
involvement	O	NOUN	B
of	O	ADP	O
endogenous	O	ADJ	B
opioid	O	NOUN	B
peptides	O	NOUN	I
in	O	ADP	O
the	O	DET	O
cardiac	O	ADJ	B
effects	O	NOUN	I
due	O	ADJ	O
to	O	PART	O
myocardial	O	ADJ	B
ischaemia	O	NOUN	I
and	O	CCONJ	O
reperfusion	O	NOUN	B
,	O	PUNCT	O
mediated	O	VERB	O
by	O	ADP	O
opiate	B-GENE	ADJ	B
receptors	I-GENE	NOUN	I
through	O	ADP	O
opiate	O	ADJ	B
antagonism	O	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
CENP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
B	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
is	O	AUX	O
conserved	O	VERB	O
in	O	ADP	O
mammalian	O	ADJ	B
species	O	NOUN	B
and	O	CCONJ	O
CENP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
B	I-GENE	NOUN	B
boxes	I-GENE	NOUN	I
are	O	AUX	O
found	O	VERB	O
also	O	ADV	O
in	O	ADP	O
mouse	O	NOUN	B
centromere	O	NOUN	I
satellite	O	NOUN	I
DNA	O	NOUN	I
(	O	PUNCT	O
minor	O	ADJ	B
satellite	O	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
this	O	DET	O
sequence	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
DNA	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interaction	O	NOUN	B
may	O	AUX	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
some	O	DET	O
kind	O	NOUN	O
of	O	ADP	O
common	O	ADJ	O
centromere	O	NOUN	B
function	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
subgroup	O	NOUN	B
with	O	ADP	O
normal	O	ADJ	O
Ht	O	NOUN	O
(	O	PUNCT	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
45	O	NUM	O
l	O	X	O
/	O	SYM	O
l	O	NOUN	O
;	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
201	O	NUM	O
)	O	PUNCT	O
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
significant	O	ADJ	O
reduction	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
mortality	O	NOUN	B
after	O	ADP	O
3	O	NUM	O
months	O	NOUN	B
(	O	PUNCT	O
27	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
16	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
independence	O	NOUN	B
at	O	ADP	O
home	O	NOUN	B
(	O	PUNCT	O
35	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
48	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
due	O	ADP	O
to	O	PART	O
a	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
viscosity	O	NOUN	B
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
haemodilution	O	NOUN	B
with	O	ADP	O
albumin	B-GENE	NOUN	B
(	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
viscosity	O	NOUN	B
effect	O	NOUN	O
in	O	ADP	O
the	O	DET	O
normovolaemic	O	ADJ	B
group	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Assay	O	NOUN	B
of	O	ADP	O
urea	O	NOUN	B
by	O	ADP	O
immobilized	O	VERB	B
urease	B-GENE	NOUN	B
coupled	O	VERB	B
to	O	PART	O
a	O	DET	O
differential	O	ADJ	B
pH	O	NOUN	B
-	O	PUNCT	O
meter	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
the	O	DET	O
estrogen	O	NOUN	B
action	O	NOUN	I
that	O	PRON	O
govern	O	VERB	O
the	O	DET	O
lactoferrin	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
expression	O	NOUN	I
differ	O	VERB	O
between	O	ADP	O
mouse	O	NOUN	B
and	O	CCONJ	O
human	O	ADJ	B
.	O	PUNCT	O


Four	O	NUM	O
short	O	ADJ	B
nucleotide	O	NOUN	I
sequences	O	NOUN	I
(	O	PUNCT	O
boxes	O	NOUN	B
I	O	NUM	I
to	O	PART	I
IV	O	NUM	I
)	O	PUNCT	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
light	O	ADJ	O
responsiveness	O	NOUN	B
of	O	ADP	O
the	O	DET	O
parsley	B-GENE	NOUN	B
chalcone	I-GENE	NOUN	I
synthase	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
.	O	PUNCT	O


Exposure	O	NOUN	B
to	O	PART	I
hepatitis	O	NOUN	B
B	O	NOUN	I
virus	O	NOUN	I
in	O	ADP	O
the	O	DET	O
general	O	ADJ	B
population	O	NOUN	I
of	O	ADP	O
Hisayama	O	PROPN	B
,	O	PUNCT	O
Japan	O	PROPN	B
:	O	PUNCT	O
significance	O	NOUN	B
of	O	ADP	O
isolated	O	VERB	B
antibody	O	NOUN	O
to	O	PART	O
hepatitis	B-GENE	NOUN	B
B	I-GENE	NOUN	I
surface	I-GENE	NOUN	I
antigen	I-GENE	NOUN	I
in	O	ADP	O
general	O	ADJ	B
population	O	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
neither	O	CCONJ	O
phosphate	O	NOUN	B
buffered	O	NOUN	O
saline	O	NOUN	B
injection	O	NOUN	I
into	O	ADP	O
the	O	DET	O
ES	O	NOUN	B
nor	O	CCONJ	O
primary	O	ADJ	O
KLH	B-GENE	NOUN	B
challenges	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ES	O	NOUN	B
were	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
elevating	O	VERB	B
the	O	DET	O
threshold	O	NOUN	B
level	O	NOUN	B
and	O	CCONJ	O
changing	O	VERB	B
the	O	DET	O
latency	O	NOUN	B
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
showed	O	VERB	O
that	O	SCONJ	O
SNF2	B-GENE	NOUN	B
,	O	PUNCT	O
SNF5	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
SNF6	B-GENE	NOUN	B
function	O	NOUN	B
interdependently	O	ADV	B
in	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
,	O	PUNCT	O
possibly	O	ADV	O
forming	O	VERB	O
a	O	DET	O
heteromeric	O	ADJ	B
complex	O	NOUN	I
.	O	PUNCT	O


NE	B-GENE	NOUN	B
and	O	CCONJ	O
PR3	B-GENE	NOUN	B
assist	O	NOUN	B
in	O	ADP	O
the	O	DET	O
destruction	O	NOUN	B
of	O	ADP	O
phagocytosed	O	VERB	B
microorganisms	O	NOUN	B
,	O	PUNCT	O
cleave	O	VERB	B
the	O	DET	O
important	O	ADJ	O
connective	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
tissue	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
elastin	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
generate	O	VERB	O
chemotactic	O	ADJ	B
activities	O	NOUN	I
by	O	ADP	O
forming	O	VERB	O
alpha	B-GENE	NOUN	O
1	I-GENE	NUM	O
-	I-GENE	PUNCT	O
proteinase	I-GENE	NOUN	B
inhibitor	I-GENE	NOUN	I
complexes	I-GENE	NOUN	B
and	O	CCONJ	O
elastin	B-GENE	NOUN	B
peptides	I-GENE	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
d	B-GENE	NOUN	O
(	I-GENE	PUNCT	O
T2AG3T	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
and	O	CCONJ	O
d	B-GENE	NOUN	O
(	I-GENE	PUNCT	O
T2G4T	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
form	O	VERB	O
only	O	ADV	O
the	O	DET	O
G	O	NOUN	B
-	O	PUNCT	O
quadruplex	O	ADJ	B
monomer	O	NOUN	B
structures	O	NOUN	I
independent	O	ADJ	B
of	O	ADP	O
K	O	NOUN	B
cation	O	NOUN	I
concentration	O	NOUN	B
as	O	ADP	O
reported	O	VERB	O
previously	O	ADV	O
[	O	PUNCT	O
Sen	O	PROPN	B
,	O	PUNCT	O
D	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
&	O	CCONJ	O
Gilbert	O	PROPN	B
,	O	PUNCT	O
W	O	PROPN	O
.	O	PUNCT	O


Exon	O	NOUN	B
-	O	PUNCT	O
intron	O	NOUN	B
junctions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
and	O	CCONJ	O
rat	B-GENE	NOUN	B
AdoMet	I-GENE	NOUN	O
decarboxylase	I-GENE	NOUN	O
genes	I-GENE	NOUN	O
were	O	AUX	O
in	O	ADP	O
identical	O	ADJ	B
positions	O	NOUN	B
except	O	SCONJ	O
that	O	DET	O
exons	O	NOUN	B
6	O	NUM	O
and	O	CCONJ	O
7	O	NUM	O
of	O	ADP	O
the	O	DET	O
human	O	ADJ	B
gene	O	NOUN	I
formed	O	VERB	O
a	O	DET	O
single	O	ADJ	O
exon	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
gene	O	NOUN	B
.	O	PUNCT	O


Among	O	ADP	O
the	O	DET	O
few	O	ADJ	O
proteins	O	NOUN	B
of	O	ADP	O
the	O	DET	O
eukaryotic	O	ADJ	B
nucleolus	O	NOUN	I
that	O	PRON	O
have	O	AUX	O
been	O	AUX	O
characterized	O	VERB	B
,	O	PUNCT	O
four	O	NUM	O
proteins	O	NOUN	B
,	O	PUNCT	O
nucleolin	B-GENE	NOUN	B
,	O	PUNCT	O
fibrillarin	B-GENE	NOUN	B
,	O	PUNCT	O
SSB1	B-GENE	NOUN	B
and	O	CCONJ	O
NSR1	B-GENE	NOUN	B
,	O	PUNCT	O
possess	O	VERB	O
a	O	DET	O
common	O	ADJ	O
structural	O	ADJ	B
motif	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
GAR	O	NOUN	B
domain	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
rich	O	ADJ	O
in	O	ADP	O
glycine	O	NOUN	B
and	O	CCONJ	O
arginine	O	NOUN	B
residues	O	NOUN	O
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
either	O	DET	O
gene	O	NOUN	B
block	O	VERB	I
some	O	DET	O
crucial	O	ADJ	O
late	O	ADJ	O
step	O	NOUN	O
in	O	ADP	O
assembly	O	NOUN	B
of	O	ADP	O
F1	B-GENE	PROPN	B
,	O	PUNCT	O
causing	O	VERB	O
the	O	DET	O
alpha	O	NOUN	B
and	O	CCONJ	O
beta	O	NOUN	B
subunits	O	NOUN	I
to	O	PART	O
accumulate	O	VERB	B
in	O	ADP	O
mitochondria	O	NOUN	B
as	O	ADP	O
inactive	O	ADJ	B
aggregates	O	NOUN	B
(	O	PUNCT	O
Ackerman	O	PROPN	B
,	O	PUNCT	O
S	O	PROPN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
however	O	ADV	O
,	O	PUNCT	O
no	O	DET	B
significant	O	ADJ	I
difference	O	NOUN	O
in	O	ADP	O
the	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
chronic	O	ADJ	B
respiratory	O	ADJ	I
symptoms	O	NOUN	I
between	O	ADP	O
animal	O	ADJ	B
food	O	NOUN	B
workers	O	NOUN	I
with	O	ADP	O
positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
skin	O	NOUN	O
tests	O	NOUN	O
to	O	PART	O
house	O	NOUN	B
dust	O	NOUN	I
or	O	CCONJ	O
to	O	PART	O
fish	O	VERB	B
flour	O	NOUN	I
or	O	CCONJ	O
among	O	ADP	O
those	O	DET	O
with	O	ADP	O
increased	O	VERB	B
or	O	CCONJ	O
normal	O	ADJ	B
IgE	B-GENE	NOUN	I
(	O	PUNCT	O
except	O	SCONJ	O
for	O	ADP	O
dyspnea	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
13	O	NUM	O
base	O	NOUN	B
-	O	PUNCT	O
pair	O	NOUN	B
oligonucleotide	O	NOUN	B
spanning	O	NOUN	O
nucleotides	O	NOUN	B
+	O	CCONJ	O
80	O	NUM	O
to	O	PART	O
+	O	CCONJ	O
92	O	NUM	O
of	O	ADP	O
the	O	DET	O
5	B-GENE	NUM	O
S	I-GENE	NOUN	O
RNA	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
retained	O	VERB	O
specific	O	ADJ	B
and	O	CCONJ	O
high	O	ADJ	B
-	O	PUNCT	O
affinity	O	NOUN	B
binding	O	NOUN	O
,	O	PUNCT	O
although	O	SCONJ	O
the	O	DET	O
latter	O	ADJ	O
was	O	AUX	O
reduced	O	VERB	B
sixfold	O	ADV	B
relative	O	ADJ	O
to	O	PART	O
longer	O	ADJ	O
DNA	O	NOUN	B
fragments	O	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
reconstitution	O	NOUN	B
of	O	ADP	O
eUSF	B-GENE	NOUN	B
and	O	CCONJ	O
TFIID	B-GENE	NOUN	B
-	O	PUNCT	O
depleted	O	VERB	B
transcription	O	NOUN	B
complexes	O	NOUN	I
with	O	ADP	O
purified	O	VERB	B
protein	O	NOUN	I
fractions	O	NOUN	O
demonstrate	O	VERB	O
that	O	SCONJ	O
not	O	PART	O
only	O	ADV	O
TFIID	B-GENE	NOUN	B
but	O	CCONJ	O
also	O	ADV	O
eUSF	B-GENE	NOUN	B
essentially	O	ADV	O
participates	O	VERB	B
in	O	ADP	O
complex	O	NOUN	B
formation	O	NOUN	B
even	O	ADV	O
on	O	ADP	O
H5	B-GENE	NOUN	B
promoter	I-GENE	NOUN	I
mutations	O	NOUN	I
lacking	O	VERB	O
the	O	DET	O
TATA	O	NOUN	B
-	O	PUNCT	O
box	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
IFN	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
gamma	I-GENE	NOUN	B
was	O	AUX	O
previously	O	ADV	O
found	O	VERB	O
to	O	PART	O
contain	O	VERB	O
an	O	DET	O
intronic	O	ADJ	B
enhancer	O	NOUN	I
element	O	NOUN	I
that	O	PRON	O
was	O	AUX	O
not	O	PART	O
tissue	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
in	O	ADP	O
its	O	PRON	O
activity	O	NOUN	B
,	O	PUNCT	O
despite	O	SCONJ	O
the	O	DET	O
restricted	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intact	O	ADJ	B
IFN	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
gamma	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
encoding	I-GENE	VERB	B
gene	I-GENE	NOUN	B
.	O	PUNCT	O


Molecular	O	ADJ	B
cloning	O	NOUN	I
of	O	ADP	O
the	O	DET	O
polypeptide	O	NOUN	B
component	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Rel	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	ADJ	B
human	I-GENE	ADJ	B
p75	I-GENE	NOUN	O
nucleoprotein	I-GENE	NOUN	O
complex	I-GENE	NOUN	O
has	O	AUX	O
revealed	O	VERB	O
its	O	PRON	O
identity	O	NOUN	B
with	O	ADP	O
the	O	DET	O
65	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
(	O	PUNCT	O
p65	B-GENE	NOUN	B
)	O	PUNCT	O
subunit	O	NOUN	B
of	O	ADP	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
.	O	PUNCT	O


Within	O	ADP	O
the	O	DET	O
human	O	ADJ	B
enhancer	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
two	O	NUM	O
sites	O	NOUN	B
are	O	AUX	O
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
previously	O	ADV	O
defined	O	VERB	O
DNase	B-GENE	NOUN	B
I	I-GENE	NUM	I
footprints	I-GENE	NOUN	B
,	O	PUNCT	O
NFAT	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
NFIL	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2B	I-GENE	PROPN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
cardiac	B-GENE	ADJ	B
myosin	I-GENE	NOUN	I
light	I-GENE	ADJ	I
chain	I-GENE	NOUN	I
-	I-GENE	SYM	O
2	I-GENE	NUM	O
(	O	PUNCT	O
MLC	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
gene	O	NOUN	B
promoter	O	NOUN	I
contains	O	VERB	O
several	O	ADJ	O
positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
cis	O	ADV	O
-	O	PUNCT	O
acting	O	VERB	B
sequences	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
expression	O	NOUN	B
.	O	PUNCT	O


Disruption	O	NOUN	B
mutations	O	NOUN	O
have	O	AUX	O
been	O	AUX	O
constructed	O	VERB	O
in	O	ADP	O
the	O	DET	O
SLK1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O
slk1	B-GENE	NOUN	B
null	I-GENE	ADJ	B
mutants	I-GENE	NOUN	I
cannot	O	VERB	B
grow	O	VERB	I
at	O	ADP	O
37	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
many	O	ADJ	O
cells	O	NOUN	B
can	O	AUX	O
grow	O	VERB	B
at	O	ADP	O
30	O	NUM	O
,	O	PUNCT	O
24	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
17	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
32P	O	NOUN	B
-	O	PUNCT	O
labeled	O	VERB	B
LAP	B-GENE	NOUN	B
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
and	O	CCONJ	O
dimerization	O	NOUN	B
domain	O	NOUN	I
"	O	PUNCT	O
zipper	O	NOUN	B
probe	O	NOUN	I
"	O	PUNCT	O
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
isolate	O	VERB	B
a	O	DET	O
clone	O	NOUN	B
that	O	PRON	O
encodes	O	VERB	B
a	O	DET	O
new	O	ADJ	O
C	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
EBP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
homologous	I-GENE	ADJ	B
protein	I-GENE	NOUN	I
:	O	PUNCT	O
CHOP	B-GENE	NOUN	B
-	I-GENE	SYM	O
10	I-GENE	NUM	O
.	O	PUNCT	O


Stringent	O	ADJ	B
hybridization	O	NOUN	I
of	O	ADP	O
EHS	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
back	O	NOUN	O
to	O	PART	O
primate	O	ADJ	B
genomic	O	ADJ	B
DNA	O	NOUN	I
indicates	O	VERB	O
two	O	NUM	O
distinct	O	ADJ	O
EHS	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
loci	I-GENE	NOUN	B
in	O	ADP	O
normal	O	ADJ	O
human	O	ADJ	B
DNA	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
identical	O	ADJ	B
band	O	NOUN	B
pattern	O	NOUN	I
in	O	ADP	O
chimpanzee	O	NOUN	B
DNA	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
single	O	ADJ	O
locus	O	NOUN	O
in	O	ADP	O
rhesus	O	NOUN	B
monkey	O	NOUN	I
DNA	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
functions	O	NOUN	B
of	O	ADP	O
isolated	O	VERB	B
portions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
insulin	B-GENE	NOUN	B
,	O	PUNCT	O
IAPP	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
beta	B-GENE	NOUN	B
GK	I-GENE	NOUN	I
promoters	I-GENE	NOUN	I
were	O	AUX	O
studied	O	VERB	O
by	O	ADP	O
using	O	VERB	O
transient	O	ADJ	B
expression	O	NOUN	B
and	O	CCONJ	O
DNA	O	NOUN	B
binding	O	NOUN	I
assays	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
c	B-GENE	X	B
-	I-GENE	PUNCT	O
Ets	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
oncoprotein	I-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
transcription	O	NOUN	B
activator	O	NOUN	I
that	O	PRON	O
specifically	O	ADV	O
binds	O	VERB	B
to	O	PART	O
DNA	O	NOUN	B
.	O	PUNCT	O


Hence	O	ADV	O
temperature	O	NOUN	B
and	O	CCONJ	O
virF	B-GENE	NOUN	B
are	O	AUX	O
both	O	DET	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
yop	B-GENE	NOUN	B
regulon	I-GENE	NOUN	I
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
the	O	DET	O
genetic	O	ADJ	B
basis	O	NOUN	O
for	O	ADP	O
the	O	DET	O
differences	O	NOUN	B
between	O	ADP	O
the	O	DET	O
cardiac	O	ADJ	B
and	O	CCONJ	O
brain	B-GENE	NOUN	B
AE3	I-GENE	NOUN	B
variants	I-GENE	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
and	O	CCONJ	O
characterized	O	VERB	B
the	O	DET	O
rat	O	NOUN	B
gene	O	NOUN	B
.	O	PUNCT	O


Overproduction	O	NOUN	B
,	O	PUNCT	O
purification	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
M	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
HinfI	I-GENE	NOUN	B
methyltransferase	I-GENE	NOUN	I
and	O	CCONJ	O
its	O	PRON	O
deletion	O	NOUN	B
mutant	O	NOUN	I
.	O	PUNCT	O


Hybridization	O	NOUN	B
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
6F6	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
corresponds	O	VERB	O
to	O	ADP	O
the	O	DET	O
previously	O	ADV	O
characterized	O	VERB	B
m6F6	B-GENE	ADJ	B
cDNA	I-GENE	NOUN	B
clone	I-GENE	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
6F6	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
1	I-GENE	NUM	O
and	O	CCONJ	O
6F6	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
3	I-GENE	NUM	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
6F6	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
,	O	PUNCT	O
are	O	AUX	O
adjacent	O	ADJ	B
to	O	PART	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
genes	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
IA4	B-GENE	NOUN	B
mAb	I-GENE	NOUN	B
was	O	AUX	O
identified	O	VERB	B
among	O	ADP	O
a	O	DET	O
series	O	NOUN	B
of	O	ADP	O
antibodies	O	NOUN	B
raised	O	VERB	O
in	O	ADP	O
BALB	O	NOUN	B
/	O	SYM	O
c	O	NOUN	B
mice	O	NOUN	B
after	O	ADP	O
immunization	O	NOUN	B
against	O	ADP	O
a	O	DET	O
HLA	B-GENE	NOUN	B
class	O	NOUN	I
I	O	NUM	I
-	O	PUNCT	O
deficient	O	ADJ	B
,	O	PUNCT	O
lymphokine	O	NOUN	B
-	O	PUNCT	O
activated	O	VERB	B
killer	O	NOUN	I
(	O	PUNCT	O
LAK	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
susceptible	O	ADJ	B
EBV	O	NOUN	B
-	O	PUNCT	O
B	O	NOUN	B
lymphocyte	O	NOUN	I
line	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
variant	O	ADJ	B
PRP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
precursor	I-GENE	NOUN	B
alleles	I-GENE	NOUN	B
occur	O	VERB	O
which	O	DET	O
slightly	O	ADV	O
differ	O	VERB	O
in	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
repeats	O	NOUN	B
in	O	ADP	O
domain	O	NOUN	B
C	O	NOUN	I
.	O	PUNCT	O


Dimerization	O	NOUN	B
of	O	ADP	O
Myf	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
5	I-GENE	NUM	O
with	O	ADP	O
the	O	DET	O
ubiquitously	O	ADV	O
expressed	O	VERB	O
bHLH	O	ADJ	B
protein	O	NOUN	I
E12	B-GENE	NOUN	B
not	O	PART	O
only	O	ADV	O
increases	O	VERB	B
the	O	DET	O
affinity	O	NOUN	B
for	O	ADP	O
DNA	O	NOUN	B
but	O	CCONJ	O
also	O	ADV	O
stimulates	O	VERB	B
transactivation	O	NOUN	B
independently	O	ADV	O
of	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
.	O	PUNCT	O


Neural	O	PROPN	B
-	O	PUNCT	O
specific	O	ADJ	B
expression	O	NOUN	B
,	O	PUNCT	O
genomic	O	ADJ	B
structure	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
chromosomal	O	ADJ	B
localization	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
zinc	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
finger	I-GENE	NOUN	B
transcription	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
NGFI	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
C	I-GENE	PROPN	B
.	O	PUNCT	O


STP1	B-GENE	NOUN	B
is	O	AUX	O
an	O	DET	O
unessential	O	ADJ	O
yeast	O	NOUN	B
gene	O	NOUN	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
removal	O	NOUN	B
of	O	ADP	O
intervening	O	VERB	O
sequences	O	NOUN	O
from	O	ADP	O
some	O	DET	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
all	O	DET	O
,	O	PUNCT	O
families	O	NOUN	B
of	O	ADP	O
intervening	O	VERB	O
sequence	O	NOUN	B
-	O	PUNCT	O
containing	O	VERB	B
pre	O	ADJ	B
-	O	PUNCT	O
tRNAs	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
these	O	DET	O
antibodies	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
define	O	VERB	O
the	O	DET	O
conditions	O	NOUN	B
to	O	PART	O
completely	O	ADV	O
solubilize	O	VERB	B
the	O	DET	O
Cdc25	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


Disruption	O	NOUN	B
demonstrates	O	VERB	O
that	O	SCONJ	O
CDC14	B-GENE	NOUN	B
is	O	AUX	O
an	O	DET	O
essential	O	ADJ	B
gene	O	NOUN	I
.	O	PUNCT	O


His	O	PRON	O
HC	B-GENE	NOUN	B
II	I-GENE	NUM	I
activity	O	NOUN	I
and	O	CCONJ	O
antigen	O	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
49	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
50	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
his	O	PRON	O
daughter	O	NOUN	B
also	O	ADV	O
showed	O	VERB	O
similar	O	ADJ	O
low	O	ADJ	B
levels	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
no	O	DET	O
transcripts	O	NOUN	B
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
size	O	NOUN	B
and	O	CCONJ	O
having	O	VERB	O
the	O	DET	O
same	O	ADJ	O
developmental	O	ADJ	B
profile	O	NOUN	I
as	O	ADP	O
those	O	DET	O
generated	O	VERB	O
by	O	ADP	O
the	O	DET	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
E10	I-GENE	NOUN	O
fragment	I-GENE	NOUN	O
were	O	AUX	O
identified	O	VERB	B
by	O	ADP	O
probes	O	NOUN	B
covering	O	VERB	O
the	O	DET	O
remainder	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cloned	O	VERB	B
region	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
sequence	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
interaction	O	NOUN	B
of	O	ADP	O
nuclear	B-GENE	ADJ	B
factor	I-GENE	NOUN	I
HiNF	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
with	O	ADP	O
this	O	DET	O
key	O	ADJ	O
proximal	O	ADJ	B
promoter	O	NOUN	B
element	O	NOUN	I
of	O	ADP	O
the	O	DET	O
H4	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
FO108	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
is	O	AUX	O
cell	O	NOUN	B
cycle	O	NOUN	I
regulated	O	VERB	O
in	O	ADP	O
normal	O	ADJ	B
diploid	O	ADJ	I
cells	O	NOUN	I
(	O	PUNCT	O
J	O	NOUN	O
.	O	PUNCT	O


Two	O	NUM	O
cDNAs	O	NOUN	B
encoding	O	VERB	O
casein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
have	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
from	O	ADP	O
a	O	DET	O
yeast	O	NOUN	B
cDNA	O	NOUN	O
library	O	NOUN	O
and	O	CCONJ	O
termed	O	VERB	O
CKI1	B-GENE	NOUN	B
and	O	CCONJ	O
CKI2	B-GENE	NOUN	B
.	O	PUNCT	O


A	O	DET	O
38	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
poly	O	NOUN	B
(	O	PUNCT	I
dA	O	NOUN	B
-	O	PUNCT	O
dT	O	NOUN	B
)	O	PUNCT	O
region	O	NOUN	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
positive	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
Act1	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
DRF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
nuclear	I-GENE	ADJ	I
protein	I-GENE	NOUN	I
has	O	AUX	O
characteristics	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
the	O	DET	O
muscle	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
regulatory	O	ADJ	B
factor	O	NOUN	I
,	O	PUNCT	O
MEF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
(	O	PUNCT	O
Buskin	O	PROPN	B
and	O	CCONJ	O
Hauschka	O	PROPN	O
1989	O	NUM	O
;	O	PUNCT	O
Gossett	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
1989	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


From	O	ADP	O
the	O	DET	O
15	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
clone	O	NOUN	B
a	O	DET	O
4	B-GENE	NUM	O
-	I-GENE	PUNCT	O
kb	I-GENE	NOUN	B
EcoRI	I-GENE	NOUN	I
fragment	I-GENE	NOUN	I
containing	O	VERB	O
the	O	DET	O
first	O	ADJ	O
two	O	NUM	O
exons	O	NOUN	B
and	O	CCONJ	O
2	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
kb	O	NOUN	O
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
opn	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
sequenced	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
start	O	NOUN	O
site	O	NOUN	O
determined	O	VERB	O
by	O	ADP	O
primer	O	NOUN	B
extension	O	NOUN	I
analysis	O	NOUN	I
and	O	CCONJ	O
S1	B-GENE	NOUN	B
nuclease	I-GENE	NOUN	I
mapping	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
was	O	AUX	O
confirmed	O	VERB	O
the	O	DET	O
correct	O	ADJ	O
one	O	NUM	O
by	O	ADP	O
direct	O	ADJ	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
overproduced	O	VERB	B
msgB	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
product	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
virus	O	NOUN	B
encodes	O	VERB	B
a	O	DET	O
40	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
protein	O	NOUN	I
,	O	PUNCT	O
tax	B-GENE	NOUN	O
,	O	PUNCT	O
that	O	PRON	O
is	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
the	O	DET	O
immortalization	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
examination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
the	O	DET	O
carboxyl	O	NOUN	B
terminus	O	NOUN	B
in	O	ADP	O
regulating	O	VERB	B
NGFI	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
B	I-GENE	NOUN	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
revealed	O	VERB	O
that	O	SCONJ	O
,	O	PUNCT	O
in	O	ADP	O
accordance	O	NOUN	O
with	O	ADP	O
other	O	ADJ	O
nuclear	O	ADJ	B
receptors	O	NOUN	I
,	O	PUNCT	O
mutants	O	NOUN	B
lacking	O	VERB	O
portions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
carboxyl	O	NOUN	B
terminus	O	NOUN	B
had	O	AUX	O
greatly	O	ADV	O
decreased	O	VERB	B
activity	O	NOUN	B
.	O	PUNCT	O


Altogether	O	ADV	O
these	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Syn	B-GENE	NOUN	B
5	I-GENE	NUM	I
locus	I-GENE	NOUN	B
segregates	O	VERB	B
from	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
specifying	O	VERB	O
gH	B-GENE	NOUN	B
,	O	PUNCT	O
to	O	PART	O
a	O	DET	O
region	O	NOUN	B
encompassing	O	VERB	O
portions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
TK	B-GENE	NOUN	B
and	O	CCONJ	O
UL	B-GENE	NOUN	B
24	I-GENE	NUM	I
genes	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
syn	B-GENE	NOUN	B
mutation	I-GENE	NOUN	I
does	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
or	O	CCONJ	O
activity	O	NOUN	B
of	O	ADP	O
TK	B-GENE	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
identify	O	VERB	O
the	O	DET	O
"	O	PUNCT	O
M	O	NOUN	O
region	O	NOUN	O
"	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
muscle	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
Xenopus	I-GENE	NOUN	B
cardiac	I-GENE	ADJ	B
actin	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
promoter	I-GENE	NOUN	O
from	O	ADP	O
-	O	PUNCT	O
282	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
348	O	NUM	O
as	O	ADP	O
necessary	O	ADJ	O
for	O	ADP	O
the	O	DET	O
embryonic	O	ADJ	B
expression	O	NOUN	I
of	O	ADP	O
a	O	DET	O
cardiac	O	ADJ	B
actin	B-GENE	NOUN	I
-	O	PUNCT	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
globin	I-GENE	NOUN	B
reporter	O	NOUN	I
gene	O	NOUN	O
injected	O	VERB	O
into	O	ADP	O
fertilized	O	VERB	B
eggs	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
the	O	DET	O
previously	O	ADV	O
identified	O	VERB	B
and	O	CCONJ	O
characterized	O	VERB	B
attenuator	B-GENE	NOUN	O
1	I-GENE	NUM	O
situated	O	VERB	O
93	O	NUM	O
nucleotides	O	NOUN	B
downstream	O	ADJ	B
from	O	ADP	O
the	O	DET	O
major	O	ADJ	O
late	O	ADJ	O
transcription	O	NOUN	O
start	O	NOUN	O
site	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
second	O	ADJ	O
attenuator	O	NOUN	B
,	O	PUNCT	O
attenuator	B-GENE	NOUN	B
2	I-GENE	NUM	I
,	O	PUNCT	O
situated	O	VERB	O
55	O	NUM	O
nucleotides	O	NOUN	B
downstream	O	ADJ	B
from	O	ADP	O
it	O	PRON	O
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


These	O	DET	O
experiments	O	NOUN	B
delineate	O	VERB	O
a	O	DET	O
186	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
,	O	PUNCT	O
EBNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
-	O	PUNCT	O
responsive	O	ADJ	B
cell	O	NOUN	B
DNA	O	NOUN	I
fragment	O	NOUN	I
and	O	CCONJ	O
provide	O	VERB	O
firm	O	ADJ	O
evidence	O	NOUN	B
that	O	SCONJ	O
EBNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
transactivates	O	VERB	B
transcription	O	NOUN	B
of	O	ADP	O
cell	O	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
sequenced	O	VERB	B
two	O	NUM	O
overlapping	O	VERB	O
cDNA	O	NOUN	B
fragments	O	NOUN	O
which	O	DET	O
could	O	AUX	O
encode	O	VERB	B
the	O	DET	O
complete	O	ADJ	B
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
rat	B-GENE	NOUN	B
testis	I-GENE	NOUN	B
fructose	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
,	I-GENE	PUNCT	O
2	I-GENE	NUM	B
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
:	O	PUNCT	O
fructose	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
,	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	I-GENE	PUNCT	O
bisphosphatase	I-GENE	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
similar	O	ADJ	O
transient	O	ADJ	B
transfection	O	NOUN	O
experiments	O	NOUN	O
in	O	ADP	O
HeLa	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
overexpression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
wt	B-GENE	ADJ	O
human	I-GENE	ADJ	B
retinoblastoma	I-GENE	NOUN	O
susceptibility	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
product	I-GENE	NOUN	O
,	O	PUNCT	O
RB	B-GENE	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
repress	O	VERB	B
the	O	DET	O
serum	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
(	O	PUNCT	O
-	O	PUNCT	O
225	O	NUM	O
to	O	ADP	O
+	O	CCONJ	O
13	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
fos	I-GENE	NOUN	B
(	O	PUNCT	O
-	O	SYM	O
711	O	NUM	O
to	O	PART	O
+	O	CCONJ	O
42	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
actin	I-GENE	NOUN	B
(	O	PUNCT	O
-	O	PUNCT	O
3400	O	NUM	O
to	O	PART	O
+	O	CCONJ	O
912	O	NUM	O
)	O	PUNCT	O
promoters	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
PRV	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
(	O	PUNCT	O
-	O	SYM	O
110	O	NUM	O
to	O	PART	O
+	O	CCONJ	O
13	O	NUM	O
)	O	PUNCT	O
or	O	CCONJ	O
the	O	DET	O
serum	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
MHC	B-GENE	NOUN	B
(	O	PUNCT	O
-	O	PUNCT	O
528	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
38	O	NUM	O
)	O	PUNCT	O
promoters	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
repression	O	NOUN	B
was	O	AUX	O
mediated	O	VERB	O
through	O	ADP	O
binding	O	VERB	B
to	O	PART	O
the	O	DET	O
E2	B-GENE	NOUN	B
DNA	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
site	I-GENE	NOUN	I
immediately	O	ADV	O
upstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
P105	B-GENE	NOUN	B
promoter	O	NOUN	I
TATA	O	NOUN	O
box	O	NOUN	O
and	O	CCONJ	O
could	O	AUX	O
be	O	AUX	O
abrogated	O	VERB	B
by	O	ADP	O
preincubation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HPV	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
18	I-GENE	NUM	O
P105	I-GENE	NOUN	O
promoter	I-GENE	NOUN	B
template	O	NOUN	I
with	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
extract	O	NOUN	I
allowing	O	VERB	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
preinitiation	O	NOUN	B
complex	O	NOUN	I
.	O	PUNCT	O


TPA	O	NOUN	B
and	O	CCONJ	O
TGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
1	I-GENE	NUM	I
did	O	AUX	O
not	O	PART	O
markedly	O	ADV	O
affect	O	VERB	O
the	O	DET	O
activities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
72	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
enzyme	O	NOUN	B
.	O	PUNCT	O


Alignment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
sequences	O	NOUN	I
surrounding	O	VERB	O
Tyr	O	NOUN	B
-	O	PUNCT	O
766	O	NUM	O
with	O	ADP	O
corresponding	O	ADJ	O
regions	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
FGFRs	B-GENE	NOUN	B
revealed	O	VERB	O
conserved	O	VERB	O
tyrosine	O	NOUN	B
residues	O	NOUN	I
in	O	ADP	O
all	O	DET	O
known	O	VERB	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
FGFR	B-GENE	NOUN	B
family	I-GENE	NOUN	B
.	O	PUNCT	O


Intron	O	NOUN	B
K1	B-GENE	NOUN	I
cox1	I-GENE	NOUN	I
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
is	O	AUX	O
not	O	PART	O
found	O	VERB	O
in	O	ADP	O
S	O	NOUN	B
.	O	PUNCT	O
cerevisiae	O	X	B
and	O	CCONJ	O
appears	O	VERB	O
at	O	ADP	O
an	O	DET	O
unique	O	ADJ	B
location	O	NOUN	B
in	O	ADP	O
K	O	NOUN	B
.	O	PUNCT	O
lactis	O	X	B
.	O	PUNCT	O


Recombination	O	NOUN	B
between	O	ADP	O
feline	O	ADJ	B
leukemia	O	NOUN	I
virus	O	NOUN	B
subgroup	O	NOUN	B
B	O	NOUN	O
or	O	CCONJ	O
C	O	NOUN	B
and	O	CCONJ	O
endogenous	O	ADJ	B
env	B-GENE	NOUN	B
elements	O	NOUN	I
alters	O	VERB	O
the	O	DET	O
in	O	X	B
vitro	O	X	I
biological	O	ADJ	B
activities	O	NOUN	O
of	O	ADP	O
the	O	DET	O
viruses	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
strategy	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
used	O	VERB	O
to	O	PART	O
determine	O	VERB	O
2	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
kilobases	O	NOUN	B
of	O	ADP	O
nucleotide	O	NOUN	B
sequence	O	NOUN	I
in	O	ADP	O
the	O	DET	O
Saccharomyces	B-GENE	X	B
cerevisiae	I-GENE	X	I
ADE	I-GENE	NOUN	B
1	I-GENE	NUM	O
locus	I-GENE	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
independent	O	ADJ	O
promoters	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
5	O	NUM	O
'	O	PART	O
untranslated	O	ADJ	B
regions	O	NOUN	I
regulate	O	VERB	B
Dd	B-GENE	NOUN	B
ras	I-GENE	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
Dictyostelium	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
genes	O	NOUN	B
code	O	VERB	I
for	O	ADP	O
polypeptides	B-GENE	NOUN	B
of	I-GENE	ADP	O
420	I-GENE	NUM	O
amino	I-GENE	NOUN	B
acids	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
M	I-GENE	NOUN	B
.	I-GENE	PUNCT	O
HgiCI	I-GENE	ADJ	B
)	I-GENE	PUNCT	O
and	O	CCONJ	O
345	B-GENE	NUM	O
amino	I-GENE	NOUN	B
acids	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
R	I-GENE	NOUN	B
.	I-GENE	PUNCT	O
HgiCI	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
factor	O	NOUN	B
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
the	O	DET	O
TR	B-GENE	NOUN	B
promoter	I-GENE	NOUN	I
co	O	X	B
-	O	PUNCT	O
sedimented	O	VERB	B
with	O	ADP	O
SV40	O	NOUN	B
chromosomes	O	NOUN	I
extracted	O	VERB	O
late	O	ADV	O
in	O	ADP	O
infection	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
resulting	O	VERB	O
clone	O	NOUN	B
pKB11	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
a	O	DET	O
1369	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
pair	O	NOUN	I
(	O	PUNCT	O
bp	O	NOUN	O
)	O	PUNCT	O
cDNA	O	NOUN	B
insert	O	NOUN	I
,	O	PUNCT	O
overlapping	O	VERB	O
pCAD142	B-GENE	NOUN	B
by	O	ADP	O
781	O	NUM	O
bp	O	NOUN	O
,	O	PUNCT	O
was	O	AUX	O
identified	O	VERB	O
by	O	ADP	O
hybridization	O	NOUN	B
methods	O	NOUN	I
and	O	CCONJ	O
sequence	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
found	O	VERB	O
to	O	PART	O
contain	O	VERB	O
the	O	DET	O
entire	O	ADJ	O
cDNA	O	NOUN	B
sequence	O	NOUN	I
for	O	ADP	O
the	O	DET	O
amino	O	NOUN	B
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
CAD	B-GENE	NOUN	B
polypeptide	I-GENE	NOUN	B
.	O	PUNCT	O


Its	O	PRON	O
clearance	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
decreased	O	VERB	B
(	O	PUNCT	O
typically	O	ADV	O
by	O	ADP	O
around	O	ADV	O
25	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
often	O	ADV	O
by	O	ADP	O
far	O	ADV	O
more	O	ADJ	O
)	O	PUNCT	O
by	O	ADP	O
erythromycin	O	NOUN	B
,	O	PUNCT	O
troleandomycin	O	NOUN	B
(	O	PUNCT	O
triacetyloleandomycin	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
roxithromycin	O	NOUN	B
,	O	PUNCT	O
enoxacin	O	NOUN	B
,	O	PUNCT	O
ciprofloxacin	O	NOUN	B
,	O	PUNCT	O
pefloxacin	O	NOUN	B
,	O	PUNCT	O
norfloxacin	O	NOUN	B
,	O	PUNCT	O
ofloxacin	O	NOUN	B
,	O	PUNCT	O
fluoroquinolone	O	ADJ	B
T	O	NOUN	I
-	O	PUNCT	O
3262	O	NUM	O
,	O	PUNCT	O
pipemidic	O	ADJ	B
acid	O	NOUN	I
,	O	PUNCT	O
cimetidine	O	NOUN	B
,	O	PUNCT	O
etintidine	O	NOUN	B
,	O	PUNCT	O
propranolol	O	NOUN	B
,	O	PUNCT	O
verapamil	O	NOUN	B
,	O	PUNCT	O
diltiazem	O	NOUN	B
,	O	PUNCT	O
nifedipine	O	NOUN	B
,	O	PUNCT	O
furosemide	O	NOUN	B
(	O	PUNCT	O
frusemide	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
at	O	ADP	O
least	O	ADJ	O
some	O	DET	O
anovulent	O	ADJ	B
agents	O	NOUN	I
,	O	PUNCT	O
viloxazine	O	NOUN	B
,	O	PUNCT	O
allopurinol	O	NOUN	B
,	O	PUNCT	O
ticlopidine	O	NOUN	B
,	O	PUNCT	O
idrocilamide	O	NOUN	B
,	O	PUNCT	O
thiabendazole	O	NOUN	B
,	O	PUNCT	O
disulfiram	O	NOUN	B
,	O	PUNCT	O
influenza	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
BCG	O	PROPN	B
-	O	PUNCT	O
vaccination	O	NOUN	B
,	O	PUNCT	O
interferon	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
caffeine	O	NOUN	B
(	O	PUNCT	O
half	O	NOUN	B
-	O	PUNCT	O
life	O	NOUN	B
increase	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


No	O	DET	O
homology	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
between	O	ADP	O
RNA14	B-GENE	NOUN	B
and	O	CCONJ	O
RNA15	B-GENE	NOUN	B
or	O	CCONJ	O
between	O	ADP	O
RNA14	B-GENE	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
proteins	O	NOUN	B
contained	O	VERB	O
in	O	ADP	O
data	O	NOUN	B
banks	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
most	O	ADV	O
striking	O	ADJ	O
difference	O	NOUN	O
in	O	ADP	O
the	O	DET	O
birch	B-GENE	NOUN	B
NAD	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
P	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
H	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
NR	I-GENE	NOUN	B
sequence	I-GENE	NOUN	B
in	O	ADP	O
comparison	O	NOUN	B
to	O	PART	O
NADH	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
NR	I-GENE	NOUN	B
sequences	I-GENE	NOUN	B
was	O	AUX	O
found	O	VERB	O
at	O	ADP	O
the	O	DET	O
putative	O	ADJ	B
pyridine	O	NOUN	I
nucleotide	O	NOUN	I
binding	O	NOUN	I
site	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
localization	O	NOUN	B
of	O	ADP	O
this	O	DET	O
proteoglycan	O	NOUN	B
locus	O	NOUN	O
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
genome	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
availability	O	NOUN	B
of	O	ADP	O
new	O	ADJ	O
RFLPs	O	NOUN	B
provide	O	VERB	O
the	O	DET	O
tools	O	NOUN	B
for	O	ADP	O
future	O	ADJ	O
studies	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
diseases	O	NOUN	I
where	O	SCONJ	O
the	O	DET	O
HSPG2	B-GENE	NOUN	B
proteoglycan	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
is	O	AUX	O
suspected	O	VERB	B
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
cis	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
element	O	NOUN	B
mediating	O	VERB	O
glucocorticoid	O	NOUN	B
inducibility	O	NOUN	I
of	O	ADP	O
the	O	DET	O
chicken	B-GENE	NOUN	B
glutamine	I-GENE	NOUN	B
synthetase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
has	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
six	O	NUM	O
genes	O	NOUN	B
,	O	PUNCT	O
ipaB	B-GENE	NOUN	B
,	O	PUNCT	O
ipaC	B-GENE	NOUN	B
,	O	PUNCT	O
invE	B-GENE	NOUN	B
,	O	PUNCT	O
invG	B-GENE	NOUN	B
,	O	PUNCT	O
invJ	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
invK	B-GENE	PROPN	B
,	O	PUNCT	O
was	O	AUX	O
apparently	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
the	O	DET	O
positive	O	ADJ	B
regulator	O	NOUN	B
virF	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
corresponding	O	ADJ	O
mature	O	ADJ	B
mRNA	O	NOUN	B
transcripts	O	NOUN	O
(	O	PUNCT	O
3	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
-	O	SYM	O
3	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
kilobase	O	NOUN	B
pairs	O	NOUN	O
(	O	PUNCT	O
kb	O	NOUN	O
]	O	PUNCT	O
in	O	ADP	O
human	O	ADJ	B
fibroblasts	O	NOUN	B
was	O	AUX	O
shown	O	VERB	O
by	O	ADP	O
Northern	O	NOUN	B
blot	O	NOUN	I
hybridization	O	NOUN	I
,	O	PUNCT	O
S1	B-GENE	NOUN	B
nuclease	I-GENE	NOUN	I
protection	O	NOUN	I
assay	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
rtFc	B-GENE	NOUN	B
gamma	I-GENE	NOUN	I
R	I-GENE	NOUN	I
alpha	I-GENE	NOUN	I
cDNA	I-GENE	NOUN	I
clone	O	NOUN	I
is	O	AUX	O
complementary	O	ADJ	O
to	O	PART	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
different	O	ADJ	B
-	O	PUNCT	O
sized	O	ADJ	B
mRNAs	O	NOUN	B
expressed	O	VERB	B
by	O	ADP	O
CRNK	O	NOUN	B
-	O	PUNCT	O
16	O	NUM	O
cells	O	NOUN	B
,	O	PUNCT	O
contrasting	O	VERB	O
the	O	DET	O
single	O	ADJ	O
Fc	B-GENE	NOUN	B
gamma	I-GENE	NOUN	I
R	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
mRNA	I-GENE	NOUN	B
species	O	NOUN	I
expressed	O	VERB	B
by	O	ADP	O
human	O	ADJ	B
and	O	CCONJ	O
mouse	O	NOUN	B
natural	O	ADJ	O
killer	O	NOUN	O
cells	O	NOUN	O
.	O	PUNCT	O


Treatment	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
myeloid	O	ADJ	O
cell	O	NOUN	O
lines	O	NOUN	O
HL	O	NOUN	B
-	O	PUNCT	O
60	O	NUM	O
and	O	CCONJ	O
U937	O	NOUN	B
with	O	ADP	O
phorbol	O	NOUN	B
12	O	NUM	I
-	O	PUNCT	O
myristate	O	NOUN	B
13	O	NUM	I
-	O	PUNCT	O
acetate	O	NOUN	B
(	O	PUNCT	O
PMA	O	NOUN	B
)	O	PUNCT	O
increased	O	VERB	B
within	O	ADP	O
2	O	NUM	O
h	O	NOUN	O
cellular	O	ADJ	B
levels	O	NOUN	I
of	O	ADP	O
the	O	DET	O
RNA	O	NOUN	B
hybridizable	O	ADJ	B
to	O	PART	O
LD78	B-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
.	O	PUNCT	O


Serum	O	NOUN	B
IgG	B-GENE	NOUN	I
was	O	AUX	O
initially	O	ADV	O
elevated	O	ADJ	B
in	O	ADP	O
6	O	NUM	O
patients	O	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
of	O	ADP	O
Jurkat	O	NOUN	B
leukemic	O	ADJ	I
T	O	NOUN	I
cells	O	NOUN	I
with	O	ADP	O
phorbol	O	NOUN	B
12	O	NUM	I
-	O	PUNCT	O
myristate	O	NOUN	B
13	O	NUM	I
-	O	PUNCT	O
acetate	O	NOUN	B
and	O	CCONJ	O
ionomycin	O	NOUN	B
did	O	AUX	O
not	O	PART	O
affect	O	VERB	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
FKBP	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
.	O	PUNCT	O


Identification	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
for	O	ADP	O
the	O	DET	O
cytotactin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Co	O	PROPN	B
-	O	PUNCT	O
existence	O	NOUN	B
of	O	ADP	O
these	O	DET	O
regulatory	O	ADJ	B
elements	O	NOUN	I
with	O	ADP	O
other	O	ADJ	O
elements	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
the	O	DET	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
element	I-GENE	NOUN	B
or	O	CCONJ	O
CCAAT	O	NOUN	B
box	O	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
also	O	ADV	O
found	O	VERB	O
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
flanking	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
is	O	AUX	O
likely	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
hormonal	O	ADJ	B
regulation	O	NOUN	I
of	O	ADP	O
its	O	PRON	O
expression	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
partially	O	ADV	O
characterized	O	VERB	B
an	O	DET	O
avian	O	ADJ	B
fatty	B-GENE	ADJ	B
acid	I-GENE	NOUN	I
synthase	I-GENE	NOUN	I
gene	O	NOUN	I
.	O	PUNCT	O


Whereas	O	SCONJ	O
cDNA	O	NOUN	B
hybridization	O	NOUN	I
to	O	PART	O
genomic	O	ADJ	B
DNA	O	NOUN	I
blots	O	NOUN	I
indicated	O	VERB	O
a	O	DET	O
small	O	ADJ	O
subfamily	O	NOUN	O
of	O	ADP	O
G0S19	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
,	O	PUNCT	O
simple	O	ADJ	O
patterns	O	NOUN	B
of	O	ADP	O
bands	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
most	O	ADJ	O
cDNAs	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
G0S30	B-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
,	O	PUNCT	O
corresponded	O	VERB	O
to	O	ADP	O
single	O	ADJ	B
-	O	PUNCT	O
copy	O	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
DNA	O	NOUN	B
sequence	O	NOUN	I
conferring	O	VERB	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
activity	O	NOUN	B
was	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
proximal	O	ADJ	B
promoter	O	NOUN	B
region	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
murine	B-GENE	ADJ	B
mutation	I-GENE	NOUN	B
dominant	I-GENE	ADJ	O
white	I-GENE	ADJ	O
spotting	I-GENE	NOUN	O
(	O	PUNCT	O
W	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
in	O	ADP	O
the	O	DET	O
proto	O	NOUN	B
-	O	PUNCT	O
oncogene	O	NOUN	B
,	O	PUNCT	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kit	I-GENE	NOUN	B
.	O	PUNCT	O


These	O	DET	O
clones	O	NOUN	B
overlapped	O	VERB	B
and	O	CCONJ	O
contained	O	VERB	O
the	O	DET	O
structural	O	ADJ	B
gene	O	NOUN	I
encoding	O	VERB	B
the	O	DET	O
complete	O	ADJ	B
C5	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
chain	I-GENE	NOUN	B
and	O	CCONJ	O
90	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
beta	O	NOUN	B
-	O	PUNCT	O
chain	O	NOUN	B
.	O	PUNCT	O


Heterozygous	O	ADJ	B
mutation	O	NOUN	O
in	O	ADP	O
the	O	DET	O
G	O	NOUN	B
+	O	CCONJ	O
5	O	NUM	O
position	O	NOUN	O
of	O	ADP	O
intron	O	NOUN	B
33	O	NUM	O
of	O	ADP	O
the	O	DET	O
pro	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
2	I-GENE	NUM	I
(	I-GENE	PUNCT	O
I	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
gene	I-GENE	NOUN	O
(	O	PUNCT	O
COL1A2	B-GENE	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
causes	O	VERB	O
aberrant	O	ADJ	O
RNA	O	NOUN	B
splicing	O	NOUN	I
and	O	CCONJ	O
lethal	O	ADJ	B
osteogenesis	O	NOUN	I
imperfecta	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
full	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
length	I-GENE	NOUN	B
human	I-GENE	ADJ	B
pim	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
cDNA	I-GENE	NOUN	B
was	O	AUX	O
subcloned	O	VERB	B
into	O	ADP	O
the	O	DET	O
bacterial	O	ADJ	B
vector	O	NOUN	O
pGEX	O	NOUN	B
-	O	PUNCT	O
2T	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
Pim	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
protein	I-GENE	NOUN	B
expressed	O	VERB	B
as	O	ADP	O
a	O	DET	O
fusion	O	NOUN	B
product	O	NOUN	I
with	O	ADP	O
bacterial	B-GENE	ADJ	B
glutathione	I-GENE	NOUN	O
S	I-GENE	NOUN	O
-	I-GENE	PUNCT	O
transferase	I-GENE	NOUN	O
(	O	PUNCT	O
GST	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Opposite	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
CYP1	B-GENE	NOUN	B
are	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
aerobic	O	ADJ	B
,	O	PUNCT	O
heme	O	NOUN	B
-	O	PUNCT	O
sufficient	O	ADJ	B
cells	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
segmental	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
key	O	ADJ	O
regions	O	NOUN	B
of	O	ADP	O
HLA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
DR1	I-GENE	NOUN	B
that	O	PRON	O
control	O	VERB	B
T	O	NOUN	B
cell	O	NOUN	I
allorecognition	O	NOUN	O
was	O	AUX	O
performed	O	VERB	O
by	O	ADP	O
using	O	VERB	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
transfected	O	VERB	B
cell	O	NOUN	B
lines	O	NOUN	I
expressing	O	VERB	B
the	O	DET	O
products	O	NOUN	B
of	O	ADP	O
recombinant	O	ADJ	B
DRB	B-GENE	NOUN	B
/	O	SYM	O
H	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2Eb	I-GENE	NOUN	B
genes	O	NOUN	B
,	O	PUNCT	O
paired	O	VERB	O
with	O	ADP	O
either	O	CCONJ	O
DR	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
or	O	CCONJ	O
H	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2E	I-GENE	NOUN	B
alpha	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
alpha	B-GENE	NOUN	B
inhibin	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
containing	O	VERB	O
a	O	DET	O
mutated	O	VERB	B
CRE	O	NOUN	B
was	O	AUX	O
not	O	PART	O
regulated	O	VERB	O
by	O	ADP	O
forskolin	O	NOUN	B
in	O	ADP	O
granulosa	O	NOUN	B
cells	O	NOUN	I
and	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
bind	O	VERB	B
the	O	DET	O
CREB	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
sulfhydryl	O	NOUN	B
group	O	NOUN	I
of	O	ADP	O
certain	O	ADJ	O
angiotensin	B-GENE	NOUN	B
converting	I-GENE	NOUN	O
enzyme	I-GENE	NOUN	B
inhibitors	O	NOUN	I
can	O	AUX	O
potentiate	O	VERB	B
their	O	PRON	O
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
endogenous	O	ADJ	B
nitrovasodilator	O	NOUN	B
EDRF	B-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
second	O	ADJ	O
even	O	ADV	O
more	O	ADV	O
significant	O	ADJ	B
match	O	NOUN	O
to	O	ADP	O
this	O	DET	O
E	O	NOUN	B
.	O	PUNCT	O
coli	O	X	B
region	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
retroviral	B-GENE	ADJ	B
ribonuclease	I-GENE	NOUN	I
H	I-GENE	NOUN	I
(	O	PUNCT	O
RNase	B-GENE	NOUN	O
H	I-GENE	NOUN	O
)	O	PUNCT	O
domain	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
corresponds	O	VERB	O
precisely	O	ADV	O
to	O	ADP	O
a	O	DET	O
region	O	NOUN	B
that	O	PRON	O
has	O	AUX	O
been	O	AUX	O
aligned	O	VERB	O
by	O	ADP	O
previous	O	ADJ	O
investigators	O	NOUN	B
with	O	ADP	O
the	O	DET	O
E	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
coli	I-GENE	X	B
RNase	I-GENE	NOUN	I
H	I-GENE	NOUN	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
Pol	B-GENE	NOUN	B
I	I-GENE	NUM	I
helices	O	NOUN	O
O	O	NOUN	O
and	O	CCONJ	O
P	O	NOUN	O
are	O	AUX	O
homologous	O	ADJ	B
to	O	PART	O
helices	O	NOUN	B
A	O	NOUN	I
and	O	CCONJ	O
D	O	NOUN	B
of	O	ADP	O
the	O	DET	O
RNase	B-GENE	NOUN	B
H	I-GENE	NOUN	I
crystal	O	NOUN	B
structure	O	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
qualitative	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
HCG	B-GENE	NOUN	B
had	O	AUX	O
a	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
37	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
a	O	DET	O
specificity	O	NOUN	B
of	O	ADP	O
100	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


They	O	PRON	O
were	O	AUX	O
checked	O	VERB	O
for	O	ADP	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
HCV	I-GENE	NOUN	B
(	O	PUNCT	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
C100	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	O
)	O	PUNCT	O
with	O	ADP	O
HCV	O	NOUN	B
EIA	O	NOUN	I
kit	O	NOUN	I
(	O	PUNCT	O
Abbott	O	PROPN	B
Lab	O	PROPN	I
.	O	PUNCT	O
,	O	PUNCT	O
North	O	PROPN	B
Chicago	O	PROPN	I
,	O	PUNCT	O
IL	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Max	B-GENE	NOUN	B
:	O	PUNCT	O
functional	O	ADJ	B
domains	O	NOUN	I
and	O	CCONJ	O
interaction	O	NOUN	B
with	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Myc	I-GENE	NOUN	B
.	O	PUNCT	O


Zn	O	NOUN	B
(	O	PUNCT	O
II	O	NUM	O
)	O	PUNCT	O
coordination	O	NOUN	B
domain	O	NOUN	I
mutants	O	NOUN	I
of	O	ADP	O
T4	O	NOUN	B
gene	B-GENE	NOUN	I
32	I-GENE	NUM	O
protein	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
tissue	O	NOUN	B
specificity	O	NOUN	B
of	O	ADP	O
gene	O	NOUN	B
expression	O	NOUN	I
was	O	AUX	O
identical	O	ADJ	B
to	O	PART	O
that	O	DET	O
described	O	VERB	O
previously	O	ADV	O
for	O	ADP	O
the	O	DET	O
CaMV	B-GENE	NOUN	B
35S	I-GENE	NOUN	I
domain	I-GENE	NOUN	I
B	I-GENE	NOUN	I
enhancer	I-GENE	NOUN	I
element	I-GENE	NOUN	I
.	O	PUNCT	O


Immunostaining	O	NOUN	B
of	O	ADP	O
cells	O	NOUN	B
transfected	O	VERB	B
with	O	ADP	O
these	O	DET	O
constructs	O	NOUN	B
revealed	O	VERB	B
that	O	SCONJ	O
both	O	CCONJ	O
the	O	DET	O
myristoylated	O	VERB	B
and	O	CCONJ	O
nonmyristoylated	O	ADJ	B
mutants	O	NOUN	I
were	O	AUX	O
localized	O	ADJ	B
in	O	ADP	O
nuclei	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
PKC	I-GENE	NOUN	B
alpha	I-GENE	NOUN	I
was	O	AUX	O
primarily	O	ADV	O
cytoplasmic	O	ADJ	B
and	O	CCONJ	O
perinuclear	O	ADJ	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
partially	O	ADV	O
sequenced	O	VERB	B
the	O	DET	O
RAP74	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
from	O	ADP	O
purified	O	VERB	B
HeLa	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
cloned	O	VERB	B
its	O	PRON	O
complementary	O	ADJ	O
DNA	O	NOUN	B
and	O	CCONJ	O
shown	O	VERB	O
that	O	SCONJ	O
its	O	PRON	O
translation	O	NOUN	B
product	O	NOUN	I
can	O	AUX	O
interact	O	VERB	B
with	O	ADP	O
RAP30	B-GENE	NOUN	B
in	O	X	B
vitro	O	X	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


The	O	DET	O
size	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mutant	O	ADJ	B
molecule	O	NOUN	I
corresponds	O	VERB	O
to	O	PART	O
the	O	DET	O
unprocessed	O	ADJ	B
cytoplasmic	O	ADJ	O
precursor	O	NOUN	O
(	O	PUNCT	O
pre	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
super	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
pro	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
PrB	I-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADP	O
detected	O	VERB	B
in	O	ADP	O
sec61	B-GENE	DET	B
mutants	I-GENE	NOUN	B
,	O	PUNCT	O
when	O	SCONJ	O
translocation	O	NOUN	B
into	O	ADP	O
the	O	DET	O
endoplasmic	O	ADJ	B
reticulum	O	NOUN	I
is	O	AUX	O
blocked	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
exhibited	O	VERB	O
70	O	NUM	O
%	O	NOUN	O
identity	O	NOUN	B
to	O	PART	O
that	O	DET	O
of	O	ADP	O
Bacillus	B-GENE	X	B
stearothermophilus	I-GENE	X	I
TyrTS	I-GENE	PROPN	I
and	O	CCONJ	O
55	O	NUM	O
%	O	NOUN	O
identity	O	NOUN	B
to	O	PART	O
that	O	DET	O
of	O	ADP	O
E	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
coli	I-GENE	X	B
TyrTS	I-GENE	NOUN	I
,	O	PUNCT	O
while	O	SCONJ	O
identity	O	NOUN	B
to	O	PART	O
a	O	DET	O
second	O	ADJ	O
cryptic	O	ADJ	B
B	B-GENE	NOUN	I
.	I-GENE	PUNCT	O
subtilis	I-GENE	X	B
TyrTS	I-GENE	NOUN	I
gene	I-GENE	NOUN	O
,	O	PUNCT	O
designated	O	VERB	O
tyrZ	B-GENE	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
only	O	ADV	O
27	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


BACKGROUND	O	NOUN	B
:	O	PUNCT	O
The	O	DET	O
effectiveness	O	NOUN	B
of	O	ADP	O
monoamine	B-GENE	NOUN	B
oxidase	I-GENE	NOUN	I
inhibitors	O	NOUN	I
(	O	PUNCT	O
MAOIs	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
tricyclic	O	ADJ	B
resistant	O	ADJ	B
depression	O	NOUN	B
has	O	AUX	O
received	O	VERB	O
surprisingly	O	ADV	O
little	O	ADJ	O
systematic	O	ADJ	B
study	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
overcome	O	VERB	O
this	O	DET	O
problem	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
overexpressed	O	VERB	B
Kex2p	B-GENE	NOUN	B
using	O	VERB	O
the	O	DET	O
baculovirus	O	NOUN	B
/	O	PUNCT	O
insect	O	NOUN	B
cell	O	NOUN	B
expression	O	NOUN	I
system	O	NOUN	I
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
Plasma	B-GENE	NOUN	B
AVP	I-GENE	NOUN	B
responses	O	NOUN	B
to	O	PART	O
osmotic	O	ADJ	B
stimulation	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
non	O	ADJ	B
-	O	PUNCT	O
osmotic	O	ADJ	B
inhibition	O	NOUN	B
by	O	ADP	O
drinking	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
normal	O	ADJ	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
compulsive	O	ADJ	B
water	O	NOUN	I
drinking	O	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
SRF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
proteins	I-GENE	NOUN	B
:	O	PUNCT	O
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
properties	O	NOUN	B
and	O	CCONJ	O
potential	O	ADJ	B
regulatory	O	ADJ	B
targets	O	NOUN	O
.	O	PUNCT	O


Growth	O	NOUN	B
factor	O	NOUN	I
stimulation	O	NOUN	I
of	O	ADP	O
cells	O	NOUN	B
causes	O	VERB	O
the	O	DET	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Myc	I-GENE	NOUN	B
transcriptional	I-GENE	ADJ	B
activation	I-GENE	NOUN	O
domain	I-GENE	NOUN	O
at	O	ADP	O
Ser62	O	NOUN	B
within	O	ADP	O
a	O	DET	O
proline	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
region	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
highly	O	ADV	O
conserved	O	VERB	O
among	O	ADP	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Myc	B-GENE	NOUN	B
family	I-GENE	NOUN	O
(	O	PUNCT	O
Alvarez	O	PROPN	B
,	O	PUNCT	O
E	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
Northwood	O	PROPN	B
,	O	PUNCT	O
I	O	PRON	B
.	O	PUNCT	O
C	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
Gonzalez	O	PROPN	B
,	O	PUNCT	O
F	O	PROPN	B
.	O	PUNCT	O


As	O	ADP	O
an	O	DET	O
initial	O	ADJ	O
step	O	NOUN	O
towards	O	ADP	O
the	O	DET	O
characterization	O	NOUN	B
of	O	ADP	O
replicative	O	ADJ	B
DNA	B-GENE	NOUN	B
polymerases	I-GENE	NOUN	I
of	I-GENE	ADP	O
trypanosomes	I-GENE	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
,	O	PUNCT	O
sequenced	O	VERB	B
and	O	CCONJ	O
examined	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Trypanosoma	O	NOUN	B
(	O	PUNCT	I
Trypanozoon	O	NOUN	O
)	O	PUNCT	O
brucei	O	X	O
brucei	O	X	O
gene	O	NOUN	O
that	O	PRON	O
encodes	O	VERB	B
the	O	DET	O
DNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
alpha	I-GENE	NOUN	I
catalytic	I-GENE	ADJ	I
core	I-GENE	NOUN	I
(	O	PUNCT	O
pol	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Hence	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
uPA	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
contains	O	VERB	O
multiple	O	ADJ	B
weak	O	ADJ	B
cis	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
elements	O	NOUN	B
distributed	O	VERB	B
over	O	ADP	O
7	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
kb	O	NOUN	O
5	O	NUM	O
'	O	PUNCT	O
to	O	ADP	O
the	O	DET	O
translation	O	NOUN	B
start	O	NOUN	O
site	O	NOUN	O
.	O	PUNCT	O


12	O	NUM	O
-	O	PUNCT	O
O	O	NOUN	B
-	O	PUNCT	O
Tetradecanoylphorbol	O	NOUN	B
13	O	NUM	O
-	O	PUNCT	O
acetate	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
inhibit	O	VERB	B
rapidly	O	ADV	B
and	O	CCONJ	O
potently	O	ADV	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
mRNAs	O	NOUN	B
coding	O	VERB	B
for	O	ADP	O
the	O	DET	O
myogenic	O	ADJ	B
regulators	O	NOUN	I
CMD1	B-GENE	NOUN	B
and	O	CCONJ	O
myogenin	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mRNA	O	NOUN	B
identified	O	VERB	B
in	O	ADP	O
both	O	CCONJ	O
human	O	ADJ	B
and	O	CCONJ	O
rat	O	NOUN	B
cells	O	NOUN	B
with	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
clathrin	I-GENE	NOUN	O
clone	O	NOUN	B
revealed	O	VERB	O
transcripts	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	B
6	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
kb	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
predicted	O	VERB	B
180	O	NUM	O
kDa	O	NOUN	O
molecular	O	ADJ	B
weight	O	NOUN	I
of	O	ADP	O
the	O	DET	O
clathrin	B-GENE	NOUN	B
heavy	I-GENE	ADJ	O
chain	I-GENE	NOUN	O
.	O	PUNCT	O


A	O	DET	O
method	O	NOUN	B
is	O	AUX	O
described	O	VERB	O
for	O	ADP	O
detecting	O	VERB	B
targeted	O	VERB	B
events	O	NOUN	I
at	O	ADP	O
the	O	DET	O
mu	B-GENE	NOUN	B
heavy	I-GENE	ADJ	I
chain	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
which	O	DET	O
relies	O	VERB	O
on	O	ADP	O
co	O	ADJ	B
-	O	PUNCT	O
conversion	O	NOUN	B
(	O	PUNCT	O
or	O	CCONJ	O
co	O	ADJ	B
-	O	PUNCT	O
exchange	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
a	O	DET	O
point	O	NOUN	O
mutation	O	NOUN	B
with	O	ADP	O
a	O	DET	O
selectable	O	ADJ	B
marker	O	NOUN	I
contained	O	VERB	O
on	O	ADP	O
a	O	DET	O
replacement	O	NOUN	B
vector	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
potential	O	ADJ	B
regulatory	O	ADJ	B
sequences	O	NOUN	I
for	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
proteins	O	NOUN	I
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
non	O	ADV	B
-	O	PUNCT	O
coding	O	VERB	B
5	O	NUM	O
'	O	PART	O
region	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
HAP2	B-GENE	NOUN	B
/	O	SYM	O
HAP3	B-GENE	NOUN	B
consensus	O	NOUN	B
recognition	O	NOUN	I
sequence	O	NOUN	I
at	O	ADP	O
nucleotide	O	NOUN	B
-	O	PUNCT	O
154	O	NUM	O
and	O	CCONJ	O
a	O	DET	O
BAF1	B-GENE	NOUN	B
consensus	I-GENE	NOUN	B
recognition	I-GENE	NOUN	I
sequence	I-GENE	NOUN	I
at	O	ADP	O
nucleotide	O	NOUN	B
-	O	PUNCT	O
136	O	NUM	O
.	O	PUNCT	O


A	O	DET	O
330	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	B
YAC	O	NOUN	I
,	O	PUNCT	O
A148A7	O	ADJ	B
,	O	PUNCT	O
spanned	O	VERB	O
from	O	ADP	O
the	O	DET	O
HLA	B-GENE	NOUN	B
-	O	PUNCT	O
DQA1	B-GENE	NOUN	B
locus	O	NOUN	O
through	O	ADP	O
the	O	DET	O
Y3	B-GENE	NOUN	B
/	O	SYM	O
Ring	B-GENE	NOUN	B
4	I-GENE	NUM	I
locus	O	NOUN	B
and	O	CCONJ	O
extended	O	VERB	B
at	O	ADP	O
least	O	ADJ	O
130	O	NUM	O
kb	O	NOUN	O
centromeric	O	ADJ	O
of	O	ADP	O
YAC	O	NOUN	O
B1D12	O	NOUN	B
.	O	PUNCT	O


First	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
finding	O	NOUN	B
of	O	ADP	O
a	O	DET	O
monomeric	O	ADJ	B
Alu	B-GENE	NOUN	I
family	O	NOUN	I
repeat	O	NOUN	O
at	O	ADP	O
the	O	DET	O
junction	O	NOUN	B
between	O	ADP	O
nonhomology	O	NOUN	B
block	O	NOUN	O
I	O	NUM	O
and	O	CCONJ	O
homology	O	NOUN	B
block	O	VERB	I
Y	O	NOUN	I
of	O	ADP	I
the	O	DET	I
alpha	B-GENE	NOUN	I
2	I-GENE	NUM	I
gene	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
containing	I-GENE	VERB	B
unit	I-GENE	NOUN	O
in	I-GENE	ADP	O
rhesus	I-GENE	NOUN	B
macaque	I-GENE	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
dimeric	O	ADJ	B
Alu	B-GENE	NOUN	O
family	O	NOUN	O
repeat	O	NOUN	O
,	O	PUNCT	O
Alu	B-GENE	NOUN	B
3	I-GENE	NUM	I
,	O	PUNCT	O
at	O	ADP	O
the	O	DET	O
orthologous	O	ADJ	B
position	O	NOUN	O
in	O	ADP	O
human	O	ADJ	B
was	O	AUX	O
generated	O	VERB	O
by	O	ADP	O
insertion	O	NOUN	B
of	O	ADP	O
a	O	DET	O
monomeric	O	ADJ	B
Alu	B-GENE	NOUN	I
family	O	NOUN	I
repeat	O	NOUN	O
into	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
another	O	DET	O
preexisting	O	VERB	O
Alu	B-GENE	NOUN	B
family	O	NOUN	I
repeat	O	NOUN	I
.	O	PUNCT	O


Ten	O	NUM	O
out	O	ADP	O
of	O	ADP	O
10	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
progressive	O	ADJ	B
disease	O	NOUN	O
had	O	AUX	O
mast	O	NOUN	B
cells	O	NOUN	I
greater	O	ADJ	O
than	O	ADP	O
or	O	CCONJ	O
equal	O	ADJ	O
to	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
hyaluronan	O	NOUN	B
greater	O	ADJ	B
than	O	ADP	O
or	O	CCONJ	O
equal	O	ADJ	O
to	O	PART	O
50	O	NUM	O
micrograms	O	NOUN	B
.	O	PUNCT	O
l	O	NOUN	O
-	O	PUNCT	O
1	O	NUM	O
and	O	CCONJ	O
fibronectin	B-GENE	NOUN	B
greater	O	ADJ	B
than	O	ADP	O
or	O	CCONJ	O
equal	O	ADJ	O
to	O	PART	O
350	O	NUM	O
micrograms	O	NOUN	B
.	O	PUNCT	O
l	O	X	O
-	O	PUNCT	O
1	O	NUM	O
compared	O	VERB	B
to	O	PART	O
eight	O	NUM	O
out	O	ADP	O
of	O	ADP	O
41	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
stable	O	ADJ	B
or	O	CCONJ	O
regressive	O	ADJ	B
disease	O	NOUN	I
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
contrast	O	NOUN	B
media	O	NOUN	I
on	O	ADP	O
coagulation	B-GENE	NOUN	B
factor	I-GENE	NOUN	I
XII	I-GENE	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
identified	O	VERB	B
a	O	DET	O
strong	O	ADJ	O
positive	O	ADJ	B
cis	O	NOUN	B
-	O	PUNCT	O
regulatory	O	ADJ	B
element	O	NOUN	I
at	O	ADP	O
-	O	PUNCT	O
70	O	NUM	O
bp	O	NOUN	O
to	O	PART	O
-	O	PUNCT	O
75	O	NUM	O
bp	O	NOUN	O
in	O	ADP	O
the	O	DET	O
LpS1	B-GENE	NOUN	B
beta	I-GENE	NOUN	I
promoter	I-GENE	NOUN	I
with	O	ADP	O
the	O	DET	O
sequence	O	NOUN	B
(	O	PUNCT	O
G	O	NOUN	B
)	O	PUNCT	O
6	O	NUM	O
and	O	CCONJ	O
a	O	DET	O
similar	O	ADJ	O
,	O	PUNCT	O
more	O	ADV	O
distal	O	ADJ	B
cis	O	NOUN	B
-	O	PUNCT	O
element	O	NOUN	B
at	O	ADP	O
-	O	PUNCT	O
721	O	NUM	O
bp	O	NOUN	O
to	O	PART	O
-	O	PUNCT	O
726	O	NUM	O
bp	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
12S	B-GENE	ADJ	B
E1A	I-GENE	NOUN	I
product	I-GENE	NOUN	O
does	O	AUX	O
not	O	PART	O
activate	O	VERB	B
a	O	DET	O
TRE	O	NOUN	B
sequence	O	NOUN	O
,	O	PUNCT	O
but	O	CCONJ	O
cotransfection	O	NOUN	B
with	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
jun	I-GENE	NOUN	B
circumvents	O	VERB	O
this	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
stimulation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
pp90rsk	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
protein	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
activity	O	NOUN	I
(	O	PUNCT	O
referred	O	VERB	O
to	O	PART	O
as	O	ADP	O
rsk	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kinase	I-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
also	O	ADV	O
not	O	PART	O
related	O	ADJ	O
to	O	PART	O
cofactor	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
signal	O	NOUN	B
transducing	O	NOUN	I
protein	O	NOUN	I
kinases	O	NOUN	I
such	O	ADJ	O
as	O	ADP	O
the	O	DET	O
cyclic	B-GENE	ADJ	B
AMP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
protein	I-GENE	NOUN	B
kinases	I-GENE	NOUN	I
,	O	PUNCT	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
C	I-GENE	NOUN	I
family	I-GENE	NOUN	O
,	O	PUNCT	O
or	O	CCONJ	O
other	O	ADJ	O
Ca2	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
+	I-GENE	CCONJ	O
)	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
protein	I-GENE	NOUN	B
kinases	I-GENE	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
UvrA	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
interacts	O	VERB	O
with	O	ADP	O
the	O	DET	O
UvrB	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
to	O	PART	O
modulate	O	VERB	B
its	O	PRON	O
activities	O	NOUN	B
,	O	PUNCT	O
both	O	CCONJ	O
in	O	ADP	O
solution	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	I
DNA	O	NOUN	B
,	O	PUNCT	O
where	O	SCONJ	O
the	O	DET	O
UvrAB	B-GENE	NOUN	B
complex	I-GENE	NOUN	O
possesses	O	VERB	O
a	O	DET	O
helicase	B-GENE	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


Southwestern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
demonstrated	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
phosphoprotein	O	NOUN	B
can	O	AUX	O
bind	O	VERB	B
the	O	DET	O
kappa	B-GENE	NOUN	B
B	I-GENE	NOUN	I
element	I-GENE	NOUN	I
directly	O	ADV	O
and	O	CCONJ	O
specifically	O	ADV	O
.	O	PUNCT	O


Imaging	O	NOUN	B
of	O	ADP	O
D2	B-GENE	NOUN	B
dopamine	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I


The	O	DET	O
murine	B-GENE	ADJ	B
Mov	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
34	I-GENE	NUM	O
gene	I-GENE	NOUN	B
:	O	PUNCT	O
full	O	ADJ	B
-	O	PUNCT	O
length	O	NOUN	B
cDNA	O	NOUN	B
and	O	CCONJ	O
genomic	O	ADJ	B
organization	O	NOUN	I
.	O	PUNCT	O


When	O	SCONJ	O
transfected	O	VERB	B
into	O	ADP	O
Drosophila	O	X	B
SL	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	O
cells	O	NOUN	B
,	O	PUNCT	O
pCAT	O	NOUN	B
plasmid	O	NOUN	I
containing	O	VERB	O
2	O	NUM	O
,	O	PUNCT	O
090	O	NUM	O
bp	O	NOUN	O
of	O	ADP	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
flanking	O	ADJ	B
region	O	NOUN	I
shows	O	VERB	O
a	O	DET	O
3	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
-	O	PUNCT	O
to	O	PART	O
3	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	O
activity	O	NOUN	O
after	O	ADP	O
induction	O	NOUN	B
with	O	ADP	O
retinoic	O	ADJ	B
acid	O	NOUN	I
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
8	O	NUM	O
-	O	PUNCT	O
bromo	O	NOUN	B
-	O	PUNCT	O
cAMP	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminus	O	NOUN	B
of	O	ADP	O
another	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
3	O	NUM	O
'	O	PUNCT	O
from	O	ADP	O
nifA	B-GENE	NOUN	B
and	O	CCONJ	O
tentatively	O	ADV	O
identified	O	VERB	B
as	O	ADP	O
nifB	B-GENE	NOUN	O
by	O	ADP	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
comparison	O	NOUN	B
.	O	PUNCT	O


Chagas	O	NOUN	B
'	O	PART	I
disease	O	NOUN	I
,	O	PUNCT	O
visceral	O	ADJ	B
leishmaniasis	O	NOUN	I
,	O	PUNCT	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
nuclear	I-GENE	ADJ	B
factor	I-GENE	NOUN	I
,	O	PUNCT	O
schistosomiasis	O	NOUN	B
,	O	PUNCT	O
rheumatoid	B-GENE	ADJ	B
factor	I-GENE	NOUN	I
and	O	CCONJ	O
normal	O	ADJ	B
controls	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
larger	O	ADJ	B
region	O	NOUN	I
upstream	O	ADJ	B
of	O	ADP	O
human	B-GENE	ADJ	B
CMV	I-GENE	NOUN	B
dbp	I-GENE	NOUN	I
also	O	ADV	O
mediated	O	VERB	O
replication	O	NOUN	B
in	O	ADP	O
transient	O	ADJ	B
assays	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
result	O	NOUN	O
suggests	O	VERB	O
that	O	SCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
Thr	O	NOUN	B
14	O	NUM	O
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
Tyr	O	NOUN	B
15	O	NUM	O
inhibits	O	VERB	B
p34cdc2	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
activity	O	NOUN	O
,	O	PUNCT	O
in	O	ADP	O
line	O	NOUN	O
with	O	ADP	O
the	O	DET	O
location	O	NOUN	B
of	O	ADP	O
these	O	DET	O
residues	O	NOUN	B
within	O	ADP	O
the	O	DET	O
putative	O	ADJ	B
ATP	O	NOUN	I
binding	O	NOUN	B
site	O	NOUN	I
of	O	ADP	O
the	O	DET	O
kinase	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
findings	O	NOUN	B
are	O	AUX	O
compatible	O	ADJ	O
with	O	ADP	O
the	O	DET	O
idea	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
genes	O	NOUN	B
encoding	O	VERB	B
PDGF	B-GENE	NOUN	B
receptors	I-GENE	NOUN	I
in	O	ADP	O
glioma	O	NOUN	B
cells	O	NOUN	I
are	O	AUX	O
regulated	O	VERB	O
in	O	ADP	O
concert	O	NOUN	O
with	O	ADP	O
other	O	ADJ	O
genes	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
which	O	DET	O
may	O	AUX	O
reflect	O	VERB	O
the	O	DET	O
developmental	O	ADJ	B
program	O	NOUN	I
of	O	ADP	O
normal	O	ADJ	O
glia	O	NOUN	B
cell	O	NOUN	B
lineages	O	NOUN	I
.	O	PUNCT	O


Suggestive	O	ADJ	B
evidence	O	NOUN	B
was	O	AUX	O
obtained	O	VERB	O
that	O	SCONJ	O
cstA	B-GENE	NOUN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
peptide	O	NOUN	B
utilization	O	NOUN	B
.	O	PUNCT	O


Heterodimers	O	NOUN	B
of	O	ADP	O
myogenin	B-GENE	NOUN	B
and	O	CCONJ	O
E12	B-GENE	NOUN	B
(	O	PUNCT	O
or	O	CCONJ	O
MyoD	B-GENE	NOUN	B
and	O	CCONJ	O
E12	B-GENE	NOUN	B
)	O	PUNCT	O
specifically	O	ADV	O
bound	O	VERB	O
a	O	DET	O
restriction	O	NOUN	B
fragment	O	NOUN	I
extending	O	VERB	O
from	O	ADP	O
-	O	PUNCT	O
200	O	NUM	O
to	O	ADP	O
-	O	PUNCT	O
103	O	NUM	O
relative	O	ADJ	O
to	O	PART	O
the	O	DET	O
start	O	NOUN	O
of	O	ADP	O
cardiac	B-GENE	ADJ	B
alpha	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
actin	I-GENE	NOUN	B
transcription	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
were	O	AUX	O
further	O	ADV	O
dissected	O	VERB	B
by	O	ADP	O
showing	O	VERB	O
that	O	SCONJ	O
c	B-GENE	X	B
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
can	O	AUX	O
inhibit	O	VERB	B
differentiation	O	NOUN	B
independently	O	ADV	O
of	O	ADP	O
Id	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
negative	O	ADJ	B
regulator	O	NOUN	B
of	O	ADP	O
muscle	O	NOUN	B
differentiation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	B-GENE	NOUN	B
encoding	I-GENE	VERB	B
Alzheimer	I-GENE	NOUN	B
beta	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
amyloid	I-GENE	NOUN	B
precursor	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
(	O	PUNCT	O
APP	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
two	O	NUM	O
blocks	O	NOUN	B
of	O	ADP	O
upstream	O	ADJ	B
sequences	O	NOUN	I
.	O	PUNCT	O


Premature	O	ADJ	B
initiation	O	NOUN	I
of	O	ADP	O
mitosis	O	NOUN	B
in	O	ADP	O
yeast	O	NOUN	B
lacking	O	VERB	O
RCC1	B-GENE	NOUN	B
or	O	CCONJ	O
an	O	DET	O
interacting	O	VERB	B
GTPase	B-GENE	NOUN	B
.	O	PUNCT	O


Space	O	PROPN	B
limitations	O	NOUN	B
prevent	O	VERB	B
an	O	DET	O
exhaustive	O	ADJ	B
review	O	NOUN	B
of	O	ADP	O
all	O	DET	O
biologic	O	ADJ	B
pharmaceuticals	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
tissue	B-GENE	NOUN	B
plasminogen	I-GENE	NOUN	B
activating	I-GENE	NOUN	I
substance	I-GENE	NOUN	O
,	O	PUNCT	O
hormones	O	NOUN	B
(	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
g	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
thyroid	O	NOUN	B
,	O	PUNCT	O
insulin	B-GENE	NOUN	B
,	O	PUNCT	O
growth	B-GENE	NOUN	B
hormone	I-GENE	NOUN	I
,	O	PUNCT	O
erythropoietin	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
clotting	O	NOUN	B
factors	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
blood	O	NOUN	B
products	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
various	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
sickle	O	ADJ	B
cell	O	NOUN	B
disease	O	NOUN	I
share	O	VERB	O
the	O	DET	O
common	O	ADJ	O
feature	O	NOUN	O
of	O	ADP	O
an	O	DET	O
abnormal	O	ADJ	B
globin	B-GENE	NOUN	B
chain	I-GENE	NOUN	I
that	O	PRON	O
,	O	PUNCT	O
under	O	ADP	O
certain	O	ADJ	O
conditions	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
hypoxia	O	NOUN	B
,	O	PUNCT	O
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
sickling	O	NOUN	B
of	O	ADP	O
red	O	ADJ	B
blood	O	NOUN	I
cells	O	NOUN	I
and	O	CCONJ	O
obstruction	O	NOUN	B
of	O	ADP	O
blood	O	NOUN	B
vessels	O	NOUN	I
.	O	PUNCT	O


Human	B-GENE	ADJ	B
immunodeficiency	I-GENE	NOUN	I
virus	I-GENE	NOUN	I
type	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	I-GENE	PUNCT	O
HIV	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	I-GENE	PUNCT	O
IN	I-GENE	ADV	O
,	O	PUNCT	O
expressed	O	VERB	B
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
,	O	PUNCT	O
was	O	AUX	O
purified	O	VERB	O
to	O	PART	O
near	O	ADJ	B
homogeneity	O	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
viral	O	ADJ	B
mutants	O	NOUN	I
in	O	X	B
vivo	O	X	I
demonstrated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
NFIII	B-GENE	PROPN	B
/	O	SYM	O
OCT	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
binding	O	NOUN	B
site	O	NOUN	I
and	O	CCONJ	O
a	O	DET	O
conserved	O	VERB	O
ATF	B-GENE	NOUN	B
motif	I-GENE	NOUN	B
were	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
efficient	O	ADJ	B
viral	O	ADJ	B
growth	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
indicates	O	VERB	O
that	O	SCONJ	O
under	O	ADP	O
certain	O	ADJ	O
experimental	O	ADJ	B
conditions	O	NOUN	B
cdc2	B-GENE	NOUN	B
/	O	SYM	O
p58	B-GENE	NOUN	B
and	O	CCONJ	O
cdc2	B-GENE	NOUN	B
/	O	PUNCT	O
p62	B-GENE	NOUN	B
may	O	AUX	O
express	O	VERB	O
some	O	DET	O
differences	O	NOUN	O
in	O	ADP	O
their	O	PRON	O
catalytic	O	ADJ	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
enzymatic	O	ADJ	B
response	O	NOUN	I
of	O	ADP	O
neutrophils	O	NOUN	B
and	O	CCONJ	O
monocytes	O	NOUN	B
was	O	AUX	O
similar	O	ADJ	O
although	O	SCONJ	O
the	O	DET	O
magnitude	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NADPH	B-GENE	NOUN	B
oxidase	I-GENE	NOUN	I
activity	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
higher	O	ADJ	O
in	O	ADP	O
neutrophils	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
monocytes	O	NOUN	B
.	O	PUNCT	O


All	O	DET	O
members	O	NOUN	B
are	O	AUX	O
also	O	ADV	O
capable	O	ADJ	O
of	O	ADP	O
activating	O	VERB	B
in	O	X	B
vivo	O	X	I
transcription	O	NOUN	B
from	O	ADP	O
promoters	O	NOUN	B
that	O	PRON	O
contain	O	VERB	O
a	O	DET	O
C	B-GENE	PROPN	B
/	I-GENE	SYM	O
EBP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
site	I-GENE	NOUN	I
.	O	PUNCT	O


POU	B-GENE	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
and	O	CCONJ	O
POU	B-GENE	NOUN	B
-	O	PUNCT	O
homeo	O	NOUN	B
domains	O	NOUN	B
of	O	ADP	O
Oct3	B-GENE	NOUN	B
were	O	AUX	O
produced	O	VERB	O
in	O	ADP	O
Echerichia	O	X	B
coli	O	X	I
for	O	ADP	O
characterization	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
binding	O	NOUN	I
to	O	PART	O
the	O	DET	O
octamer	O	NOUN	B
sequence	O	NOUN	O
.	O	PUNCT	O


Determinants	O	NOUN	B
of	O	ADP	O
recurrent	O	ADJ	B
ischaemia	O	NOUN	B
and	O	CCONJ	O
revascularisation	O	NOUN	B
procedures	O	NOUN	I
after	O	ADP	O
thrombolysis	O	NOUN	B
with	O	ADP	O
recombinant	O	ADJ	B
tissue	B-GENE	NOUN	I
plasminogen	I-GENE	NOUN	I
activator	I-GENE	NOUN	I
in	O	ADP	O
primary	O	ADJ	B
coronary	O	ADJ	I
occlusion	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
rbcL	B-GENE	NOUN	B
-	O	PUNCT	O
rbcS	B-GENE	NOUN	B
locus	O	NOUN	B
seems	O	VERB	O
to	O	PART	O
be	O	AUX	O
barely	O	ADV	O
expressed	O	VERB	B
under	O	ADP	O
a	O	DET	O
standard	O	ADJ	B
condition	O	NOUN	I
for	O	ADP	O
photoautotrophic	O	ADJ	B
growth	O	NOUN	I
.	O	PUNCT	O


Sequence	O	NOUN	B
requirements	O	NOUN	B
for	O	ADP	O
premature	O	ADJ	B
transcription	O	NOUN	I
arrest	O	NOUN	I
within	O	ADP	O
the	O	DET	O
first	O	ADJ	O
intron	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
c	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
fos	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


If	O	SCONJ	O
this	O	DET	O
is	O	AUX	O
the	O	DET	O
case	O	NOUN	B
,	O	PUNCT	O
identification	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
transcripts	O	NOUN	B
from	O	ADP	O
the	O	DET	O
Ig	B-GENE	NOUN	B
loci	I-GENE	NOUN	I
should	O	AUX	O
permit	O	VERB	O
a	O	DET	O
better	O	ADJ	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
rearrangement	O	NOUN	I
process	O	NOUN	I
.	O	PUNCT	O


Transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
metH	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
in	I-GENE	ADP	O
Salmonella	I-GENE	X	B
typhimurium	I-GENE	X	I
and	I-GENE	CCONJ	O
Escherichia	I-GENE	X	B
coli	I-GENE	X	I
is	O	AUX	O
positively	O	ADV	O
regulated	O	VERB	O
by	O	ADP	O
the	O	DET	O
metR	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	I
,	O	PUNCT	O
a	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
protein	O	NOUN	I
.	O	PUNCT	O


Additionally	O	ADV	O
,	O	PUNCT	O
I	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
B	I-GENE	NOUN	I
beta	I-GENE	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
I	B-GENE	NOUN	O
kappa	I-GENE	NOUN	O
B	I-GENE	NOUN	O
alpha	I-GENE	NOUN	O
,	O	PUNCT	O
also	O	ADV	O
prevented	O	VERB	B
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
Rel	B-GENE	NOUN	B
to	O	PART	O
the	O	DET	O
kappa	B-GENE	NOUN	B
B	I-GENE	NOUN	I
site	I-GENE	NOUN	I
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
reveals	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
domain	O	NOUN	I
of	O	ADP	O
ILF	B-GENE	PROPN	B
has	O	AUX	O
strong	O	ADJ	O
homology	O	NOUN	B
to	O	PART	O
the	O	DET	O
recently	O	ADV	O
described	O	VERB	O
fork	B-GENE	NOUN	B
head	I-GENE	NOUN	I
DNA	I-GENE	NOUN	O
binding	I-GENE	NOUN	O
domain	I-GENE	NOUN	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
Drosophila	B-GENE	X	B
homeotic	I-GENE	ADJ	B
protein	I-GENE	NOUN	I
fork	I-GENE	NOUN	I
head	I-GENE	NOUN	I
and	O	CCONJ	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
hepatocyte	B-GENE	NOUN	B
nuclear	I-GENE	ADJ	O
factors	I-GENE	NOUN	O
,	O	PUNCT	O
HNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
.	O	PUNCT	O


The	O	DET	O
structural	O	ADJ	B
changes	O	NOUN	O
in	O	ADP	O
intra	O	ADJ	B
-	O	PUNCT	O
acinar	O	ADJ	B
artery	O	NOUN	I
manifested	O	VERB	O
mainly	O	ADV	O
by	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
number	O	NOUN	O
of	O	ADP	O
muscular	O	ADJ	B
artery	O	NOUN	I
resulting	O	VERB	O
from	O	ADP	O
muscularization	O	NOUN	B
of	O	ADP	O
precursor	O	NOUN	B
cells	O	NOUN	I
(	O	PUNCT	O
pericytes	O	NOUN	B
and	O	CCONJ	O
intermediate	O	ADJ	B
cells	O	NOUN	I
)	O	PUNCT	O
located	O	ADJ	O
within	O	ADP	O
partially	O	ADV	O
muscular	O	ADJ	B
and	O	CCONJ	O
nonmuscular	O	ADJ	B
arterial	O	ADJ	I
wall	O	NOUN	I
to	O	ADP	O
smooth	O	ADJ	B
muscle	O	NOUN	I
cell	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
by	O	ADP	O
the	O	DET	O
medial	O	ADJ	B
wall	O	NOUN	I
thickened	O	ADJ	B
due	O	ADP	O
to	O	PART	O
hypertrophy	O	NOUN	B
and	O	CCONJ	O
hyperplasia	O	NOUN	B
of	O	ADP	O
smooth	O	ADJ	B
muscle	O	NOUN	I
cells	O	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
accumulation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
large	O	ADJ	O
amount	O	NOUN	O
of	O	ADP	O
collagen	B-GENE	NOUN	B
,	O	PUNCT	O
especially	O	ADV	O
the	O	DET	O
type	B-GENE	NOUN	B
1	I-GENE	NUM	I
collagen	I-GENE	NOUN	I
.	O	PUNCT	O


Lipoprotein	B-GENE	NOUN	B
lipase	I-GENE	NOUN	I
(	O	PUNCT	O
LPL	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
key	O	ADJ	O
enzyme	O	NOUN	B
in	O	ADP	O
normal	O	ADJ	O
lipoprotein	O	NOUN	B
metabolism	O	NOUN	I
,	O	PUNCT	O
has	O	AUX	O
a	O	DET	O
complex	O	ADJ	B
pattern	O	NOUN	B
of	O	ADP	O
regulation	O	NOUN	B
and	O	CCONJ	O
tissue	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
expression	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
examined	O	VERB	O
the	O	DET	O
binding	O	NOUN	B
of	O	ADP	O
purified	O	VERB	B
T3	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
alpha	I-GENE	NOUN	I
(	O	PUNCT	O
T3R	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
overexpressed	O	VERB	B
in	O	ADP	O
Escherichia	O	X	B
coli	O	X	I
,	O	PUNCT	O
to	O	PART	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
and	O	CCONJ	O
up	O	ADV	O
and	O	CCONJ	O
down	O	ADP	O
mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rGH	B-GENE	NOUN	B
T3RE	B-GENE	NOUN	B
to	O	PART	O
evaluate	O	VERB	B
whether	O	SCONJ	O
transcriptional	O	ADJ	B
potency	O	NOUN	B
correlates	O	VERB	O
with	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
T3R	B-GENE	NOUN	B
binding	O	NOUN	I
.	O	PUNCT	O


Position	O	NOUN	B
22	O	NUM	O
is	O	AUX	O
an	O	DET	O
isoleucine	O	NOUN	B
in	O	ADP	O
the	O	DET	O
complete	B-GENE	ADJ	B
SsoL12	I-GENE	ADJ	O
protein	I-GENE	NOUN	O
sequence	I-GENE	NOUN	O
,	O	PUNCT	O
coded	O	VERB	O
by	O	ADP	O
an	O	DET	O
AUA	O	PROPN	B
codon	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
yeast	O	NOUN	B
Saccharomyces	O	X	B
cerevisiae	O	X	I
,	O	PUNCT	O
copper	O	NOUN	B
levels	O	NOUN	B
exert	O	VERB	O
some	O	DET	O
control	O	NOUN	B
over	O	ADP	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
SOD1	B-GENE	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


Twenty	O	NUM	B
-	O	PUNCT	O
four	O	NUM	O
hours	O	NOUN	B
later	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
animals	O	NOUN	B
were	O	AUX	O
randomized	O	VERB	B
to	O	PART	O
subretinal	O	ADJ	B
treatment	O	NOUN	B
with	O	ADP	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
micrograms	O	NOUN	B
of	O	ADP	O
tissue	B-GENE	NOUN	B
plasminogen	I-GENE	NOUN	B
activator	I-GENE	NOUN	I
or	O	CCONJ	O
a	O	DET	O
similar	O	ADJ	O
volume	O	NOUN	B
of	O	ADP	O
physiologic	O	ADJ	B
saline	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
salmon	B-GENE	NOUN	B
calcitonin	I-GENE	NOUN	I
nasal	O	ADJ	B
spray	O	NOUN	I
in	O	ADP	O
women	O	NOUN	B
with	O	ADP	O
established	O	ADJ	O
osteoporosis	O	NOUN	B
has	O	AUX	O
also	O	ADV	O
been	O	AUX	O
studied	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
solidification	O	NOUN	B
could	O	AUX	O
occur	O	VERB	O
in	O	ADP	O
all	O	DET	O
feeds	O	NOUN	B
containing	O	VERB	O
casein	B-GENE	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
alternative	O	ADJ	B
feeds	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
considered	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
increased	O	VERB	B
gastric	O	ADJ	B
acidity	O	NOUN	I
.	O	PUNCT	O


Heterogeneous	O	ADJ	B
electron	O	NOUN	I
transfer	O	NOUN	I
of	O	ADP	O
cytochrome	B-GENE	NOUN	B
c	I-GENE	NOUN	I
facilitated	O	VERB	O
by	O	ADP	O
polypyrrole	O	NOUN	B
and	O	CCONJ	O
methylene	O	ADJ	B
blue	O	ADJ	I
polypyrrole	O	NOUN	I
film	O	NOUN	B
modified	O	ADJ	B
electrodes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
1489	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
pair	O	NOUN	I
EFIA	B-GENE	NOUN	B
cDNA	O	NOUN	B
encodes	O	VERB	B
a	O	DET	O
322	O	NUM	O
-	O	PUNCT	O
amino	O	NOUN	B
acid	O	NOUN	I
protein	O	NOUN	I
which	O	DET	O
is	O	AUX	O
nearly	O	ADV	O
identical	O	ADJ	B
to	O	PART	O
two	O	NUM	O
previously	O	ADV	O
described	O	VERB	O
human	O	ADJ	B
DNA	O	NOUN	B
binding	O	NOUN	I
proteins	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
coding	O	VERB	B
sequence	O	NOUN	I
for	O	ADP	O
a	O	DET	O
260	O	NUM	O
-	O	PUNCT	O
amino	O	NOUN	B
-	O	PUNCT	O
acid	O	NOUN	B
residue	O	NOUN	O
polypeptide	O	NOUN	B
was	O	AUX	O
interrupted	O	VERB	B
by	O	ADP	O
a	O	DET	O
single	O	ADJ	O
short	O	ADJ	B
intron	O	NOUN	I
of	O	ADP	O
60	O	NUM	O
base	O	NOUN	O
pairs	O	NOUN	O
(	O	PUNCT	O
bp	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
about	O	ADV	O
70	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
deduced	O	VERB	B
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Drosophila	B-GENE	X	B
PCNA	I-GENE	NOUN	B
was	O	AUX	O
identical	O	ADJ	B
to	O	PART	O
the	O	DET	O
rat	O	NOUN	B
and	O	CCONJ	O
human	B-GENE	ADJ	B
PCNA	I-GENE	NOUN	O
polypeptides	I-GENE	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
conserved	O	VERB	O
unique	O	ADJ	B
repeats	O	NOUN	B
of	O	ADP	O
leucine	O	NOUN	B
in	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
region	O	NOUN	O
.	O	PUNCT	O


Translational	O	ADJ	B
fusions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
aroF	B-GENE	NOUN	B
regulatory	I-GENE	ADJ	B
regions	I-GENE	NOUN	I
to	O	PART	O
lacZ	B-GENE	NOUN	B
were	O	AUX	O
constructed	O	VERB	O
and	O	CCONJ	O
then	O	ADV	O
introduced	O	VERB	O
in	O	ADP	O
single	O	ADJ	O
copy	O	NOUN	B
into	O	ADP	O
the	O	DET	O
E	O	NOUN	B
.	O	PUNCT	O
coli	O	X	B
chromosome	O	NOUN	I
.	O	PUNCT	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Galactosidase	I-GENE	PROPN	B
assays	O	NOUN	I
for	O	ADP	O
tyrR	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
regulation	O	NOUN	B
of	O	ADP	O
aroF	B-GENE	NOUN	B
-	O	PUNCT	O
lacZ	B-GENE	NOUN	B
expression	O	NOUN	B
revealed	O	VERB	B
that	O	SCONJ	O
the	O	DET	O
E	B-GENE	PROPN	B
.	I-GENE	PUNCT	O
coli	I-GENE	X	B
TyrR	I-GENE	NOUN	B
repressor	I-GENE	NOUN	B
apparently	O	ADV	O
recognizes	O	VERB	O
the	O	DET	O
operators	O	NOUN	B
of	O	ADP	O
both	O	DET	O
organisms	O	NOUN	B
with	O	ADP	O
about	O	ADV	O
equal	O	ADJ	O
efficiency	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
high	O	ADJ	B
-	O	PUNCT	O
frequency	O	NOUN	B
restriction	O	NOUN	O
fragment	O	NOUN	O
length	O	NOUN	O
polymorphism	O	NOUN	B
was	O	AUX	O
evident	O	ADJ	O
in	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
from	O	ADP	O
29	O	NUM	O
unrelated	O	ADJ	O
individuals	O	NOUN	B
using	O	VERB	O
the	O	DET	O
enzyme	O	NOUN	B
BglII	B-GENE	NOUN	I
.	O	PUNCT	O


Judicious	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
laboratory	O	ADJ	B
testing	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
monitoring	O	NOUN	B
of	O	ADP	O
CD4	B-GENE	NOUN	B
cell	O	NOUN	I
counts	O	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
recommended	O	VERB	B
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
growth	O	NOUN	B
-	O	PUNCT	O
regulated	O	VERB	B
Syrian	B-GENE	ADJ	B
hamster	I-GENE	NOUN	B
CAD	I-GENE	NOUN	I
gene	I-GENE	NOUN	B
.	O	PUNCT	O


Cloning	O	NOUN	B
,	O	PUNCT	O
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
nucleotide	O	NOUN	B
sequence	O	NOUN	I
of	O	ADP	O
rat	B-GENE	NOUN	B
liver	I-GENE	NOUN	B
sterol	I-GENE	NOUN	I
carrier	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
2	I-GENE	NUM	I
cDNAs	I-GENE	NOUN	B
.	O	PUNCT	O


Induction	O	NOUN	B
requires	O	VERB	O
the	O	DET	O
ACE1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	I
,	O	PUNCT	O
which	O	DET	O
binds	O	VERB	B
to	O	PART	O
specific	O	ADJ	O
sites	O	NOUN	B
in	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CUP1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
sequence	O	NOUN	B
of	O	ADP	O
four	O	NUM	O
clones	O	NOUN	B
was	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
construct	O	VERB	O
a	O	DET	O
3018	B-GENE	NUM	O
-	I-GENE	PUNCT	O
bp	I-GENE	NOUN	B
BAL	I-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
structure	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
strengthen	O	VERB	O
the	O	DET	O
conclusion	O	NOUN	O
that	O	SCONJ	O
predominantly	O	ADV	O
dynamic	O	ADJ	B
activity	O	NOUN	I
increases	O	VERB	B
the	O	DET	O
G4	B-GENE	NOUN	B
content	O	NOUN	B
of	O	ADP	O
mature	O	ADJ	B
innervated	O	ADJ	B
fast	O	ADJ	B
muscles	O	NOUN	I
.	O	PUNCT	O


Nucleotide	O	NOUN	B
sequence	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Pseudomonas	B-GENE	X	B
putida	I-GENE	X	I
PpG7	I-GENE	NOUN	I
salicylate	I-GENE	NOUN	B
hydroxylase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
(	O	PUNCT	O
nahG	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
its	O	PRON	O
3	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
flanking	O	ADJ	B
region	O	NOUN	I
.	O	PUNCT	O


All	O	DET	O
six	O	NUM	O
ARF	B-GENE	NOUN	B
cDNAs	I-GENE	NOUN	B
are	O	AUX	O
more	O	ADV	O
similar	O	ADJ	O
to	O	ADP	O
each	O	DET	O
other	O	ADJ	O
than	O	ADP	O
to	O	ADP	O
other	O	ADJ	O
approximately	O	ADV	O
20	B-GENE	NUM	O
-	I-GENE	PUNCT	O
kDa	I-GENE	NOUN	B
guanine	I-GENE	NOUN	B
nucleotide	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
proteins	I-GENE	NOUN	I
.	O	PUNCT	O


DNA	O	NOUN	B
from	O	ADP	O
PCR	O	NOUN	B
was	O	AUX	O
labeled	O	VERB	B
and	O	CCONJ	O
used	O	VERB	O
to	O	PART	O
isolate	O	VERB	B
several	O	ADJ	O
lambda	O	NOUN	B
gt11	O	NOUN	I
cDNA	O	NOUN	B
clones	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
one	O	NUM	O
full	O	ADJ	B
-	O	PUNCT	O
length	O	NOUN	B
one	O	NUM	O
(	O	PUNCT	O
Dd	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
cdr1	B-GENE	NOUN	B
sequence	I-GENE	NOUN	B
includes	O	VERB	O
an	O	DET	O
additional	O	ADJ	O
237	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
of	O	ADP	O
the	O	DET	O
contiguous	O	ADJ	B
fragment	O	NOUN	O
and	O	CCONJ	O
encodes	O	VERB	B
a	O	DET	O
product	O	NOUN	B
of	O	ADP	O
predicted	O	VERB	B
Mr	O	NOUN	O
67	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
.	O	PUNCT	O


Despite	O	SCONJ	O
the	O	DET	O
small	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
patients	O	NOUN	B
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
this	O	DET	O
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
can	O	AUX	O
confirm	O	VERB	O
that	O	SCONJ	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
MU	O	NOUN	B
/	O	PUNCT	O
day	O	NOUN	B
of	O	ADP	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
IFN	I-GENE	NOUN	B
is	O	AUX	O
an	O	DET	O
adequate	O	ADJ	B
treatment	O	NOUN	B
for	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
hairy	O	ADJ	B
cell	O	NOUN	I
leukemia	O	NOUN	I
.	O	PUNCT	O


Occupational	O	ADJ	B
asthma	O	NOUN	I
and	O	CCONJ	O
rhinoconjunctivitis	O	NOUN	B
from	O	ADP	O
inhalation	O	NOUN	B
of	O	ADP	O
crystalline	O	ADJ	B
bovine	B-GENE	ADJ	B
serum	I-GENE	NOUN	O
albumin	I-GENE	NOUN	O
powder	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
dose	O	NOUN	B
of	O	ADP	O
3	O	NUM	O
and	O	CCONJ	O
6	O	NUM	O
micrograms	O	NOUN	B
/	O	SYM	O
kg	O	NOUN	B
/	O	PUNCT	O
day	O	NOUN	B
GM	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
CSF	I-GENE	PROPN	B
reduces	O	VERB	B
the	O	DET	O
severity	O	NOUN	B
of	O	ADP	O
neutropenia	O	NOUN	B
and	O	CCONJ	O
thrombocytopenia	O	NOUN	B
after	O	ADP	O
carboplatin	O	NOUN	B
-	O	PUNCT	O
cyclophosphamide	O	NOUN	B
chemotherapy	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
may	O	AUX	O
lead	O	VERB	O
to	O	ADP	O
more	O	ADV	O
effective	O	ADJ	B
chemotherapy	O	NOUN	B
for	O	ADP	O
ovarian	O	ADJ	B
cancer	O	NOUN	I
in	O	ADP	O
the	O	DET	O
future	O	NOUN	B
.	O	PUNCT	O


Biochemical	O	ADJ	B
analysis	O	NOUN	I
demonstrates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
BJ1	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
nucleosomes	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
released	O	VERB	O
from	O	ADP	O
chromatin	O	NOUN	B
by	O	ADP	O
agents	O	NOUN	B
which	O	DET	O
intercalate	O	VERB	B
into	O	ADP	O
DNA	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
previously	O	ADV	O
shown	O	VERB	O
for	O	ADP	O
the	O	DET	O
high	B-GENE	ADJ	O
mobility	I-GENE	NOUN	B
group	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
(	O	PUNCT	O
HMGs	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
human	B-GENE	ADJ	B
immunodeficiency	I-GENE	NOUN	I
virus	I-GENE	NOUN	I
type	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	I-GENE	PUNCT	O
HIV	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	I-GENE	PUNCT	O
Rev	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
is	O	AUX	O
a	O	DET	O
positive	O	ADJ	B
posttranscriptional	O	ADJ	B
regulator	O	NOUN	I
of	O	ADP	O
viral	O	ADJ	B
structural	O	ADJ	I
gene	O	NOUN	B
expression	O	NOUN	I
and	O	CCONJ	O
essential	O	ADJ	B
for	O	ADP	O
virus	O	NOUN	B
replication	O	NOUN	B
.	O	PUNCT	O


Temporal	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
GUS	B-GENE	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
involve	O	VERB	O
two	O	NUM	O
negative	O	ADJ	B
regulatory	O	ADJ	B
sequences	O	NOUN	I
,	O	PUNCT	O
NRS1	O	NOUN	B
(	O	PUNCT	O
-	O	PUNCT	O
391	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
295	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
NRS2	O	PROPN	B
(	O	PUNCT	O
-	O	PUNCT	O
518	O	NUM	O
to	O	ADP	O
-	O	PUNCT	O
418	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
the	O	DET	O
positive	O	ADJ	B
domain	O	NOUN	O
UAS1	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
most	O	ADJ	O
cases	O	NOUN	B
,	O	PUNCT	O
DR4	B-GENE	NOUN	B
-	O	PUNCT	O
homozygous	O	ADJ	B
,	O	PUNCT	O
DRB1	B-GENE	NOUN	B
-	O	PUNCT	O
heterozygous	O	ADJ	B
individuals	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
genotyped	O	VERB	B
with	O	ADP	O
the	O	DET	O
panel	O	NOUN	B
of	O	ADP	I
probes	O	NOUN	I
.	O	PUNCT	O


Polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
ETS1	B-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
identified	O	VERB	O
several	O	ADJ	O
amplified	O	VERB	B
products	O	NOUN	I
,	O	PUNCT	O
indicating	O	VERB	O
alternative	O	ADJ	B
splicing	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
test	O	VERB	O
promotor	O	NOUN	O
function	O	NOUN	O
,	O	PUNCT	O
chimeric	O	ADJ	B
genes	O	NOUN	I
were	O	AUX	O
constructed	O	VERB	O
linking	O	VERB	O
fragments	O	NOUN	B
of	O	ADP	O
chicken	O	NOUN	B
IGF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
I	I-GENE	PROPN	B
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
flanking	O	ADJ	B
DNA	O	NOUN	B
to	O	PART	O
a	O	DET	O
promoterless	O	ADJ	B
reporter	O	NOUN	I
plasmid	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
alpha	B-GENE	NOUN	B
4	I-GENE	NUM	I
gene	I-GENE	NOUN	I
5	O	NUM	I
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
acted	O	VERB	O
as	O	ADP	O
a	O	DET	O
promoter	O	NOUN	B
in	O	ADP	O
transfection	O	NOUN	B
assays	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
homologues	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rhombotin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
have	O	AUX	O
now	O	ADV	O
been	O	AUX	O
isolated	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
gcd2	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
503	I-GENE	NUM	O
mutation	O	NOUN	B
also	O	ADV	O
results	O	VERB	O
in	O	ADP	O
polysome	O	NOUN	B
runoff	O	NOUN	B
,	O	PUNCT	O
accumulation	O	NOUN	B
of	O	ADP	O
inactive	O	ADJ	B
80S	B-GENE	ADJ	B
ribosomal	I-GENE	ADJ	I
couples	I-GENE	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
accumulation	O	NOUN	B
of	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
subunits	O	NOUN	B
of	O	ADP	O
the	O	DET	O
general	B-GENE	ADJ	B
translation	I-GENE	NOUN	I
initiation	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
2	I-GENE	NUM	I
(	O	PUNCT	O
eIF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
alpha	I-GENE	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
43S	B-GENE	NOUN	B
-	O	PUNCT	O
48S	B-GENE	NOUN	B
particles	O	NOUN	B
following	O	VERB	O
a	O	DET	O
shift	O	NOUN	B
to	O	ADP	O
the	O	DET	O
restrictive	O	ADJ	B
temperature	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
the	O	DET	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
the	O	DET	O
U6	B-GENE	NOUN	B
RNA	I-GENE	NOUN	I
genes	I-GENE	NOUN	I
of	O	ADP	O
52	O	NUM	O
organisms	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
mononuclear	O	ADJ	B
cell	O	NOUN	I
secretory	O	ADJ	B
products	O	NOUN	I
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
changes	O	NOUN	B
in	O	ADP	O
bone	O	NOUN	B
turnover	O	NOUN	B
that	O	PRON	O
characterize	O	VERB	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
postmenopausal	O	ADJ	B
osteoporosis	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
evaluated	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
oophorectomy	O	NOUN	B
and	O	CCONJ	O
subsequent	O	ADJ	O
estrogen	O	NOUN	B
replacement	O	NOUN	I
on	O	ADP	O
the	O	DET	O
spontaneous	O	ADJ	B
secretion	O	NOUN	B
of	O	ADP	O
interleukin	B-GENE	NOUN	B
1	I-GENE	NUM	I
(	O	PUNCT	O
IL	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
tumor	B-GENE	NOUN	B
necrosis	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
alpha	I-GENE	NOUN	I
(	O	PUNCT	O
TNF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
on	O	ADP	O
the	O	DET	O
phytohemagglutinin	B-GENE	NOUN	B
A	I-GENE	NOUN	I
-	O	PUNCT	O
induced	O	VERB	B
secretion	O	NOUN	B
of	O	ADP	O
granulocyte	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
macrophage	I-GENE	NOUN	B
colony	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
stimulating	I-GENE	VERB	B
factor	I-GENE	NOUN	B
(	O	PUNCT	O
GM	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
CSF	I-GENE	PROPN	B
)	O	PUNCT	O
from	O	ADP	O
peripheral	O	ADJ	B
blood	O	NOUN	I
mononuclear	O	ADJ	I
cells	O	NOUN	I
.	O	PUNCT	O


Some	O	DET	O
of	O	ADP	O
the	O	DET	O
PCR	O	NOUN	B
products	O	NOUN	I
contained	O	VERB	O
mutations	O	NOUN	B
in	O	ADP	O
ATG1	B-GENE	NOUN	B
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
ATG2	B-GENE	NOUN	B
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
occurrence	O	NOUN	B
of	O	ADP	O
putative	O	ADJ	O
4	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
phosphopantetheine	O	NOUN	B
-	O	PUNCT	O
attachment	O	NOUN	B
sites	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
putative	O	ADJ	B
thioesterase	B-GENE	NOUN	I
site	I-GENE	NOUN	I
,	O	PUNCT	O
are	O	AUX	O
discussed	O	VERB	O
with	O	ADP	O
reference	O	NOUN	O
to	O	ADP	O
the	O	DET	O
reaction	O	NOUN	B
sequence	O	NOUN	I
leading	O	VERB	O
to	O	PART	O
production	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ACV	B-GENE	NOUN	B
tripeptide	I-GENE	NOUN	B
.	O	PUNCT	O


Very	O	ADV	B
small	O	ADJ	I
deletions	O	NOUN	I
within	O	ADP	O
the	O	DET	O
conserved	O	VERB	B
region	O	NOUN	I
completely	O	ADV	O
abolished	O	VERB	O
transforming	O	VERB	B
activity	O	NOUN	I
of	O	ADP	O
dbl	B-GENE	NOUN	B
,	O	PUNCT	O
while	O	SCONJ	O
extensive	O	ADJ	B
deletion	O	NOUN	B
outside	O	ADP	O
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
present	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
negative	O	ADJ	B
regulatory	O	ADJ	B
element	O	NOUN	I
in	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Mlu	B-GENE	NOUN	B
I	I-GENE	NUM	I
upstream	I-GENE	ADJ	O
activation	I-GENE	NOUN	O
sequence	I-GENE	NOUN	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
plasma	O	NOUN	B
fibrinogen	B-GENE	NOUN	I
levels	O	NOUN	I
increased	O	VERB	B
by	O	ADP	O
a	O	DET	O
mean	O	NOUN	O
of	O	ADP	O
17	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
potentially	O	ADV	O
adverse	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
gemfibrozil	O	NOUN	B
that	O	PRON	O
has	O	AUX	O
not	O	PART	O
been	O	AUX	O
previously	O	ADV	O
reported	O	VERB	O
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
Spec	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
region	O	NOUN	B
around	O	ADP	O
the	O	DET	O
Spec1	B-GENE	NOUN	B
transcriptional	I-GENE	ADJ	B
initiation	I-GENE	NOUN	O
site	I-GENE	NOUN	O
was	O	AUX	O
analyzed	O	VERB	B
for	O	ADP	O
sites	O	NOUN	B
of	O	ADP	O
protein	O	NOUN	B
-	O	PUNCT	O
DNA	O	NOUN	B
interaction	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
new	O	ADJ	O
method	O	NOUN	B
for	O	ADP	O
the	O	DET	O
in	O	X	B
vitro	O	X	I
transfer	O	NOUN	I
of	O	ADP	O
delayed	O	VERB	B
hypersensitivity	O	NOUN	I
by	O	ADP	O
dialysed	O	VERB	B
transfer	B-GENE	NOUN	I
factor	I-GENE	NOUN	I
.	O	PUNCT	O


Diagnostic	O	ADJ	B
value	O	NOUN	I
of	O	ADP	O
adenosine	B-GENE	NOUN	B
deaminase	I-GENE	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
tuberculous	O	ADJ	B
effusions	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
evolutionary	O	ADJ	B
comparison	O	NOUN	B
of	O	ADP	O
amino	O	NOUN	B
acid	O	NOUN	I
sequences	O	NOUN	I
of	O	ADP	O
34	O	NUM	O
HSP70	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
from	O	ADP	O
17	O	NUM	O
species	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
BiP	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
share	O	VERB	O
a	O	DET	O
common	O	ADJ	O
ancestor	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
diverged	O	VERB	O
from	O	ADP	O
other	O	ADJ	O
HSP70	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
near	O	ADP	O
the	O	DET	O
time	O	NOUN	O
when	O	SCONJ	O
eukaryotes	O	NOUN	B
first	O	ADV	O
appeared	O	VERB	O
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
overexpression	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
STE4	B-GENE	NOUN	B
and	O	CCONJ	O
STE18	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
did	O	AUX	O
not	O	PART	O
generate	O	VERB	O
a	O	DET	O
stronger	O	ADJ	B
pheromone	O	NOUN	B
response	O	NOUN	O
than	O	ADP	O
overexpression	O	NOUN	B
of	O	ADP	O
STE4	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
STE18	B-GENE	NOUN	B
.	O	PUNCT	O


Sequencing	O	VERB	B
the	O	DET	O
gene	O	NOUN	B
for	O	ADP	O
an	O	DET	O
imipenem	O	NOUN	B
-	O	PUNCT	O
cefoxitin	O	NOUN	B
-	O	PUNCT	O
hydrolyzing	O	VERB	B
enzyme	O	NOUN	B
(	O	PUNCT	O
CfiA	B-GENE	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
Bacteroides	O	X	B
fragilis	O	X	I
TAL2480	O	NOUN	I
reveals	O	VERB	O
strong	O	ADJ	O
similarity	O	NOUN	B
between	O	ADP	O
CfiA	B-GENE	NOUN	B
and	O	CCONJ	O
Bacillus	B-GENE	X	B
cereus	I-GENE	X	I
beta	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
lactamase	I-GENE	NOUN	B
II	I-GENE	NUM	I
.	O	PUNCT	O


The	O	DET	O
cloned	O	VERB	B
HindIII	B-GENE	NOUN	B
fragment	I-GENE	NOUN	I
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
shown	O	VERB	O
by	O	ADP	O
DNA	O	NOUN	B
sequence	O	NOUN	I
analysis	O	NOUN	I
to	O	PART	O
encode	O	VERB	B
the	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
half	O	NOUN	B
of	O	ADP	O
the	O	DET	O
B	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
subtilis	I-GENE	X	B
IF2	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
kb	O	NOUN	O
of	O	ADP	O
upstream	O	ADJ	B
flanking	O	ADJ	I
sequence	O	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
utilized	O	VERB	O
as	O	ADP	O
a	O	DET	O
homologous	O	ADJ	B
probe	O	NOUN	I
to	O	PART	O
clone	O	NOUN	B
an	O	DET	O
overlapping	O	VERB	O
2	B-GENE	NUM	O
.	I-GENE	PUNCT	O
76	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kb	I-GENE	NOUN	B
ClaI	I-GENE	NOUN	B
chromosomal	I-GENE	ADJ	O
fragment	I-GENE	NOUN	O
containing	O	VERB	O
the	O	DET	O
entire	B-GENE	ADJ	O
IF2	I-GENE	NOUN	B
structural	I-GENE	ADJ	O
gene	I-GENE	NOUN	O
.	O	PUNCT	O


Expression	O	NOUN	B
,	O	PUNCT	O
nucleotide	O	NOUN	B
sequence	O	NOUN	I
and	O	CCONJ	O
mutational	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
two	O	NUM	O
open	O	ADJ	O
reading	O	NOUN	O
frames	O	NOUN	O
in	O	ADP	O
the	O	DET	O
nif	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
region	I-GENE	NOUN	I
of	I-GENE	ADP	O
Anabaena	I-GENE	X	B
sp	I-GENE	X	I
.	I-GENE	PUNCT	O
strain	I-GENE	NOUN	B
PCC7120	I-GENE	NOUN	I
.	O	PUNCT	O


This	O	DET	O
Mr	O	NOUN	B
is	O	AUX	O
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
the	O	DET	O
purified	B-GENE	VERB	B
smg	I-GENE	NOUN	B
p25A	I-GENE	NOUN	B
GDI	I-GENE	NOUN	B
estimated	O	VERB	B
by	O	ADP	O
sodium	O	NOUN	B
dodecyl	O	NOUN	I
sulfate	O	NOUN	I
-	O	PUNCT	O
polyacrylamide	O	NOUN	B
gel	O	NOUN	I
electrophoresis	O	NOUN	I
and	O	CCONJ	O
sucrose	O	NOUN	B
density	O	NOUN	I
gradient	O	NOUN	I
ultracentrifugation	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
about	O	ADV	O
54	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
and	O	CCONJ	O
65	O	NUM	O
,	O	PUNCT	O
000	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Critical	O	ADJ	B
residues	O	NOUN	I
required	O	VERB	O
for	O	ADP	O
repression	O	NOUN	B
are	O	AUX	O
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
27	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
,	O	PUNCT	O
since	O	SCONJ	O
v	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
and	O	CCONJ	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
truncations	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
Fos	I-GENE	NOUN	B
did	O	AUX	O
not	O	PART	O
down	O	ADV	O
regulate	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
paper	O	NOUN	O
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
analyzed	O	VERB	B
the	O	DET	O
structure	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
gene	O	NOUN	I
for	O	ADP	O
Gx	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
,	O	PUNCT	O
which	O	DET	O
spans	O	VERB	O
more	O	ADJ	O
than	O	ADP	O
60	O	NUM	O
kilobases	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
-	O	PUNCT	O
119	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
81	O	NUM	O
fragment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CCK	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
contains	O	VERB	O
a	O	DET	O
transcriptional	O	ADJ	B
enhancer	O	NOUN	I
that	O	PRON	O
potentiates	O	VERB	B
the	O	DET	O
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
herpes	O	NOUN	B
simplex	O	NOUN	I
virus	O	NOUN	I
thymidine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
position	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
orientation	O	NOUN	B
-	O	PUNCT	O
independent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
NF1	B-GENE	NOUN	B
locus	I-GENE	NOUN	O
encodes	O	VERB	O
a	O	DET	O
protein	O	NOUN	B
functionally	O	ADV	O
related	O	ADJ	O
to	O	PART	O
mammalian	B-GENE	ADJ	B
GAP	I-GENE	NOUN	B
and	O	CCONJ	O
yeast	B-GENE	NOUN	B
IRA	I-GENE	PROPN	O
proteins	I-GENE	NOUN	B
.	O	PUNCT	O


Disruption	O	NOUN	B
of	O	ADP	O
ARF2	B-GENE	NOUN	B
causes	O	VERB	O
no	O	DET	O
detectable	O	ADJ	B
phenotype	O	NOUN	B
.	O	PUNCT	O


Human	O	ADJ	B
recombinant	O	ADJ	O
DNA	O	NOUN	O
-	O	PUNCT	O
derived	O	VERB	B
antihemophilic	B-GENE	ADJ	B
factor	I-GENE	NOUN	I
(	O	PUNCT	O
factor	B-GENE	NOUN	B
VIII	I-GENE	NOUN	I
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
treatment	O	NOUN	B
of	O	ADP	O
hemophilia	O	NOUN	B
A	O	NOUN	I
.	O	PUNCT	O
recombinant	O	ADJ	B
Factor	B-GENE	NOUN	I
VIII	I-GENE	PROPN	I
Study	O	PROPN	I
Group	O	PROPN	B
.	O	PUNCT	O


Effects	O	NOUN	B
of	O	ADP	I
a	O	DET	O
selective	O	ADJ	O
monoamine	B-GENE	NOUN	B
oxidase	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
MAO	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
A	I-GENE	NOUN	B
inhibitor	O	NOUN	B
,	O	PUNCT	O
clorgyline	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
selective	O	ADJ	O
MAO	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
B	I-GENE	NOUN	B
inhibitor	O	NOUN	B
,	O	PUNCT	O
deprenyl	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
non	O	ADJ	B
-	O	PUNCT	O
selective	O	ADJ	B
MAO	B-GENE	NOUN	B
inhibitor	O	NOUN	B
,	O	PUNCT	O
nialamide	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
investigated	O	VERB	B
on	O	ADP	O
footshock	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
aggression	O	NOUN	B
(	O	PUNCT	O
FIA	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
paired	O	ADJ	O
rats	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
identify	O	VERB	O
structural	O	ADJ	B
features	O	NOUN	I
of	O	ADP	O
residues	O	NOUN	B
flanking	O	VERB	I
the	O	DET	O
c	O	NOUN	B
-	O	PUNCT	O
region	O	NOUN	B
that	O	PRON	O
influence	O	VERB	B
the	O	DET	O
fidelity	O	NOUN	B
and	O	CCONJ	O
efficiency	O	NOUN	B
of	O	ADP	O
signal	O	NOUN	B
peptidase	O	NOUN	I
cleavage	O	NOUN	B
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
co	O	X	B
-	O	PUNCT	O
translational	O	ADJ	B
translocation	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
introduced	O	VERB	O
six	O	NUM	O
amino	O	NOUN	B
acid	O	NOUN	I
substitutions	O	NOUN	I
into	O	ADP	O
the	O	DET	O
COOH	O	NOUN	B
terminus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hydrophobic	O	ADJ	B
core	O	NOUN	O
and	O	CCONJ	O
seven	O	NUM	O
substitutions	O	NOUN	B
at	O	ADP	O
the	O	DET	O
NH2	O	NOUN	B
terminus	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mature	O	ADJ	B
region	O	NOUN	O
(	O	PUNCT	O
the	O	DET	O
+	O	CCONJ	O
1	O	NUM	O
position	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
a	O	DET	O
model	O	ADJ	B
eukaryotic	B-GENE	ADJ	B
preprotein	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
human	I-GENE	ADJ	B
pre	I-GENE	NOUN	B
(	I-GENE	PUNCT	O
delta	I-GENE	NOUN	B
pro	I-GENE	NOUN	I
)	I-GENE	PUNCT	O
apoA	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
II	I-GENE	PROPN	B
.	O	PUNCT	O


This	O	DET	O
model	O	NOUN	B
is	O	AUX	O
further	O	ADV	O
supported	O	VERB	O
by	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Fos	B-GENE	NOUN	B
-	O	PUNCT	O
Jun	B-GENE	NOUN	B
complex	O	NOUN	I
at	O	ADP	O
an	O	DET	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
site	I-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
type	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
I	I-GENE	NOUN	I
collagen	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
that	O	PRON	O
is	O	AUX	O
contiguous	O	ADJ	B
with	O	ADP	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
overlapping	O	VERB	O
,	O	PUNCT	O
the	O	DET	O
VDRE	O	NOUN	B
.	O	PUNCT	O


PBSX	B-GENE	NOUN	B
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
agents	O	NOUN	B
which	O	DET	O
elicit	O	VERB	O
the	O	DET	O
SOS	O	NOUN	B
response	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
p36	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
is	O	AUX	O
at	O	ADP	O
least	O	ADJ	O
22	O	NUM	O
kb	O	NOUN	O
in	O	ADP	O
length	O	NOUN	B
and	O	CCONJ	O
has	O	AUX	O
a	O	DET	O
coding	O	VERB	B
sequence	O	NOUN	I
of	O	ADP	O
approximately	O	ADV	O
1	O	NUM	O
kb	O	NOUN	O
,	O	PUNCT	O
representing	O	VERB	O
only	O	ADV	O
4	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
.	O	PUNCT	O
(	O	PUNCT	O
ABSTRACT	O	NOUN	B
TRUNCATED	O	VERB	I
AT	O	ADP	I
250	O	NUM	I
WORDS	O	NOUN	I
)	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
indicates	O	VERB	O
that	O	SCONJ	O
AHA2	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
relative	O	ADJ	O
to	O	PART	O
total	O	ADJ	O
cellular	O	ADJ	O
RNA	O	NOUN	O
is	O	AUX	O
expressed	O	VERB	B
at	O	ADP	O
significantly	O	ADV	O
higher	O	ADJ	O
levels	O	NOUN	B
in	O	ADP	O
root	O	NOUN	B
tissue	O	NOUN	I
as	O	ADP	O
compared	O	VERB	B
with	O	ADP	O
shoot	O	NOUN	B
tissue	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
3	O	NUM	O
'	O	PART	O
stem	O	NOUN	B
-	O	PUNCT	O
loop	O	NOUN	B
is	O	AUX	O
highly	O	ADV	O
divergent	O	ADJ	B
in	O	ADP	O
structure	O	NOUN	B
among	O	ADP	O
species	O	NOUN	B
and	O	CCONJ	O
lies	O	VERB	O
immediately	O	ADV	O
upstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
binding	O	VERB	B
site	O	NOUN	I
for	O	ADP	O
Sm	B-GENE	NOUN	B
proteins	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
deleted	O	ADJ	B
nucleotide	O	NOUN	I
sequence	O	NOUN	I
corresponded	O	VERB	O
to	O	PART	O
sequences	O	NOUN	B
that	O	PRON	O
,	O	PUNCT	O
by	O	ADP	O
analogy	O	NOUN	O
to	O	ADP	O
the	O	DET	O
organization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
type	B-GENE	NOUN	B
I	I-GENE	NUM	I
collagen	I-GENE	NOUN	I
genes	I-GENE	NOUN	I
,	O	PUNCT	O
should	O	AUX	O
be	O	AUX	O
precisely	O	ADV	O
encoded	O	VERB	B
by	O	ADP	O
exon	O	NOUN	B
41	O	NUM	O
of	O	ADP	O
the	O	DET	O
COL3A1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
sequenced	O	VERB	B
the	O	DET	O
gene	O	NOUN	B
encoding	O	VERB	B
the	O	DET	O
human	B-GENE	ADJ	B
U1	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
70K	I-GENE	NOUN	B
snRNP	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
.	O	PUNCT	O


Cutaneous	O	ADJ	B
necrosis	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
protein	B-GENE	NOUN	B
S	I-GENE	NOUN	I
deficiency	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
strongly	O	ADV	O
implicate	O	VERB	O
the	O	DET	O
normal	O	ADJ	O
product	O	NOUN	O
of	O	ADP	O
the	O	DET	O
int	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
gene	I-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
fibroblast	B-GENE	NOUN	B
growth	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
family	I-GENE	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
contributory	O	ADJ	B
factor	O	NOUN	O
in	O	ADP	O
virally	O	ADV	B
induced	O	VERB	B
mammary	O	ADJ	B
tumors	O	NOUN	I
.	O	PUNCT	O


Whether	O	SCONJ	O
or	O	CCONJ	O
not	O	PART	O
there	O	PRON	O
are	O	AUX	O
sequences	O	NOUN	B
conferring	O	VERB	O
cAMP	O	NOUN	B
responsiveness	O	NOUN	O
which	O	DET	O
are	O	AUX	O
common	O	ADJ	O
both	O	CCONJ	O
to	O	PART	O
P	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
450scc	I-GENE	NOUN	B
and	O	CCONJ	O
the	O	DET	O
other	O	ADJ	O
steroidogenic	O	ADJ	B
P	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
450	I-GENE	NUM	O
genes	I-GENE	NOUN	B
remains	O	VERB	O
to	O	PART	O
be	O	AUX	O
established	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
zta	B-GENE	NOUN	B
transactivator	I-GENE	NOUN	I
involved	O	VERB	O
in	O	ADP	O
induction	O	NOUN	B
of	O	ADP	O
lytic	O	ADJ	B
cycle	O	NOUN	I
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
Epstein	O	NOUN	B
-	O	PUNCT	O
Barr	O	PROPN	B
virus	O	NOUN	I
-	O	PUNCT	O
infected	O	VERB	B
lymphocytes	O	NOUN	B
binds	O	VERB	B
to	O	PART	O
both	O	CCONJ	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
ZRE	B-GENE	NOUN	B
sites	I-GENE	NOUN	I
in	O	ADP	O
target	O	NOUN	B
promoter	O	NOUN	B
and	O	CCONJ	O
enhancer	O	NOUN	B
regions	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
deduced	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
of	O	ADP	O
destrin	B-GENE	NOUN	B
is	O	AUX	O
165	O	NUM	O
residues	O	NOUN	B
long	O	ADJ	O
and	O	CCONJ	O
is	O	AUX	O
very	O	ADV	O
similar	O	ADJ	O
(	O	PUNCT	O
71	O	NUM	O
%	O	NOUN	O
identical	O	ADJ	B
)	O	PUNCT	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
cofilin	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
widely	O	ADV	O
distributed	O	VERB	B
,	O	PUNCT	O
pH	O	NOUN	B
-	O	PUNCT	O
sensitive	O	ADJ	B
actin	B-GENE	NOUN	B
-	O	PUNCT	O
modulating	O	VERB	B
protein	O	NOUN	B
.	O	PUNCT	O


With	O	ADP	O
only	O	ADV	O
purified	O	VERB	B
T	B-GENE	NOUN	B
antigen	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
topoisomerase	B-GENE	NOUN	B
I	I-GENE	NUM	I
to	O	PART	O
unwind	O	VERB	O
purified	O	VERB	O
DNA	O	NOUN	O
,	O	PUNCT	O
ori	O	NOUN	B
-	O	PUNCT	O
auxiliary	O	NOUN	B
sequences	O	NOUN	I
strongly	O	ADV	O
facilitated	O	VERB	O
T	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
antigen	I-GENE	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
DNA	O	NOUN	B
conformational	O	ADJ	O
changes	O	NOUN	O
consistent	O	ADJ	B
with	O	ADP	I
melting	O	VERB	B
the	O	DET	O
first	O	ADJ	O
50	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
cloned	O	VERB	B
and	O	CCONJ	O
sequenced	O	VERB	B
the	O	DET	O
cDNAs	O	NOUN	B
against	O	ADP	O
genomic	O	ADJ	B
RNA	O	NOUN	I
and	O	CCONJ	O
mRNA	O	NOUN	B
for	O	ADP	O
phosphoprotein	B-GENE	NOUN	B
(	I-GENE	PUNCT	O
P	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
of	O	ADP	O
human	O	ADJ	B
parainfluenza	O	NOUN	O
type	O	NOUN	O
2	O	NUM	O
virus	O	NOUN	O
(	O	PUNCT	O
PIV	O	NOUN	B
-	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O
cDNA	O	NOUN	B
clone	O	NOUN	B
from	O	ADP	O
genomic	O	ADJ	B
RNA	O	NOUN	I
was	O	AUX	O
1439	O	NUM	O
nucleotides	O	NOUN	B
in	O	ADP	O
length	O	NOUN	O
excluding	O	VERB	O
poly	O	NOUN	B
(	O	PUNCT	I
A	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
have	O	AUX	O
two	O	NUM	O
small	O	ADJ	O
open	O	ADJ	O
reading	O	NOUN	O
frames	O	NOUN	O
encoding	O	VERB	O
proteins	O	NOUN	B
of	O	ADP	O
233	O	NUM	O
and	O	CCONJ	O
249	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
cDNA	O	NOUN	B
sequence	O	NOUN	I
has	O	AUX	O
an	O	DET	O
813	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
(	O	PUNCT	O
ORF	O	NOUN	B
)	O	PUNCT	O
whose	O	DET	O
predicted	O	VERB	B
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
is	O	AUX	O
97	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
%	O	NOUN	O
identical	O	ADJ	B
to	O	PART	O
the	O	DET	O
272	O	NUM	O
carboxy	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
amino	O	NOUN	B
acids	O	NOUN	I
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
ets	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
protein	I-GENE	NOUN	B
.	O	PUNCT	O


To	O	PART	O
characterize	O	VERB	O
the	O	DET	O
O7	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
LPS	I-GENE	NOUN	B
region	I-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
recombinant	O	ADJ	B
cosmids	O	NOUN	I
pJHCV31	O	NOUN	I
and	O	CCONJ	O
pJHCV32	O	NOUN	B
were	O	AUX	O
mutagenized	O	VERB	B
by	O	ADP	O
transposon	O	NOUN	B
mutagenesis	O	NOUN	I
with	O	ADP	O
Tn3HoHo1	B-GENE	ADJ	B
,	O	PUNCT	O
which	O	DET	O
carries	O	VERB	O
a	O	DET	O
promoterless	O	ADJ	B
lac	B-GENE	NOUN	I
operon	I-GENE	NOUN	I
and	O	CCONJ	O
can	O	AUX	O
therefore	O	ADV	O
generate	O	VERB	O
lacZ	B-GENE	NOUN	B
transcriptional	O	ADJ	B
fusions	O	NOUN	I
with	O	ADP	O
target	O	NOUN	B
DNA	O	NOUN	B
sequences	O	NOUN	I
.	O	PUNCT	O


Various	O	ADJ	O
mutant	B-GENE	ADJ	B
HN	I-GENE	ADJ	B
genes	I-GENE	NOUN	O
were	O	AUX	O
constructed	O	VERB	O
to	O	PART	O
examine	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
residues	O	NOUN	B
flanking	O	VERB	I
the	O	DET	O
signal	O	NOUN	B
-	O	PUNCT	O
anchor	O	NOUN	B
domain	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
cytoplasmic	O	ADJ	B
tail	O	NOUN	I
,	O	PUNCT	O
on	O	ADP	O
assembly	O	NOUN	B
and	O	CCONJ	O
intracellular	O	ADJ	B
transport	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HN	B-GENE	ADJ	B
glycoprotein	I-GENE	NOUN	I
.	O	PUNCT	O


Disruption	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IRA2	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
resulted	O	VERB	O
in	O	ADP	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
increased	O	VERB	B
sensitivity	O	NOUN	B
to	O	PART	O
heat	O	NOUN	B
shock	O	NOUN	I
and	O	CCONJ	O
nitrogen	O	NOUN	B
starvation	O	NOUN	I
,	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
sporulation	O	NOUN	B
defects	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
suppression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lethality	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cdc25	B-GENE	NOUN	B
mutant	I-GENE	NOUN	B
.	O	PUNCT	O


A	O	DET	O
DNA	O	NOUN	B
motif	O	NOUN	I
related	O	ADJ	O
to	O	PART	O
the	O	DET	O
cAMP	O	NOUN	B
-	O	PUNCT	O
responsive	O	ADJ	B
element	O	NOUN	B
and	O	CCONJ	O
an	O	DET	O
exon	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
located	I-GENE	ADJ	B
activator	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
binding	I-GENE	NOUN	B
site	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
tissue	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
plasminogen	I-GENE	NOUN	I
activator	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
cooperate	O	VERB	O
in	O	ADP	O
basal	O	ADJ	B
expression	O	NOUN	I
and	O	CCONJ	O
convey	O	VERB	O
activation	O	NOUN	B
by	O	ADP	O
phorbol	O	NOUN	B
ester	O	NOUN	I
and	O	CCONJ	O
cAMP	O	NOUN	B
.	O	PUNCT	O


Transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
first	O	ADJ	O
operon	O	NOUN	B
coding	O	VERB	B
for	O	ADP	O
m	O	NOUN	B
-	O	PUNCT	O
xylene	O	NOUN	B
-	O	PUNCT	O
degrading	O	VERB	B
enzymes	O	NOUN	B
on	O	ADP	O
the	O	DET	O
TOL	O	NOUN	B
plasmid	O	NOUN	I
of	O	ADP	O
Pseudomonas	O	X	B
putida	O	NOUN	I
is	O	AUX	O
activated	O	VERB	B
by	O	ADP	O
the	O	DET	O
xylR	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
m	O	NOUN	B
-	O	PUNCT	O
xylene	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
also	O	ADV	O
that	O	SCONJ	O
RA	O	NOUN	B
represses	O	VERB	B
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
a	O	DET	O
reporter	O	NOUN	B
gene	O	NOUN	I
containing	O	VERB	O
a	O	DET	O
TPA	O	NOUN	B
responding	O	NOUN	O
AP1	B-GENE	NOUN	B
binding	I-GENE	NOUN	B
site	I-GENE	NOUN	I
driving	O	VERB	O
the	O	DET	O
HSV	B-GENE	NOUN	B
tk	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
radiolabeled	O	VERB	B
EFI	B-GENE	NOUN	B
,	O	PUNCT	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Y	I-GENE	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
CBF	B-GENE	NOUN	B
DNAs	I-GENE	NOUN	B
give	O	VERB	O
rise	O	NOUN	O
to	O	PART	O
identical	O	ADJ	B
gel	O	NOUN	B
retardation	O	NOUN	I
patterns	O	NOUN	B
in	O	ADP	O
extracts	O	NOUN	B
from	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
different	O	ADJ	O
cell	O	NOUN	B
types	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
was	O	AUX	O
measured	O	VERB	B
by	O	ADP	O
a	O	DET	O
transient	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
(	O	PUNCT	O
CAT	B-GENE	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	B
connected	O	VERB	O
with	O	ADP	O
various	O	ADJ	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
deletion	O	NOUN	B
mutants	O	NOUN	B
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
flanking	O	ADJ	B
region	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Saccharomyces	B-GENE	X	B
cerevisiae	I-GENE	X	I
14DM	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
,	O	PUNCT	O
encoding	O	VERB	O
cytochrome	B-GENE	NOUN	B
P450	I-GENE	NOUN	I
lanosterol	I-GENE	NOUN	I
14	I-GENE	NUM	I
alpha	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
demethylase	I-GENE	NOUN	B
(	O	PUNCT	O
14DM	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
was	O	AUX	O
overexpressed	O	VERB	B
in	O	ADP	O
various	O	ADJ	O
S	O	NOUN	B
.	O	PUNCT	O
cerevisiae	O	X	B
strains	O	NOUN	I
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
three	O	NUM	O
strong	O	ADJ	O
heterologous	O	ADJ	B
yeast	O	NOUN	B
transcription	O	NOUN	O
promoters	O	NOUN	O
(	O	PUNCT	O
pADC1	B-GENE	NOUN	B
,	O	PUNCT	O
pGPD	B-GENE	NOUN	B
,	O	PUNCT	O
pPHO5	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
under	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
own	O	ADJ	O
promoter	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ANB1	B-GENE	NOUN	B
locus	I-GENE	NOUN	B
of	O	ADP	O
Saccharomyces	O	X	B
cerevisiae	O	X	I
encodes	O	VERB	B
the	O	DET	O
protein	B-GENE	NOUN	B
synthesis	I-GENE	NOUN	I
initiation	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
eIF	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
4D	I-GENE	PROPN	B
.	O	PUNCT	O


Specific	O	ADJ	O
hyperimmune	B-GENE	ADJ	B
globulins	I-GENE	NOUN	I
to	O	ADP	O
pathogens	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
Haemophilus	O	NOUN	B
influenzae	O	NOUN	I
and	O	CCONJ	O
Streptococcus	O	X	B
pneumoniae	O	X	I
have	O	AUX	O
also	O	ADV	O
been	O	AUX	O
studied	O	VERB	O
.	O	PUNCT	O


Homozygous	O	ADJ	B
individuals	O	NOUN	B
usually	O	ADV	O
develop	O	VERB	O
purpura	O	NOUN	B
fulminans	O	NOUN	I
as	O	ADP	O
newborns	O	NOUN	B
;	O	PUNCT	O
heterozygous	O	ADJ	B
protein	B-GENE	NOUN	I
C	I-GENE	NOUN	I
-	O	PUNCT	O
deficient	O	ADJ	B
individuals	O	NOUN	B
are	O	AUX	O
at	O	ADP	O
increased	O	VERB	B
risk	O	NOUN	B
for	O	ADP	O
venous	O	ADJ	B
thrombosis	O	NOUN	I
and	O	CCONJ	O
pulmonary	O	ADJ	B
embolism	O	NOUN	I
.	O	PUNCT	O


TREB7	B-GENE	NOUN	B
and	O	CCONJ	O
TREB36	B-GENE	NOUN	B
protected	O	VERB	O
all	O	DET	O
three	O	NUM	O
repeats	O	NOUN	B
of	O	ADP	O
the	O	DET	O
21	O	NUM	O
bp	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
TREB5	B-GENE	NOUN	B
protected	O	VERB	O
only	O	ADV	O
the	O	DET	O
second	O	ADJ	O
repeat	O	NOUN	O
.	O	PUNCT	O


Since	O	SCONJ	O
general	B-GENE	ADJ	O
regulatory	I-GENE	ADJ	O
factor	I-GENE	NOUN	O
I	I-GENE	NOUN	O
(	O	PUNCT	O
GRFI	B-GENE	NOUN	B
)	O	PUNCT	O
/	O	SYM	O
repressor	B-GENE	NOUN	B
/	I-GENE	SYM	O
activator	I-GENE	NOUN	B
site	I-GENE	NOUN	I
binding	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	O	PUNCT	O
RAP1	B-GENE	NOUN	B
)	O	PUNCT	O
/	O	SYM	O
translation	B-GENE	NOUN	B
upstream	I-GENE	ADJ	I
factor	I-GENE	NOUN	I
(	O	PUNCT	O
TUF	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
be	O	AUX	O
an	O	DET	O
activator	O	NOUN	B
of	O	ADP	O
MAT	B-GENE	NOUN	B
alpha	I-GENE	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
whether	O	SCONJ	O
PYK1	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
regulated	O	VERB	O
by	O	ADP	O
GRFI	B-GENE	NOUN	B
/	O	PUNCT	O
RAP1	B-GENE	NOUN	B
/	O	SYM	O
TUF	B-GENE	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
also	O	ADV	O
affected	O	VERB	B
by	O	ADP	O
the	O	DET	O
gal11	B-GENE	NOUN	B
mutation	I-GENE	NOUN	B
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
extracts	O	NOUN	I
from	O	ADP	O
ret1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
cells	O	NOUN	B
terminate	O	VERB	B
less	O	ADV	O
efficiently	O	ADV	B
at	O	ADP	O
weak	O	ADJ	B
transcription	O	NOUN	B
termination	O	NOUN	I
signals	O	NOUN	I
than	O	ADP	O
those	O	DET	O
from	O	ADP	O
RET1	B-GENE	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
using	O	VERB	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
tRNA	O	NOUN	B
templates	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
factors	O	NOUN	B
belong	O	VERB	O
to	O	PART	O
a	O	DET	O
set	O	NOUN	O
of	O	ADP	O
genetically	O	ADV	B
distinct	O	ADJ	O
molecules	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
4	I-GENE	NUM	B
and	O	CCONJ	O
MLTF	B-GENE	NOUN	B
,	O	PUNCT	O
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
CACCTGTC	O	NOUN	B
motif	O	NOUN	B
or	O	CCONJ	O
related	O	ADJ	O
sequences	O	NOUN	B
.	O	PUNCT	O


RNase	B-GENE	NOUN	B
protection	O	NOUN	B
assays	O	NOUN	I
reveal	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
gene	O	NOUN	B
,	O	PUNCT	O
unr	B-GENE	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
transcribed	O	VERB	B
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
direction	O	NOUN	B
as	O	ADP	O
N	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
ras	I-GENE	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
its	O	PRON	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
is	O	AUX	O
located	O	ADJ	O
just	O	ADV	O
130	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
away	O	ADV	O
from	O	ADP	O
the	O	DET	O
point	O	NOUN	O
at	O	ADP	O
which	O	DET	O
N	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
ras	I-GENE	NOUN	B
transcription	O	NOUN	I
begins	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
juxtamembrane	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
insulin	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
IR	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
subunit	I-GENE	NOUN	B
contains	O	VERB	O
an	O	DET	O
unphosphorylated	O	ADJ	B
tyrosyl	O	NOUN	O
residue	O	NOUN	O
(	O	PUNCT	O
Tyr960	O	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
is	O	AUX	O
essential	O	ADJ	O
for	O	ADP	O
insulin	B-GENE	NOUN	B
-	O	PUNCT	O
stimulated	O	VERB	B
tyrosyl	O	NOUN	B
phosphorylation	O	NOUN	I
of	O	ADP	O
some	O	DET	O
endogenous	O	ADJ	B
substrates	O	NOUN	B
and	O	CCONJ	O
certain	O	ADJ	O
biological	O	ADJ	B
responses	O	NOUN	I
(	O	PUNCT	O
White	O	PROPN	B
,	O	PUNCT	O
M	O	PROPN	B
.	O	PUNCT	O
F	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Livingston	O	PROPN	B
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O
N	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
Backer	O	PROPN	B
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O
M	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Lauris	O	PROPN	B
,	O	PUNCT	O
V	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
Dull	O	PROPN	B
,	O	PUNCT	O
T	O	NOUN	B
.	O	PUNCT	O
J	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
Ullrich	O	PROPN	B
,	O	PUNCT	O
A	O	PROPN	O
.	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
Kahn	O	PROPN	B
,	O	PUNCT	O
C	O	PROPN	B
.	O	PUNCT	O
R	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
gene	O	NOUN	B
joins	O	VERB	O
the	O	DET	O
group	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
whose	O	DET	O
members	O	NOUN	B
are	O	AUX	O
rapidly	O	ADV	O
transcribed	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
insulin	B-GENE	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
mitogens	O	NOUN	B
.	O	PUNCT	O


Homozygous	O	ADJ	B
protein	B-GENE	NOUN	I
C	I-GENE	NOUN	I
(	O	PUNCT	O
PC	B-GENE	NOUN	O
)	O	PUNCT	O
deficiency	O	NOUN	B
is	O	AUX	O
reported	O	VERB	O
in	O	ADP	O
two	O	NUM	O
siblings	O	NOUN	B
(	O	PUNCT	O
girl	O	NOUN	B
and	O	CCONJ	O
boy	O	NOUN	B
)	O	PUNCT	O
who	O	PRON	O
received	O	VERB	O
their	O	PRON	O
proper	O	ADJ	O
diagnoses	O	NOUN	B
at	O	ADP	O
the	O	DET	O
ages	O	NOUN	B
of	O	ADP	O
7	O	NUM	O
4	O	NUM	O
/	O	SYM	O
12	O	NUM	O
and	O	CCONJ	O
1	O	NUM	O
3	O	NUM	O
/	O	SYM	O
12	O	NUM	O
years	O	NOUN	B
respectively	O	ADV	O
.	O	PUNCT	O


Within	O	ADP	O
this	O	DET	O
sequence	O	NOUN	B
the	O	DET	O
MSAS	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
identified	O	VERB	O
as	O	ADP	O
a	O	DET	O
5322	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
-	O	PUNCT	O
long	O	ADJ	B
open	O	ADJ	I
reading	O	NOUN	I
frame	O	NOUN	I
coding	O	VERB	I
for	O	ADP	O
a	O	DET	O
protein	O	NOUN	B
of	O	ADP	O
1774	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
and	O	CCONJ	O
190	O	NUM	O
,	O	PUNCT	O
731	O	NUM	O
Da	O	NOUN	B
molecular	O	ADJ	I
mass	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
interrelation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
glucocorticoids	O	NOUN	B
and	O	CCONJ	O
insulin	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
of	O	ADP	O
irradiated	O	ADJ	B
animals	O	NOUN	I


Primer	O	NOUN	B
extension	O	NOUN	I
analysis	O	NOUN	I
and	O	CCONJ	O
RNA	O	NOUN	B
sequencing	O	NOUN	I
demonstrates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcription	O	NOUN	B
start	O	NOUN	O
point	O	NOUN	O
of	O	ADP	O
rat	B-GENE	NOUN	B
ODC	I-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
is	O	AUX	O
located	O	ADJ	O
303	O	NUM	O
nt	O	NOUN	O
upstream	O	ADJ	O
from	O	ADP	O
the	O	DET	O
A	O	NOUN	B
residue	O	NOUN	B
in	O	ADP	O
the	O	DET	O
start	O	NOUN	O
codon	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
cis	O	ADJ	B
-	O	PUNCT	O
regulatory	O	ADJ	B
elements	O	NOUN	I
required	O	VERB	O
for	O	ADP	O
developmental	O	ADJ	B
control	O	NOUN	O
of	O	ADP	O
the	O	DET	O
HaG3	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
A	I-GENE	PROPN	O
helianthinin	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
are	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
a	O	DET	O
2	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
kb	O	NOUN	O
upstream	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
.	O	PUNCT	O


Some	O	DET	O
mutations	O	NOUN	B
affected	O	VERB	O
Dhfr	B-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
qualitative	O	ADJ	B
manner	O	NOUN	O
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
by	O	ADP	O
changing	O	VERB	B
the	O	DET	O
startpoint	O	NOUN	B
of	O	ADP	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
major	O	ADJ	O
Dhfr	B-GENE	NOUN	B
transcripts	I-GENE	NOUN	B
or	O	CCONJ	O
changing	O	VERB	B
the	O	DET	O
relative	O	ADJ	O
abundance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
major	O	ADJ	O
Dhfr	B-GENE	NOUN	B
transcripts	I-GENE	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
in	O	ADP	O
mammals	O	NOUN	B
,	O	PUNCT	O
considerable	O	ADJ	O
nucleotide	O	NOUN	B
diversity	O	NOUN	I
was	O	AUX	O
observed	O	VERB	O
at	O	ADP	O
the	O	DET	O
junctions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
variable	O	ADJ	B
,	O	PUNCT	O
diversity	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
joining	O	VERB	B
elements	O	NOUN	I
in	O	ADP	O
chicken	B-GENE	NOUN	B
TCR	I-GENE	NOUN	B
beta	I-GENE	NOUN	B
cDNAs	I-GENE	NOUN	I
.	O	PUNCT	O


S6	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
activation	O	NOUN	B
requires	O	VERB	O
displacement	O	NOUN	B
of	O	ADP	O
this	O	DET	O
inhibitory	O	ADJ	B
segment	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
proposed	O	VERB	O
to	O	PART	O
occur	O	VERB	O
consequent	O	ADJ	B
to	O	ADP	O
its	O	PRON	O
multiple	O	ADJ	B
phosphorylation	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
SUP44	B-GENE	NOUN	B
suppressor	I-GENE	NOUN	I
mutation	I-GENE	NOUN	O
occurs	O	VERB	O
near	O	ADP	O
a	O	DET	O
region	O	NOUN	O
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
that	O	PRON	O
corresponds	O	VERB	O
to	O	PART	O
the	O	DET	O
known	O	ADJ	O
positions	O	NOUN	B
of	O	ADP	O
alterations	O	NOUN	B
in	O	ADP	O
E	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
coli	I-GENE	X	B
S5	I-GENE	NOUN	I
ram	I-GENE	NOUN	B
mutations	I-GENE	NOUN	I
.	O	PUNCT	O


Results	O	NOUN	B
have	O	AUX	O
surprisingly	O	ADV	O
revealed	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
three	O	NUM	O
U14	B-GENE	NOUN	B
snRNA	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
homologous	I-GENE	ADJ	B
regions	I-GENE	NOUN	B
positioned	O	ADJ	O
within	O	ADP	O
introns	O	NOUN	B
5	O	NUM	O
,	O	PUNCT	O
6	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
8	O	NUM	O
of	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
cognate	O	ADJ	O
hsc70	B-GENE	NOUN	B
heat	O	NOUN	B
shock	O	NOUN	I
gene	O	NOUN	I
.	O	PUNCT	O


65	O	NUM	O
-	O	PUNCT	O
kilodalton	O	NOUN	B
protein	O	NOUN	I
phosphorylated	O	VERB	B
by	O	ADP	O
interleukin	B-GENE	NOUN	B
2	I-GENE	NUM	I
stimulation	O	NOUN	B
bears	O	VERB	O
two	O	NUM	O
putative	O	ADJ	B
actin	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
sites	I-GENE	NOUN	I
and	O	CCONJ	O
two	O	NUM	O
calcium	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
sites	O	NOUN	I
.	O	PUNCT	O


Serum	O	NOUN	B
Fibrin	B-GENE	NOUN	B
Degradation	I-GENE	PROPN	I
Products	I-GENE	PROPN	I
(	O	PUNCT	O
FDP	B-GENE	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
50	O	NUM	O
oral	O	ADJ	B
cancer	O	NOUN	I
patients	O	NOUN	B
and	O	CCONJ	O
50	O	NUM	O
normal	O	ADJ	B
individuals	O	NOUN	B
prior	O	ADV	O
to	O	ADP	O
any	O	DET	O
kind	O	NOUN	O
of	O	ADP	O
treatment	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mean	O	ADJ	O
change	O	NOUN	O
in	O	ADP	O
HbA1	B-GENE	NOUN	B
,	O	PUNCT	O
adjusted	O	VERB	O
for	O	ADP	O
the	O	DET	O
initial	O	ADJ	O
value	O	NOUN	O
,	O	PUNCT	O
was	O	AUX	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
the	O	DET	O
experimental	O	ADJ	B
and	O	CCONJ	O
+	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
group	O	NOUN	I
(	O	PUNCT	O
p	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Effect	O	NOUN	B
of	O	ADP	O
biliary	O	ADJ	B
obstruction	O	NOUN	I
and	O	CCONJ	O
cholangitis	O	NOUN	B
on	O	ADP	O
serum	B-GENE	NOUN	B
SPan	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
level	O	NOUN	B


By	O	ADP	O
introducing	O	VERB	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
deletions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
vimentin	B-GENE	NOUN	B
promoter	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
further	O	ADV	O
restrict	O	VERB	O
these	O	DET	O
sequences	O	NOUN	B
to	O	PART	O
30	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
,	O	PUNCT	O
located	O	ADJ	O
between	O	ADP	O
241	O	NUM	O
and	O	CCONJ	O
210	O	NUM	O
base	O	NOUN	B
pairs	O	NOUN	I
upstream	O	ADJ	I
of	O	ADP	O
the	O	DET	O
mRNA	O	NOUN	B
cap	O	NOUN	I
site	O	NOUN	I
.	O	PUNCT	O


All	O	DET	O
89	O	NUM	O
participating	O	VERB	B
household	O	NOUN	B
members	O	NOUN	I
were	O	AUX	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
HIV	I-GENE	NOUN	B
seronegative	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
78	O	NUM	O
who	O	PRON	O
were	O	AUX	O
tested	O	VERB	B
were	O	AUX	O
serum	B-GENE	NOUN	B
p24	I-GENE	NOUN	I
antigen	I-GENE	NOUN	I
negative	O	ADJ	B
.	O	PUNCT	O


To	O	PART	O
define	O	VERB	O
the	O	DET	O
mechanism	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
elongation	O	NOUN	I
blockage	O	NOUN	B
and	O	CCONJ	O
resulting	O	VERB	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
deregulation	O	NOUN	B
in	O	ADP	O
Burkitt	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
lymphoma	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
transcription	O	NOUN	B
patterns	O	NOUN	I
after	O	ADP	O
transfer	O	NOUN	B
of	O	ADP	O
normal	O	ADJ	B
and	O	CCONJ	O
Burkitt	O	NOUN	B
'	O	PART	I
s	O	NOUN	I
lymphoma	O	NOUN	I
c	B-GENE	NOUN	I
-	I-GENE	PUNCT	O
myc	I-GENE	NOUN	B
alleles	O	NOUN	B
into	O	ADP	O
murine	O	ADJ	B
cells	O	NOUN	B
and	O	CCONJ	O
Xenopus	O	NOUN	B
oocyte	O	NOUN	O
germinal	O	ADJ	B
vesicles	O	NOUN	I
.	O	PUNCT	O


From	O	ADP	O
an	O	DET	O
RNK	O	NOUN	B
-	O	PUNCT	O
16	O	NUM	O
lambda	O	NOUN	B
-	O	PUNCT	O
gt11	O	NOUN	B
library	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
sequenced	O	VERB	B
a	O	DET	O
novel	O	ADJ	O
cDNA	O	NOUN	B
rat	B-GENE	NOUN	O
NK	I-GENE	NOUN	B
cell	I-GENE	NOUN	I
protease	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	O	PUNCT	O
RNKP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
)	O	PUNCT	O
that	O	PRON	O
has	O	AUX	O
characteristics	O	NOUN	B
unique	O	ADJ	O
to	O	PART	O
serine	B-GENE	NOUN	B
proteases	I-GENE	NOUN	I
.	O	PUNCT	O


Patients	O	NOUN	B
with	O	ADP	O
acute	O	ADJ	B
myocardial	O	ADJ	I
infarction	O	NOUN	I
had	O	AUX	O
higher	O	ADJ	O
plasma	O	NOUN	B
concentrations	O	NOUN	B
of	O	ADP	O
neutrophil	B-GENE	NOUN	B
elastase	I-GENE	NOUN	I
and	O	CCONJ	O
the	O	DET	O
non	O	ADJ	B
-	O	PUNCT	O
peroxide	O	NOUN	B
diene	O	NOUN	B
conjugated	O	VERB	B
isomer	O	NOUN	B
of	O	ADP	O
linoleic	O	ADJ	B
acid	O	NOUN	I
than	O	ADP	O
normal	O	ADJ	B
volunteers	O	NOUN	I
or	O	CCONJ	O
patients	O	NOUN	B
with	O	ADP	O
stable	O	ADJ	B
ischaemic	O	ADJ	O
heart	O	NOUN	O
disease	O	NOUN	O
.	O	PUNCT	O


TMBr	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
is	O	AUX	O
identical	O	ADJ	B
to	O	PART	O
striated	B-GENE	ADJ	B
muscle	I-GENE	NOUN	I
alpha	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
tropomyosin	I-GENE	NOUN	B
from	O	ADP	O
amino	O	NOUN	B
acids	O	NOUN	I
1	O	NUM	I
through	O	ADP	O
258	O	NUM	O
but	O	CCONJ	O
contains	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
COOH	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
region	O	NOUN	B
from	O	ADP	O
amino	O	NOUN	B
acids	O	NOUN	I
259	O	NUM	O
through	O	ADP	O
281	O	NUM	O
.	O	PUNCT	O


Comparison	O	NOUN	B
of	O	ADP	O
transmembrane	O	NOUN	B
and	O	CCONJ	O
cytoplasmic	O	ADJ	B
domains	O	NOUN	O
to	O	PART	O
a	O	DET	O
third	O	ADJ	O
cell	O	NOUN	B
-	O	PUNCT	O
surface	O	NOUN	B
proteoglycan	O	NOUN	B
,	O	PUNCT	O
48K5	B-GENE	NOUN	B
from	O	ADP	O
human	O	ADJ	B
lung	O	NOUN	O
fibroblasts	O	NOUN	O
(	O	PUNCT	O
Marynen	O	PROPN	O
,	O	PUNCT	O
P	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
Zhang	O	PROPN	O
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O
,	O	PUNCT	O
Cassiman	O	PROPN	B
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O
,	O	PUNCT	O
Vanden	O	PROPN	B
Berghe	O	PROPN	I
,	O	PUNCT	I
H	O	PROPN	I
.	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
David	O	PROPN	B
,	O	PUNCT	O
C	O	PROPN	B
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
C	B-GENE	NOUN	B
subunits	I-GENE	NOUN	I
are	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
several	O	ADJ	O
subsequent	O	ADJ	O
larval	O	NOUN	B
and	O	CCONJ	O
adult	O	ADJ	B
stages	O	NOUN	B
of	O	ADP	O
development	O	NOUN	B
.	O	PUNCT	O


Plasma	O	NOUN	B
lecithin	B-GENE	NOUN	B
/	I-GENE	SYM	O
cholesterol	I-GENE	NOUN	B
acyltransferase	I-GENE	NOUN	I
(	O	PUNCT	O
LCAT	B-GENE	NOUN	B
)	O	PUNCT	O
activity	O	NOUN	B
in	O	ADP	O
multiple	O	ADJ	B
-	O	PUNCT	O
organ	O	NOUN	B
donors	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
predictor	O	NOUN	B
of	O	ADP	O
allograft	O	NOUN	B
viability	O	NOUN	B
in	O	ADP	O
clinical	O	ADJ	B
liver	O	NOUN	I
transplantation	O	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
,	O	PUNCT	O
cellular	O	ADJ	B
localization	O	NOUN	I
and	O	CCONJ	O
in	O	X	B
vitro	O	X	I
transcription	O	NOUN	B
studies	O	NOUN	I
establish	O	VERB	O
that	O	SCONJ	O
cloned	B-GENE	VERB	B
hUBF	I-GENE	NOUN	B
encodes	O	VERB	O
a	O	DET	O
nucleolar	O	ADJ	B
factor	O	NOUN	I
that	O	PRON	O
binds	O	VERB	B
specifically	O	ADV	O
to	O	PART	O
the	O	DET	O
upstream	O	ADJ	B
control	O	NOUN	I
element	O	NOUN	I
and	O	CCONJ	O
core	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rRNA	O	NOUN	B
gene	O	NOUN	I
promoter	O	NOUN	O
to	O	PART	O
activate	O	VERB	B
transcription	O	NOUN	B
in	O	ADP	O
a	O	DET	O
binding	O	VERB	B
site	O	NOUN	I
-	O	PUNCT	O
dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
distribution	O	NOUN	B
of	O	ADP	O
their	O	PRON	O
fibrinogen	B-GENE	NOUN	B
levels	O	NOUN	I
was	O	AUX	O
Gaussian	O	ADJ	B
,	O	PUNCT	O
but	O	CCONJ	O
more	O	ADV	O
wide	O	ADV	B
-	O	PUNCT	O
based	O	VERB	O
than	O	ADP	O
the	O	DET	O
distribution	O	NOUN	B
of	O	ADP	O
our	O	PRON	O
normal	O	ADJ	B
controls	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
NF1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
vitellogenin	I-GENE	NOUN	B
activator	I-GENE	NOUN	I
element	I-GENE	NOUN	B
mediates	O	VERB	O
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
estrogen	O	NOUN	B
-	O	PUNCT	O
regulated	O	VERB	B
Xenopus	B-GENE	NOUN	B
laevis	I-GENE	NOUN	I
vitellogenin	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
hypergastrinemia	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
surgical	O	ADJ	B
removal	O	NOUN	I
of	O	ADP	O
acid	O	NOUN	B
-	O	PUNCT	O
producing	O	VERB	B
mucosa	O	NOUN	B
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
has	O	AUX	O
the	O	DET	O
same	O	ADJ	O
effects	O	NOUN	B
on	O	ADP	O
oxyntical	O	ADJ	B
mucosal	B-GENE	ADJ	B
HDC	I-GENE	NOUN	B
activity	O	NOUN	B
,	O	PUNCT	O
histamine	O	NOUN	B
concentration	O	NOUN	B
and	O	CCONJ	O
ECL	O	NOUN	B
cell	O	NOUN	O
density	O	NOUN	O
as	O	ADP	O
hypergastrinemia	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
continuous	O	ADJ	B
gastrin	B-GENE	NOUN	B
infusion	O	NOUN	B
or	O	CCONJ	O
by	O	ADP	O
long	O	ADJ	B
-	O	PUNCT	O
term	O	NOUN	B
treatment	O	NOUN	B
with	O	ADP	O
effective	O	ADJ	B
antisecretagogues	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
consensus	O	NOUN	B
binding	O	NOUN	I
site	O	NOUN	I
for	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
factor	O	NOUN	I
SP1	B-GENE	NOUN	I
was	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
intron	O	NOUN	B
As	O	ADP	O
downstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
proenkephalin	B-GENE	NOUN	B
germ	I-GENE	NOUN	I
cell	I-GENE	NOUN	I
cap	I-GENE	NOUN	I
site	I-GENE	NOUN	I
region	I-GENE	NOUN	I
.	O	PUNCT	O


PCR	O	NOUN	B
-	O	PUNCT	O
derived	O	VERB	B
fragments	O	NOUN	B
were	O	AUX	O
used	O	VERB	O
as	O	ADP	O
probes	O	NOUN	B
for	O	ADP	O
the	O	DET	O
isolation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
U3	B-GENE	NOUN	B
snRNA	I-GENE	NOUN	I
genes	I-GENE	NOUN	I
from	O	ADP	O
a	O	DET	O
genomic	O	ADJ	B
library	O	NOUN	I
of	O	ADP	O
Arabidopsis	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
at	O	ADP	O
18	O	NUM	O
months	O	NOUN	B
of	O	ADP	O
age	O	NOUN	B
,	O	PUNCT	O
significantly	O	ADV	O
higher	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
IgG1	B-GENE	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
IgG4	B-GENE	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
less	O	ADJ	O
than	O	ADP	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
infants	O	NOUN	B
with	O	ADP	O
an	O	DET	O
elevated	O	ADJ	B
IgE	B-GENE	NOUN	O
(	O	PUNCT	O
greater	O	ADJ	O
than	O	ADP	O
or	O	CCONJ	O
equal	O	ADJ	O
to	O	PART	O
8	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
kU	O	NOUN	O
/	O	SYM	O
l	O	NOUN	B
)	O	PUNCT	O
than	O	ADP	O
in	O	ADP	O
those	O	DET	O
with	O	ADP	O
a	O	DET	O
lower	O	ADJ	O
level	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
also	O	ADV	O
showed	O	VERB	O
that	O	SCONJ	O
although	O	SCONJ	O
oyster	O	ADJ	B
shell	O	NOUN	B
supplementation	O	NOUN	B
generally	O	ADV	O
increased	O	VERB	B
alkaline	B-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
activity	O	NOUN	I
,	O	PUNCT	O
bone	O	NOUN	B
mineralization	O	NOUN	B
was	O	AUX	O
relatively	O	ADV	O
uninfluenced	O	VERB	O
as	O	ADP	O
judged	O	VERB	O
by	O	ADP	O
the	O	DET	O
low	O	ADJ	B
coefficients	O	NOUN	I
of	O	ADP	I
variation	O	NOUN	I
(	O	PUNCT	O
CV	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
3	O	NUM	O
.	O	PUNCT	O
14	O	NUM	O
-	O	SYM	O
3	O	NUM	O
.	O	PUNCT	O
51	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
3	O	NUM	O
.	O	PUNCT	O
39	O	NUM	O
-	O	SYM	O
4	O	NUM	O
.	O	PUNCT	O
82	O	NUM	O
%	O	NOUN	O
for	O	ADP	O
calcium	O	NOUN	B
and	O	CCONJ	O
phosphorus	O	NOUN	B
content	O	NOUN	B
in	O	ADP	O
the	O	DET	O
femur	O	NOUN	B
and	O	CCONJ	O
tibia	O	NOUN	B
respectively	O	ADV	O
.	O	PUNCT	O


Serotonin	B-GENE	NOUN	B
5	I-GENE	NUM	I
-	I-GENE	PUNCT	O
HT2	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
binding	O	NOUN	B
on	O	ADP	O
blood	O	NOUN	B
platelets	O	NOUN	I
as	O	ADP	O
a	O	DET	O
state	O	NOUN	B
dependent	O	ADJ	I
marker	O	NOUN	B
in	O	ADP	O
major	O	ADJ	O
affective	O	ADJ	B
disorder	O	NOUN	I
.	O	PUNCT	O


Eucaryotic	O	ADJ	B
transcription	O	NOUN	O
factors	O	NOUN	O
that	O	PRON	O
stimulate	O	VERB	B
RNA	B-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
II	I-GENE	NUM	I
by	O	ADP	O
increasing	O	VERB	B
the	O	DET	O
efficiency	O	NOUN	B
of	O	ADP	O
elongation	O	NOUN	B
of	O	ADP	O
specifically	O	ADV	O
or	O	CCONJ	O
randomly	O	ADV	O
initiated	O	VERB	O
RNA	O	NOUN	B
chains	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
characterized	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
trk	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
2h	I-GENE	NOUN	B
oncogene	I-GENE	NOUN	B
,	O	PUNCT	O
isolated	O	VERB	B
from	O	ADP	O
the	O	DET	O
human	O	ADJ	B
breast	O	NOUN	O
carcinoma	O	NOUN	O
cell	O	NOUN	B
line	O	NOUN	I
MDA	O	NOUN	B
-	O	PUNCT	O
MB	O	PROPN	B
231	O	NUM	O
by	O	ADP	O
genomic	O	ADJ	B
DNA	O	NOUN	I
-	O	PUNCT	O
transfection	O	NOUN	B
into	O	ADP	O
NIH3T3	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
consists	O	VERB	O
of	O	ADP	O
the	O	DET	O
trk	B-GENE	NOUN	B
proto	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
oncogene	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
domain	I-GENE	NOUN	I
fused	O	VERB	O
to	O	PART	O
a	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
41	O	NUM	O
amino	O	NOUN	B
acid	O	NOUN	I
activating	O	NOUN	I
sequence	O	NOUN	I
(	O	PUNCT	O
Kozma	O	PROPN	B
,	O	PUNCT	O
S	O	PROPN	B
.	O	PUNCT	O
C	O	NOUN	O
.	O	PUNCT	O
,	O	PUNCT	O
Redmond	O	PROPN	B
,	O	PUNCT	O
S	O	PROPN	B
.	O	PUNCT	O
M	O	NOUN	B
.	O	PUNCT	O
S	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Xiao	O	PROPN	O
-	O	PUNCT	O
Chang	O	PROPN	B
,	O	PUNCT	O
F	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
Saurer	O	PROPN	B
,	O	PUNCT	O
S	O	PROPN	B
.	O	PUNCT	O
M	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
Groner	O	PROPN	B
,	O	PUNCT	O
B	O	NOUN	B
.	O	PUNCT	O
and	O	CCONJ	O
Hynes	O	PROPN	B
,	O	PUNCT	O
N	O	PROPN	B
.	O	PUNCT	O
E	O	NOUN	B
.	O	PUNCT	O


Antibodies	O	NOUN	B
raised	O	VERB	O
against	O	ADP	O
a	O	DET	O
bacterially	O	ADV	B
produced	O	VERB	O
beta	B-GENE	NOUN	B
gal	I-GENE	ADJ	I
-	O	PUNCT	O
trk	B-GENE	NOUN	B
receptor	O	NOUN	I
kinase	O	NOUN	I
fusion	O	NOUN	I
protein	O	NOUN	I
recognized	O	VERB	O
a	O	DET	O
44	O	NUM	O
kd	O	NOUN	O
phosphoprotein	O	NOUN	B
phosphorylated	O	VERB	I
on	O	ADP	O
serine	O	NOUN	B
,	O	PUNCT	O
threonine	O	NOUN	B
and	O	CCONJ	O
tyrosine	O	NOUN	B
in	O	ADP	O
extracts	O	NOUN	B
of	O	ADP	O
trk	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2h	I-GENE	NOUN	B
transformed	O	VERB	O
NIH3T3	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Molecular	O	ADJ	B
and	O	CCONJ	O
functional	O	ADJ	B
characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
of	O	ADP	O
ETS2	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
human	O	ADJ	B
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
ets	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
gene	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
examination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
properties	O	NOUN	B
of	O	ADP	O
sequences	O	NOUN	B
surrounding	O	VERB	O
ARS1	O	NOUN	B
left	O	VERB	I
open	O	ADJ	O
the	O	DET	O
possibility	O	NOUN	O
that	O	SCONJ	O
ABFI	B-GENE	NOUN	B
enhances	O	VERB	B
the	O	DET	O
initiation	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
replication	O	NOUN	I
at	O	ADP	O
ARS1	O	NOUN	B
by	O	ADP	O
transcriptional	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
priming	O	NOUN	B
activity	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
incised	O	VERB	I
by	O	ADP	O
either	O	DET	O
of	O	ADP	O
the	O	DET	O
Drosophila	O	NOUN	B
enzymes	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
enhanced	O	VERB	B
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
by	O	ADP	O
an	O	DET	O
additional	O	ADJ	O
incubation	O	NOUN	B
with	O	ADP	O
E	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
coli	I-GENE	X	B
endonuclease	I-GENE	NOUN	I
IV	I-GENE	NUM	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
cleave	O	VERB	B
depurinated	O	VERB	B
DNA	O	NOUN	I
on	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
side	O	NOUN	B
of	O	ADP	O
an	O	DET	O
apurinic	O	ADJ	B
site	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
MAP1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
and	I-GENE	CCONJ	O
MAP2	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
mRNAs	I-GENE	NOUN	B
decline	O	NOUN	B
in	O	ADP	O
the	O	DET	O
postnatal	O	ADJ	B
developing	O	VERB	O
brain	O	NOUN	B
;	O	PUNCT	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
MAP1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
mRNA	I-GENE	NOUN	B
also	O	ADV	O
increases	O	VERB	B
slightly	O	ADV	O
in	O	ADP	O
rat	O	NOUN	B
PC12	O	NOUN	B
cells	O	NOUN	I
upon	O	SCONJ	O
exposure	O	NOUN	B
to	O	PART	I
nerve	B-GENE	NOUN	B
growth	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
.	O	PUNCT	O


Deletion	O	NOUN	B
analysis	O	NOUN	I
was	O	AUX	O
carried	O	VERB	O
out	O	ADP	O
within	O	ADP	O
a	O	DET	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
flanking	O	ADJ	B
region	O	NOUN	I
showing	O	VERB	O
homology	O	NOUN	B
to	O	PART	O
the	O	DET	O
upstream	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
yeast	B-GENE	NOUN	B
CYC1	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Lysozyme	B-GENE	NOUN	B
activity	O	NOUN	B
was	O	AUX	O
evidently	O	ADV	O
increased	O	VERB	B
as	O	ADV	O
well	O	ADV	O
in	O	ADP	O
undiluted	O	ADJ	O
as	O	ADP	O
in	O	ADP	O
diluted	O	ADJ	B
sera	O	NOUN	B
in	O	ADP	O
all	O	DET	O
our	O	PRON	O
tested	O	VERB	B
patients	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
5	B-GENE	NUM	O
.	I-GENE	PUNCT	O
8S	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
structure	I-GENE	NOUN	B
is	O	AUX	O
present	O	ADJ	O
within	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
terminal	O	ADJ	B
region	O	NOUN	B
of	O	ADP	O
all	O	DET	O
three	O	NUM	O
fungal	B-GENE	ADJ	B
mitochondrial	I-GENE	ADJ	B
LSU	I-GENE	NOUN	B
rRNAs	I-GENE	NOUN	B
;	O	PUNCT	O
in	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
no	O	DET	O
4	B-GENE	NUM	O
.	I-GENE	PUNCT	O
5S	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
like	I-GENE	ADJ	B
structure	I-GENE	NOUN	B
is	O	AUX	O
evident	O	ADJ	O
at	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
these	O	DET	O
molecules	O	NOUN	B
.	O	PUNCT	O


ASL	O	PROPN	B
-	O	PUNCT	O
8123	O	NUM	O
demonstrated	O	VERB	O
weak	O	ADJ	B
competitive	O	ADJ	B
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
adrenoreceptor	I-GENE	NOUN	B
blocking	O	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
isolated	O	VERB	B
guinea	O	NOUN	B
pig	O	NOUN	B
right	O	ADV	B
atria	O	NOUN	I
with	O	ADP	O
a	O	DET	O
pA2	O	NOUN	B
of	O	ADP	O
3	O	NUM	O
.	O	PUNCT	O
73	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
07	O	NUM	O
;	O	PUNCT	O
no	O	DET	O
agonist	O	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
activity	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
this	O	DET	O
tissue	O	NOUN	B
at	O	ADP	O
concentrations	O	NOUN	B
of	O	ADP	O
ASL	O	PROPN	B
-	O	PUNCT	O
8123	O	NUM	O
from	O	ADP	O
3	O	NUM	O
X	O	NOUN	O
10	O	NUM	O
(	O	PUNCT	O
-	O	PUNCT	O
5	O	NUM	O
)	O	PUNCT	O
to	O	PART	O
1	O	NUM	O
X	O	NOUN	O
10	O	NUM	O
(	O	PUNCT	O
-	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
M	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
size	O	NOUN	B
discrepancy	O	NOUN	B
is	O	AUX	O
not	O	PART	O
due	O	ADJ	O
to	O	PART	O
glycosylation	O	NOUN	B
or	O	CCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
Ag35	B-GENE	NOUN	B
but	O	CCONJ	O
may	O	AUX	O
result	O	VERB	O
from	O	ADP	O
a	O	DET	O
proline	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
sequence	O	NOUN	B
which	O	DET	O
occurs	O	VERB	O
in	O	ADP	O
this	O	DET	O
polypeptide	O	NOUN	B
.	O	PUNCT	O


Serum	O	NOUN	B
prostatic	B-GENE	ADJ	I
acid	I-GENE	NOUN	I
phosphatase	I-GENE	NOUN	I
levels	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
significantly	O	ADV	O
weaker	O	ADJ	O
correlation	O	NOUN	B
with	O	ADP	O
cancer	O	NOUN	B
volume	O	NOUN	I
(	O	PUNCT	O
r	O	NOUN	O
equals	O	VERB	O
0	O	NUM	O
.	O	PUNCT	O
51	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
every	O	DET	O
other	O	ADJ	O
pathological	O	ADJ	B
parameter	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
investigation	O	NOUN	B
was	O	AUX	O
thereafter	O	ADV	O
continued	O	VERB	O
in	O	ADP	O
an	O	DET	O
open	O	ADJ	O
fashion	O	NOUN	O
by	O	ADP	O
administering	O	VERB	B
a	O	DET	O
single	O	ADJ	O
10	O	NUM	O
mg	O	NOUN	O
dose	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MAO	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
B	I-GENE	NOUN	B
inhibitor	O	NOUN	B
deprenyl	O	NOUN	B
to	O	PART	O
the	O	DET	O
same	O	ADJ	O
subjects	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
approach	O	NOUN	O
was	O	AUX	O
examined	O	VERB	O
utilizing	O	VERB	O
the	O	DET	O
fetal	O	ADJ	B
protein	O	NOUN	I
,	O	PUNCT	O
HGB	B-GENE	NOUN	B
F	I-GENE	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
to	O	PART	O
the	O	DET	O
significant	O	ADJ	O
reduction	O	NOUN	B
in	O	ADP	O
blood	O	NOUN	B
pressure	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
angiotensin	B-GENE	NOUN	B
converting	I-GENE	NOUN	I
enzyme	I-GENE	NOUN	I
(	O	PUNCT	O
ACE	B-GENE	NOUN	B
)	O	PUNCT	O
inhibitor	O	NOUN	B
ramipril	O	NOUN	B
caused	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
regression	O	NOUN	B
of	O	ADP	O
pathologic	O	ADJ	B
left	O	ADJ	I
ventricular	O	ADJ	I
hypertrophy	O	NOUN	I
demonstrated	O	VERB	O
by	O	ADP	O
magnetic	O	ADJ	B
resonance	O	NOUN	I
imaging	O	NOUN	I
and	O	CCONJ	O
echocardiography	O	NOUN	B
.	O	PUNCT	O


Previously	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
reported	O	VERB	O
the	O	DET	O
sequence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	B-GENE	NOUN	B
encoding	I-GENE	VERB	O
human	I-GENE	ADJ	B
K14	I-GENE	NOUN	O
(	O	PUNCT	O
D	O	NOUN	B
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
human	O	ADJ	B
but	O	CCONJ	O
not	O	PART	O
a	O	DET	O
bovine	B-GENE	ADJ	B
alpha	I-GENE	NOUN	O
transgene	I-GENE	NOUN	O
was	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
placenta	O	NOUN	B
in	O	ADP	O
transgenic	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
diagnostic	O	ADJ	B
value	O	NOUN	I
of	O	ADP	O
blood	O	NOUN	B
serum	O	NOUN	I
and	O	CCONJ	O
urinary	B-GENE	ADJ	B
amylase	I-GENE	NOUN	I
,	O	PUNCT	O
lipase	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
trypsin	B-GENE	NOUN	B
in	O	ADP	O
exacerbations	O	NOUN	B
of	O	ADP	O
chronic	O	ADJ	B
relapsing	O	VERB	I
pancreatitis	O	NOUN	I
is	O	AUX	O
discussed	O	VERB	O
.	O	PUNCT	O


Intravenous	O	ADJ	B
gamma	B-GENE	NOUN	I
globulins	I-GENE	NOUN	I


Once	O	SCONJ	O
NGF	B-GENE	NOUN	B
administration	O	NOUN	B
is	O	AUX	O
proven	O	VERB	O
effective	O	ADJ	B
it	O	PRON	O
will	O	AUX	O
be	O	AUX	O
possible	O	ADJ	O
to	O	PART	O
develop	O	VERB	O
alternative	O	ADJ	B
ways	O	NOUN	O
of	O	ADP	O
NGF	B-GENE	NOUN	B
administration	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
thrombolytic	O	ADJ	B
effects	O	NOUN	I
of	O	ADP	O
native	O	ADJ	B
tissue	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
plasminogen	I-GENE	NOUN	I
activator	I-GENE	NOUN	I
(	O	PUNCT	O
AK	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
124	I-GENE	NUM	O
)	O	PUNCT	O
on	O	ADP	O
experimental	O	ADJ	B
canine	O	ADJ	I
coronary	O	ADJ	B
thrombosis	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
experiments	O	NOUN	B
with	O	ADP	O
S1	B-GENE	NOUN	B
mapping	O	NOUN	I
of	O	ADP	O
in	O	X	B
vivo	O	X	I
transcripts	O	NOUN	B
,	O	PUNCT	O
gene	O	NOUN	B
disruptions	O	NOUN	I
in	O	ADP	O
the	O	DET	O
alpha	O	NOUN	B
region	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
single	O	ADJ	B
-	O	PUNCT	O
copy	O	NOUN	B
transcriptional	O	ADJ	O
fusion	O	NOUN	O
vector	O	NOUN	O
all	O	DET	O
suggested	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
possible	O	ADJ	O
promoters	O	NOUN	B
were	O	AUX	O
largely	O	ADV	O
inactive	O	ADJ	B
during	O	ADP	O
logarithmic	O	ADJ	B
growth	O	NOUN	I
,	O	PUNCT	O
that	O	SCONJ	O
the	O	DET	O
major	O	ADJ	O
promoter	O	NOUN	B
for	O	ADP	O
the	O	DET	O
alpha	O	NOUN	B
operon	O	NOUN	I
lay	O	VERB	I
upstream	O	ADV	I
from	O	ADP	O
the	O	DET	O
region	O	NOUN	B
cloned	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
genes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
IF1	B-GENE	NOUN	B
to	O	PART	O
L17	B-GENE	NOUN	B
interval	O	NOUN	I
were	O	AUX	O
cotranscribed	O	VERB	B
.	O	PUNCT	O


Tonometry	O	NOUN	B
of	O	ADP	O
blood	O	NOUN	B
samples	O	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
may	O	AUX	O
also	O	ADV	O
be	O	AUX	O
used	O	VERB	O
in	O	ADP	O
the	O	DET	O
determination	O	NOUN	B
of	O	ADP	O
acid	O	NOUN	B
-	O	PUNCT	O
base	O	NOUN	B
quantities	O	NOUN	B
and	O	CCONJ	O
hemoglobin	B-GENE	NOUN	B
-	O	PUNCT	O
oxygen	O	NOUN	B
affinity	O	NOUN	B
e	O	PUNCT	I
.	O	PUNCT	O
g	O	NOUN	O
.	O	PUNCT	O
p50	O	NOUN	B
.	O	PUNCT	O


Among	O	ADP	O
100	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
post	O	NOUN	B
-	O	PUNCT	O
transfusion	O	NOUN	B
hepatitis	O	NOUN	B
,	O	PUNCT	O
10	O	NUM	O
are	O	AUX	O
due	O	ADJ	O
to	O	PART	O
the	O	DET	O
hepatitis	O	NOUN	B
B	O	NOUN	I
virus	O	NOUN	I
(	O	PUNCT	O
despite	O	SCONJ	O
systematic	O	ADJ	B
search	O	NOUN	I
for	O	ADP	O
HBs	B-GENE	NOUN	B
Ag	I-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
89	O	NUM	O
are	O	AUX	O
due	O	ADJ	O
to	O	PART	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
non	O	ADJ	B
-	O	PUNCT	O
A	O	NOUN	B
non	O	ADJ	B
-	O	PUNCT	O
B	O	NOUN	B
viruses	O	NOUN	I
(	O	PUNCT	O
not	O	PART	O
detectable	O	ADJ	B
by	O	ADP	O
specific	O	ADJ	O
serological	O	ADJ	B
tests	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
to	O	PART	O
several	O	ADJ	O
viruses	O	NOUN	B
,	O	PUNCT	O
specially	O	ADV	B
CMV	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
215	O	NUM	O
-	O	PUNCT	O
base	O	NOUN	B
-	O	PUNCT	O
pair	O	NOUN	B
(	O	PUNCT	O
bp	O	NOUN	O
)	O	PUNCT	O
region	O	NOUN	O
of	O	ADP	O
the	O	DET	O
mouse	B-GENE	NOUN	B
MOPC	I-GENE	NOUN	B
41	I-GENE	NUM	O
kappa	I-GENE	NOUN	O
light	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
chain	I-GENE	NOUN	B
immunoglobulin	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
enhancer	I-GENE	NOUN	I
has	O	AUX	O
been	O	AUX	O
analyzed	O	VERB	B
for	O	ADP	O
specific	O	ADJ	O
binding	O	NOUN	B
of	O	ADP	O
lymphoid	O	ADJ	B
and	O	CCONJ	O
nonlymphoid	O	ADJ	B
nuclear	O	ADJ	B
factors	O	NOUN	I
.	O	PUNCT	O


Mapping	O	NOUN	B
of	O	ADP	O
RNA	O	NOUN	B
-	O	PUNCT	O
temperature	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
sensitive	I-GENE	ADJ	B
mutants	I-GENE	NOUN	B
of	I-GENE	ADP	O
Sindbis	I-GENE	NOUN	B
virus	I-GENE	NOUN	I
:	I-GENE	PUNCT	O
complementation	I-GENE	NOUN	B
group	I-GENE	NOUN	I
F	I-GENE	NOUN	I
mutants	I-GENE	NOUN	B
have	O	AUX	O
lesions	O	NOUN	B
in	O	ADP	O
nsP4	B-GENE	NOUN	B
.	O	PUNCT	O


S1	B-GENE	NOUN	O
nuclease	I-GENE	NOUN	O
analysis	O	NOUN	O
of	O	ADP	O
RNA	O	NOUN	B
prepared	O	VERB	O
after	O	ADP	O
transfection	O	NOUN	B
of	O	ADP	O
these	O	DET	O
HIV	O	NOUN	B
constructs	O	NOUN	B
into	O	ADP	O
HeLa	O	NOUN	B
cells	O	NOUN	I
infected	O	VERB	B
with	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
adenovirus	O	NOUN	I
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
enhancer	O	NOUN	B
,	O	PUNCT	O
SP1	B-GENE	NOUN	B
,	O	PUNCT	O
TATA	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transactivation	O	NOUN	B
-	O	PUNCT	O
responsive	O	ADJ	B
element	O	NOUN	B
were	O	AUX	O
each	O	DET	O
required	O	VERB	O
for	O	ADP	O
complete	O	ADJ	O
E1A	B-GENE	NOUN	B
/	O	SYM	O
E1B	B-GENE	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV	B-GENE	NOUN	B
LTR	I-GENE	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
supine	O	ADJ	B
position	O	NOUN	I
,	O	PUNCT	O
plasma	O	NOUN	B
ANP	B-GENE	NOUN	B
levels	O	NOUN	B
ranged	O	VERB	O
from	O	ADP	O
12	O	NUM	O
pg	O	NOUN	O
/	O	SYM	O
ml	O	NOUN	O
to	O	ADP	O
51	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
pg	O	NOUN	O
/	O	SYM	O
ml	O	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
average	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
35	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
11	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
pg	O	NOUN	O
/	O	SYM	O
ml	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
HeLa	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
activated	O	VERB	B
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
herpes	B-GENE	NOUN	B
simplex	I-GENE	NOUN	I
virus	I-GENE	NOUN	I
type	I-GENE	NOUN	I
1	I-GENE	NUM	I
thymidine	I-GENE	NOUN	I
kinase	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
linked	O	VERB	O
to	O	PART	O
the	O	DET	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
when	O	SCONJ	O
located	O	ADJ	O
in	O	ADP	O
inverted	O	ADJ	B
orientation	O	NOUN	I
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
thymidine	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
or	O	CCONJ	O
downstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
gene	I-GENE	NOUN	B
coding	I-GENE	NOUN	I
sequence	I-GENE	NOUN	I
.	O	PUNCT	O


At	O	ADP	O
the	O	DET	O
basal	O	ADJ	B
unstimulated	O	ADJ	I
condition	O	NOUN	I
,	O	PUNCT	O
Ren1d	B-GENE	NOUN	B
5	I-GENE	NUM	O
'	I-GENE	PART	O
flanking	I-GENE	ADJ	B
sequence	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
sense	O	NOUN	B
orientation	O	NOUN	I
inhibited	O	VERB	B
basal	O	ADJ	B
CAT	B-GENE	NOUN	B
expression	O	NOUN	B
from	O	ADP	O
the	O	DET	O
TK	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
of	O	ADP	O
pUTKAT1	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
same	O	ADJ	O
sequence	O	NOUN	B
in	O	ADP	O
the	O	DET	O
antisense	O	ADJ	B
orientation	O	NOUN	B
did	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
isolated	O	VERB	B
cDNA	O	NOUN	B
clones	O	NOUN	I
from	O	ADP	O
rat	O	NOUN	B
brain	O	NOUN	B
and	O	CCONJ	O
human	O	ADJ	B
liver	O	NOUN	B
encoding	O	VERB	B
a	O	DET	O
putative	O	ADJ	O
isoform	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Na	B-GENE	PROPN	B
,	I-GENE	PUNCT	O
K	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
ATPase	I-GENE	NOUN	B
beta	I-GENE	NOUN	B
subunit	I-GENE	NOUN	I
.	O	PUNCT	O


UbiA	B-GENE	NOUN	B
is	O	AUX	O
also	O	ADV	O
unique	O	ADJ	B
among	O	ADP	O
known	O	VERB	O
polyubiquitin	B-GENE	NOUN	B
genes	I-GENE	NOUN	B
in	O	ADP	O
containing	O	VERB	O
four	O	NUM	O
cis	O	ADV	B
-	O	PUNCT	O
spliced	O	VERB	B
introns	O	NOUN	B
within	O	ADP	O
its	O	PRON	O
coding	O	VERB	B
sequence	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
methylation	O	NOUN	B
of	O	ADP	O
nuclear	O	ADJ	B
and	O	CCONJ	O
chloroplast	O	NOUN	B
DNAs	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
examined	O	VERB	O
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
the	O	DET	O
known	O	ADJ	O
differential	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
C4	B-GENE	NOUN	B
photosynthesis	I-GENE	NOUN	I
genes	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
bundle	O	NOUN	B
sheath	O	NOUN	I
and	O	CCONJ	O
mesophyll	O	NOUN	B
cells	O	NOUN	I
of	O	ADP	O
etiolated	O	ADJ	B
,	O	PUNCT	O
greening	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
fully	O	ADV	O
green	O	ADJ	B
maize	O	NOUN	I
leaves	O	NOUN	B
.	O	PUNCT	O


Synthetic	O	ADJ	B
oligonucleotides	O	NOUN	I
representing	O	VERB	O
the	O	DET	O
19	O	NUM	O
bp	O	NOUN	O
repeat	O	NOUN	O
unit	O	NOUN	O
strongly	O	ADV	O
reduced	O	VERB	B
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IE1	B-GENE	NOUN	B
/	I-GENE	SYM	O
2	I-GENE	NUM	B
enhancer	I-GENE	NOUN	B
/	I-GENE	PUNCT	O
promoter	I-GENE	NOUN	B
in	O	ADP	O
cotransfection	O	NOUN	B
assays	O	NOUN	I
after	O	ADP	O
transient	O	ADJ	B
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mustard	B-GENE	NOUN	B
chloroplast	I-GENE	NOUN	I
gene	I-GENE	NOUN	O
rps16	I-GENE	NOUN	B
is	O	AUX	O
split	O	VERB	O
by	O	ADP	O
an	O	DET	O
887	O	NUM	O
bp	O	NOUN	B
group	O	NOUN	I
II	O	NUM	I
(	O	PUNCT	O
or	O	CCONJ	O
III	O	NUM	O
)	O	PUNCT	O
intron	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
unique	O	ADJ	B
nature	O	NOUN	B
and	O	CCONJ	O
arrangement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ANT1	B-GENE	NOUN	B
transcriptional	I-GENE	ADJ	B
control	I-GENE	NOUN	I
elements	I-GENE	NOUN	I
may	O	AUX	O
account	O	VERB	O
for	O	ADP	O
this	O	DET	O
differential	O	ADJ	B
expression	O	NOUN	B
.	O	PUNCT	O


VP5	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
encodes	O	VERB	B
the	O	DET	O
major	B-GENE	ADJ	O
capsid	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
,	O	PUNCT	O
each	O	DET	O
fused	O	VERB	B
to	O	PART	O
the	O	DET	O
chloramphenicol	B-GENE	NOUN	B
acetyltransferase	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
.	O	PUNCT	O


Insert2	O	NOUN	B
contains	O	VERB	O
repetitive	O	ADJ	B
non	O	ADJ	B
-	O	PUNCT	O
Ig	B-GENE	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
sequences	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
small	B-GENE	ADJ	B
Ig	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
sequence	I-GENE	NOUN	B
.	O	PUNCT	O


Since	O	SCONJ	O
considerable	O	ADJ	O
variations	O	NOUN	B
in	O	ADP	O
length	O	NOUN	B
and	O	CCONJ	O
primary	O	ADJ	B
sequence	O	NOUN	I
in	O	ADP	O
the	O	DET	O
CDR3	B-GENE	NOUN	B
(	O	PUNCT	O
complementarity	B-GENE	NOUN	B
determining	I-GENE	NOUN	O
region	I-GENE	NOUN	O
)	O	PUNCT	O
peptides	O	NOUN	B
of	O	ADP	O
all	O	DET	O
the	O	DET	O
H	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
chains	I-GENE	NOUN	B
are	O	AUX	O
evident	O	ADJ	O
,	O	PUNCT	O
conservation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
D	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
region	I-GENE	NOUN	B
structure	O	NOUN	B
does	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
be	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
effective	O	ADJ	B
hapten	O	NOUN	B
binding	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
DNA	O	NOUN	B
helix	O	NOUN	I
at	O	ADP	O
the	O	DET	O
tandemly	O	ADJ	B
repeated	O	VERB	O
,	O	PUNCT	O
13mer	O	ADJ	O
sequence	O	NOUN	B
is	O	AUX	O
thermodynamically	O	ADV	B
unstable	O	ADJ	B
,	O	PUNCT	O
as	O	ADP	O
evidenced	O	VERB	O
by	O	ADP	O
hypersensitivity	O	NOUN	B
to	O	PART	O
single	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
strand	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
nuclease	I-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
negatively	O	ADV	O
supercoiled	O	ADJ	B
plasmid	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
demonstrated	O	VERB	O
by	O	ADP	O
stable	O	ADJ	B
DNA	O	NOUN	B
unwinding	O	NOUN	I
seen	O	VERB	O
after	O	ADP	O
two	O	NUM	O
-	O	PUNCT	O
dimensional	O	ADJ	B
gel	O	NOUN	B
electrophoresis	O	NOUN	I
of	O	ADP	O
topoisomers	O	NOUN	B
.	O	PUNCT	O


Other	O	ADJ	O
hemostatic	O	ADJ	B
values	O	NOUN	I
evaluated	O	VERB	B
were	O	AUX	O
activated	O	VERB	B
partial	O	ADJ	I
thromboplastin	B-GENE	NOUN	I
times	O	NOUN	I
,	O	PUNCT	O
prothrombin	B-GENE	NOUN	B
times	O	NOUN	I
,	O	PUNCT	O
thrombin	B-GENE	NOUN	B
times	O	NOUN	O
,	O	PUNCT	O
fibrinogen	B-GENE	NOUN	B
,	O	PUNCT	O
platelet	O	NOUN	B
counts	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
fibrin	B-GENE	NOUN	B
/	O	SYM	O
fibrinogen	B-GENE	NOUN	B
degradation	O	NOUN	I
products	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
designated	O	VERB	O
the	O	DET	O
protein	O	NOUN	B
"	B-GENE	PUNCT	O
cellular	I-GENE	ADJ	B
NBP	I-GENE	NOUN	B
"	I-GENE	PUNCT	O
(	O	PUNCT	O
CNBP	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Isolation	O	NOUN	B
and	O	CCONJ	O
characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cDNA	O	NOUN	B
encoding	O	VERB	B
a	O	DET	O
putative	O	ADJ	B
cytokine	O	NOUN	I
which	O	DET	O
is	O	AUX	O
induced	O	VERB	B
by	O	ADP	O
stimulation	O	NOUN	B
via	O	ADP	O
the	O	DET	O
CD2	B-GENE	NOUN	B
structure	I-GENE	NOUN	B
on	O	ADP	O
human	O	ADJ	B
T	O	NOUN	B
lymphocytes	O	NOUN	I
.	O	PUNCT	O


Tumour	B-GENE	NOUN	B
necrosis	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
and	O	CCONJ	O
adult	O	ADJ	B
respiratory	O	ADJ	B
distress	O	NOUN	I
syndrome	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
assess	O	VERB	O
the	O	DET	O
functional	O	ADJ	B
importance	O	NOUN	O
of	O	ADP	O
these	O	DET	O
NBS	O	NOUN	B
in	O	ADP	O
the	O	DET	O
overall	O	ADJ	B
drug	O	NOUN	B
resistance	O	NOUN	I
phenotype	O	NOUN	B
conferred	O	VERB	O
by	O	ADP	O
mdr1	B-GENE	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
introduced	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
substitutions	O	NOUN	I
in	O	ADP	O
the	O	DET	O
core	O	NOUN	B
consensus	O	NOUN	I
sequence	O	NOUN	I
for	O	ADP	O
nucleotide	O	NOUN	B
binding	O	NOUN	I
,	O	PUNCT	O
GXGKST	O	NOUN	B
.	O	PUNCT	O


Northern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
revealed	O	VERB	O
multiple	O	ADJ	B
oIGF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
I	I-GENE	NOUN	B
transcripts	I-GENE	NOUN	B
in	O	ADP	O
a	O	DET	O
broad	O	ADJ	O
band	O	NOUN	O
at	O	ADP	O
800	O	NUM	O
-	O	SYM	O
1	O	NUM	O
,	O	PUNCT	O
100	O	NUM	O
nucleotides	O	NOUN	B
and	O	CCONJ	O
other	O	ADJ	O
transcripts	O	NOUN	B
of	O	ADP	O
higher	O	ADJ	O
molecular	O	ADJ	B
weight	O	NOUN	I
in	O	ADP	O
liver	O	NOUN	B
.	O	PUNCT	O


After	O	ADP	O
hepatitis	O	NOUN	B
B	O	NOUN	I
vaccine	O	NOUN	I
immunization	O	NOUN	B
,	O	PUNCT	O
serum	O	NOUN	B
antibody	O	NOUN	I
response	O	NOUN	I
was	O	AUX	O
of	O	ADP	O
primary	O	ADJ	B
type	O	NOUN	O
in	O	ADP	O
33	O	NUM	O
cases	O	NOUN	B
with	O	ADP	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
HBs	I-GENE	NOUN	B
less	O	ADJ	O
than	O	ADP	O
2	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
S	O	NOUN	B
/	O	SYM	O
N	O	NOUN	B
(	O	PUNCT	O
S	O	PROPN	B
/	O	SYM	O
N	O	PROPN	B
Ratio	O	PROPN	I
Unit	O	PROPN	I
)	O	PUNCT	O
at	O	ADP	O
T0	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
anti	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
HBs	I-GENE	NOUN	B
positive	O	ADJ	B
rate	O	NOUN	B
was	O	AUX	O
39	O	NUM	O
.	O	PUNCT	O
4	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
84	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
96	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
96	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
T1	O	NOUN	B
,	O	PUNCT	O
T2	O	NOUN	B
,	O	PUNCT	O
T0	O	NOUN	B
and	O	CCONJ	O
T12	O	NOUN	B
respectively	O	ADV	O
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
inferred	O	VERB	O
1	B-GENE	NUM	O
,	I-GENE	PUNCT	O
859	I-GENE	NUM	O
-	I-GENE	PUNCT	O
residue	I-GENE	NOUN	B
ama	I-GENE	NOUN	O
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
product	I-GENE	NOUN	B
showed	O	VERB	O
considerable	O	ADJ	O
identity	O	NOUN	B
with	O	ADP	O
the	O	DET	O
largest	O	ADJ	O
subunit	O	NOUN	B
of	O	ADP	O
RNAP	B-GENE	NOUN	B
II	I-GENE	NUM	I
from	O	ADP	O
other	O	ADJ	O
organisms	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
zinc	O	NOUN	B
finger	O	NOUN	I
motif	O	NOUN	B
near	O	ADP	O
the	O	DET	O
amino	O	NOUN	B
terminus	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
carboxyl	O	ADJ	B
-	O	PUNCT	O
terminal	O	ADJ	B
domain	O	NOUN	B
of	O	ADP	O
42	O	NUM	O
tandemly	O	ADV	B
reiterated	O	VERB	O
heptamers	O	NOUN	B
with	O	ADP	O
the	O	DET	O
consensus	O	NOUN	B
Tyr	O	NOUN	I
Ser	O	NOUN	I
Pro	O	NOUN	I
Thr	O	NOUN	I
Ser	O	NOUN	B
Pro	O	NOUN	I
Ser	O	NOUN	I
.	O	PUNCT	O


Of	O	ADP	O
165	O	NUM	O
women	O	NOUN	B
with	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
malignant	O	ADJ	B
diagnoses	O	NOUN	B
26	O	NUM	O
(	O	PUNCT	O
16	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
had	O	AUX	O
CA	B-GENE	PROPN	B
125	I-GENE	NUM	O
levels	O	NOUN	B
in	O	ADP	O
excess	O	NOUN	B
of	O	ADP	O
35	O	NUM	O
U	O	NOUN	B
/	O	PUNCT	O
ml	O	NOUN	O
and	O	CCONJ	O
8	O	NUM	O
(	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
greater	O	ADJ	O
than	O	ADP	O
65	O	NUM	O
U	O	NOUN	B
/	O	PUNCT	O
ml	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
elements	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
glucocorticoid	O	NOUN	B
stimulation	O	NOUN	I
of	O	ADP	O
ADH	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
transcription	O	NOUN	I
appear	O	VERB	O
to	O	PART	O
reside	O	VERB	O
outside	O	ADV	B
of	O	ADP	O
this	O	DET	O
region	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
two	O	NUM	O
most	O	ADV	O
recent	O	ADJ	O
patients	O	NOUN	B
(	O	PUNCT	O
35	O	NUM	O
and	O	CCONJ	O
132	O	NUM	O
days	O	NOUN	B
)	O	PUNCT	O
received	O	VERB	O
only	O	ADV	O
oral	O	ADJ	B
dipyridamole	O	NOUN	I
(	O	PUNCT	O
75	O	NUM	O
mg	O	NOUN	O
X	O	NOUN	O
3	O	NUM	O
/	O	SYM	O
day	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
aspirin	O	NOUN	B
(	O	PUNCT	O
80	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
day	O	NOUN	B
)	O	PUNCT	O
after	O	ADP	O
the	O	DET	O
early	O	ADJ	B
recovery	O	NOUN	B
period	O	NOUN	B
(	O	PUNCT	O
four	O	NUM	O
-	O	PUNCT	O
six	O	NUM	B
days	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
normal	O	ADJ	B
prothrombin	B-GENE	NOUN	I
and	O	CCONJ	O
partial	O	ADJ	B
thromboplastin	B-GENE	NOUN	O
times	O	NOUN	O
.	O	PUNCT	O


Gel	O	NOUN	B
retardation	O	NOUN	I
assays	O	NOUN	I
combined	O	VERB	O
with	O	ADP	O
DNase	B-GENE	NOUN	B
I	I-GENE	NUM	I
footprinting	O	NOUN	I
and	O	CCONJ	O
diethyl	O	NOUN	B
pyrocarbonate	O	NOUN	I
interference	O	NOUN	O
showed	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
nuclear	O	ADJ	B
factor	O	NOUN	I
from	O	ADP	O
differentiated	O	VERB	B
C2	O	NOUN	B
myotubes	O	NOUN	I
and	O	CCONJ	O
BC3H1	O	NOUN	B
myocytes	O	NOUN	O
recognized	O	VERB	O
a	O	DET	O
conserved	O	VERB	O
A	O	NOUN	O
+	O	CCONJ	O
T	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
sequence	O	NOUN	B
within	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
activating	O	NOUN	I
region	O	NOUN	I
.	O	PUNCT	O


During	O	ADP	O
challenge	O	NOUN	O
,	O	PUNCT	O
rebiopsy	O	NOUN	B
was	O	AUX	O
done	O	VERB	O
when	O	SCONJ	O
reticulin	B-GENE	NOUN	B
antibodies	I-GENE	NOUN	I
turned	O	VERB	O
positive	O	ADJ	B
(	O	PUNCT	O
mean	O	NOUN	O
0	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
range	O	NOUN	O
0	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
-	O	SYM	O
2	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
)	O	PUNCT	O
or	O	CCONJ	O
at	O	ADP	O
the	O	DET	O
end	O	NOUN	O
of	O	ADP	O
the	O	DET	O
two	O	NUM	O
year	O	NOUN	B
study	O	NOUN	B
.	O	PUNCT	O


Serological	O	ADJ	B
studies	O	NOUN	I
at	O	ADP	O
the	O	DET	O
early	O	ADJ	O
relapse	O	NOUN	B
stage	O	NOUN	B
of	O	ADP	O
this	O	DET	O
disease	O	NOUN	B
showed	O	VERB	O
increased	O	VERB	B
serum	B-GENE	NOUN	B
ANA	I-GENE	NOUN	B
,	O	PUNCT	O
IgA	B-GENE	NOUN	B
and	O	CCONJ	O
IgM	B-GENE	NOUN	B
level	O	NOUN	B
with	O	ADP	O
normal	O	ADJ	B
IgG	B-GENE	NOUN	I
and	O	CCONJ	O
decrease	O	NOUN	B
of	O	ADP	O
C3	B-GENE	NOUN	B
and	O	CCONJ	O
C4	B-GENE	NOUN	B
.	O	PUNCT	O


Concomitant	O	ADJ	B
chronic	O	ADJ	B
lymphocytic	O	ADJ	I
leukemia	O	NOUN	I
,	O	PUNCT	O
acute	O	ADJ	B
myeloid	O	ADJ	I
leukemia	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
thrombosis	O	NOUN	B
with	O	ADP	O
protein	B-GENE	NOUN	B
C	I-GENE	NOUN	I
deficiency	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
whole	O	ADJ	B
group	O	NOUN	I
,	O	PUNCT	O
basal	O	ADJ	B
GH	B-GENE	NOUN	I
and	O	CCONJ	O
somatomedin	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
C	I-GENE	NOUN	B
levels	O	NOUN	B
decreased	O	VERB	B
from	O	ADP	O
a	O	DET	O
mean	O	NOUN	O
(	O	PUNCT	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
standard	O	ADJ	B
error	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mean	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
52	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
12	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
to	O	PART	O
11	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
6	O	NUM	O
.	O	PUNCT	O
3	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
ml	O	NOUN	O
and	O	CCONJ	O
from	O	ADP	O
7	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
to	O	PART	O
2	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
U	O	NOUN	B
/	O	PUNCT	O
ml	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
formation	O	NOUN	B
of	O	ADP	O
foci	O	NOUN	B
of	O	ADP	O
transformed	O	VERB	O
RECs	O	NOUN	B
by	O	ADP	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
jun	I-GENE	NOUN	B
/	O	PUNCT	O
ras	B-GENE	NOUN	B
combination	O	NOUN	B
was	O	AUX	O
augmented	O	VERB	B
3	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
by	O	ADP	O
the	O	DET	O
tumor	O	NOUN	B
promoter	O	NOUN	I
phorbol	O	NOUN	O
12	O	NUM	O
-	O	SYM	O
tetradecanoate	O	NOUN	B
13	O	NUM	O
-	O	PUNCT	O
acetate	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
no	O	DET	O
significant	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
baseline	O	NOUN	B
PC40	O	NOUN	B
methacholine	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
maximal	O	ADJ	B
fall	O	NOUN	B
in	O	ADP	O
Vp30	O	NOUN	B
after	O	ADP	O
either	O	CCONJ	O
the	O	DET	O
first	O	ADJ	O
(	O	PUNCT	O
12	O	NUM	O
micrograms	O	NOUN	B
)	O	PUNCT	O
or	O	CCONJ	O
the	O	DET	O
second	O	ADJ	B
dose	O	NOUN	I
(	O	PUNCT	O
24	O	NUM	O
micrograms	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
platelet	B-GENE	NOUN	B
activating	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
well	O	ADV	O
known	O	VERB	O
that	O	SCONJ	O
calcium	O	NOUN	B
channel	O	NOUN	I
blockers	O	NOUN	I
can	O	AUX	O
influence	O	VERB	B
contraction	O	NOUN	B
of	O	ADP	O
vascular	O	ADJ	B
smooth	O	ADJ	I
muscle	O	NOUN	I
,	O	PUNCT	O
there	O	PRON	O
is	O	AUX	O
less	O	ADJ	O
knowledge	O	NOUN	B
on	O	ADP	O
its	O	PRON	O
effect	O	NOUN	B
on	O	ADP	O
excitation	O	NOUN	B
contraction	O	NOUN	I
coupling	O	NOUN	B
in	O	ADP	O
the	O	DET	O
endocrine	O	ADJ	B
glands	O	NOUN	I
and	O	CCONJ	O
more	O	ADV	O
specifically	O	ADV	O
on	O	ADP	O
insulin	B-GENE	NOUN	B
and	O	CCONJ	O
glucagon	B-GENE	NOUN	B
release	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
site	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
DNA	O	NOUN	B
inversion	O	NOUN	I
system	O	NOUN	I
Cin	B-GENE	NOUN	O
encoded	O	VERB	B
by	O	ADP	O
the	O	DET	O
bacteriophage	O	NOUN	B
P1	O	NOUN	I
consists	O	VERB	O
of	O	ADP	O
a	O	DET	O
recombinase	B-GENE	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
inverted	O	VERB	O
crossing	O	VERB	O
-	O	PUNCT	O
over	O	ADP	B
sites	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
recombinational	O	ADJ	B
enhancer	O	NOUN	I
.	O	PUNCT	O


Tumor	B-GENE	NOUN	B
necrosis	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
(	O	PUNCT	O
TNF	B-GENE	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
reported	O	VERB	O
to	O	PART	O
cause	O	VERB	O
a	O	DET	O
shock	O	NOUN	B
syndrome	O	NOUN	I
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
produced	O	VERB	O
by	O	ADP	O
endotoxin	O	NOUN	B
(	O	PUNCT	O
LPS	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Of	O	ADP	O
the	O	DET	O
single	O	ADJ	B
-	O	PUNCT	O
stranded	O	VERB	B
DNA	O	NOUN	B
transformants	O	NOUN	I
,	O	PUNCT	O
65	O	NUM	O
%	O	NOUN	O
resulted	O	VERB	O
from	O	ADP	O
replacement	O	NOUN	B
of	O	ADP	O
the	O	DET	O
resident	O	ADJ	B
met2	B-GENE	NOUN	B
mutation	I-GENE	NOUN	B
by	O	ADP	O
the	O	DET	O
exogenous	O	ADJ	B
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
allele	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
strongly	O	ADV	O
support	O	VERB	O
the	O	DET	O
notion	O	NOUN	O
that	O	SCONJ	O
the	O	DET	O
OBF1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
sites	I-GENE	NOUN	I
and	O	CCONJ	O
the	O	DET	O
OBF1	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
are	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
normal	O	ADJ	O
ARS	O	NOUN	B
function	O	NOUN	O
as	O	ADP	O
an	O	DET	O
origin	O	NOUN	B
of	O	ADP	O
replication	O	NOUN	B
.	O	PUNCT	O


Four	O	NUM	O
out	O	ADP	O
of	O	ADP	O
10	O	NUM	O
patients	O	NOUN	B
showed	O	VERB	O
clinical	O	ADJ	B
improvement	O	NOUN	I
according	O	VERB	O
to	O	ADP	O
Ritchie	O	PROPN	B
-	O	PUNCT	O
Index	O	PROPN	O
,	O	PUNCT	O
pain	O	NOUN	B
score	O	NOUN	I
,	O	PUNCT	O
ESR	O	NOUN	B
and	O	CCONJ	O
CRP	B-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
R	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
meliloti	I-GENE	X	B
nifH	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
K	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
pneumoniae	I-GENE	X	B
nifH	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
showed	O	VERB	O
sigma	B-GENE	NOUN	O
54	I-GENE	NUM	O
-	O	PUNCT	O
dependent	O	ADJ	B
methylation	O	NOUN	B
protection	O	NOUN	B
of	O	ADP	O
guanine	O	NOUN	B
residues	O	NOUN	I
at	O	ADP	O
-	O	PUNCT	O
14	O	NUM	O
,	O	PUNCT	O
-	O	PUNCT	O
25	O	NUM	O
and	O	CCONJ	O
-	O	PUNCT	O
26	O	NUM	O
,	O	PUNCT	O
the	O	DET	O
most	O	ADV	O
conserved	O	VERB	O
nucleotides	O	NOUN	B
characteristic	O	ADJ	O
of	O	ADP	O
sigma	B-GENE	NOUN	O
54	I-GENE	NUM	O
-	I-GENE	PUNCT	O
dependent	I-GENE	ADJ	B
promoters	I-GENE	NOUN	B
.	O	PUNCT	O


To	O	PART	O
assess	O	VERB	O
the	O	DET	O
health	O	NOUN	B
significance	O	NOUN	I
of	O	ADP	O
the	O	DET	O
early	O	ADJ	B
renal	O	ADJ	B
changes	O	NOUN	O
after	O	ADP	O
chronic	O	ADJ	B
exposure	O	NOUN	O
to	O	PART	O
cadmium	O	NOUN	B
,	O	PUNCT	O
23	O	NUM	O
workers	O	NOUN	B
removed	O	VERB	B
from	O	ADP	O
exposure	O	NOUN	B
because	O	SCONJ	O
of	O	ADP	O
the	O	DET	O
discovery	O	NOUN	B
of	O	ADP	O
an	O	DET	O
increased	O	VERB	B
urinary	O	ADJ	B
excretion	O	NOUN	B
of	O	ADP	O
beta	B-GENE	NOUN	B
2	I-GENE	NUM	I
-	I-GENE	PUNCT	O
microglobulin	I-GENE	NOUN	B
or	O	CCONJ	O
retinol	B-GENE	NOUN	B
binding	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
both	O	DET	O
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
examined	O	VERB	O
once	O	ADV	O
a	O	DET	O
year	O	NOUN	B
for	O	ADP	O
five	O	NUM	O
years	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
cytosolic	O	ADJ	B
glutathione	B-GENE	NOUN	I
S	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
transferases	I-GENE	NOUN	B
(	O	PUNCT	O
GSTs	B-GENE	NOUN	B
,	O	PUNCT	O
EC	B-GENE	NOUN	B
2	I-GENE	NUM	O
.	I-GENE	PUNCT	O
5	I-GENE	NUM	O
.	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	I-GENE	PUNCT	O
18	I-GENE	NUM	O
)	O	PUNCT	O
are	O	AUX	O
a	O	DET	O
superfamily	O	NOUN	B
of	O	ADP	O
dimeric	O	ADJ	B
isoenzymes	O	NOUN	O
which	O	DET	O
catalyze	O	VERB	B
the	O	DET	O
conjugation	O	NOUN	B
of	O	ADP	O
electrophilic	O	ADJ	B
substrates	O	NOUN	I
with	O	ADP	O
glutathione	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
data	O	NOUN	B
also	O	ADV	O
suggest	O	VERB	O
that	O	SCONJ	O
when	O	SCONJ	O
compared	O	VERB	B
to	O	PART	O
the	O	DET	O
systemic	O	ADJ	B
vascular	O	ADJ	B
bed	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
pulmonary	O	ADJ	B
vascular	O	ADJ	I
bed	O	NOUN	I
is	O	AUX	O
less	O	ADV	O
responsive	O	ADJ	B
to	O	PART	O
bolus	O	NOUN	B
administration	O	NOUN	I
of	O	ADP	O
ET	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
.	O	PUNCT	O


Diagnosis	O	NOUN	B
of	O	ADP	O
primary	O	ADJ	B
sclerosing	O	NOUN	I
cholangitis	O	NOUN	I
in	O	ADP	O
a	O	DET	O
blood	O	NOUN	B
donor	O	NOUN	I
with	O	ADP	O
elevated	O	ADJ	B
serum	B-GENE	NOUN	O
alanine	I-GENE	NOUN	O
aminotransferase	I-GENE	NOUN	O
.	O	PUNCT	O


Primer	O	NOUN	B
extension	O	NOUN	O
experiments	O	NOUN	O
indicated	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcription	O	NOUN	B
initiation	O	NOUN	I
site	O	NOUN	I
mapped	O	VERB	B
to	O	PART	O
a	O	DET	O
position	O	NOUN	B
on	O	ADP	O
gene	B-GENE	NOUN	B
IV	I-GENE	NUM	I
that	O	PRON	O
was	O	AUX	O
analogous	O	ADJ	O
to	O	PART	O
that	O	DET	O
reported	O	VERB	O
for	O	ADP	O
the	O	DET	O
structurally	O	ADV	B
similar	O	ADJ	O
P	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
450e	I-GENE	NOUN	O
gene	I-GENE	NOUN	B
.	O	PUNCT	O


From	O	ADP	O
day	O	NOUN	B
30	O	NUM	O
after	O	ADP	O
turnout	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
PFB	O	PROPN	B
-	O	PUNCT	O
group	O	NOUN	B
had	O	AUX	O
significantly	O	ADV	O
lower	O	ADJ	O
serum	B-GENE	NOUN	B
pepsinogen	I-GENE	NOUN	O
levels	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
reflects	O	VERB	O
the	O	DET	O
low	O	ADJ	B
degree	O	NOUN	B
of	O	ADP	O
abomasal	O	ADJ	B
damage	O	NOUN	B
in	O	ADP	O
these	O	DET	O
animals	O	NOUN	B
.	O	PUNCT	O


Chronic	O	ADJ	B
dose	O	NOUN	I
effects	O	NOUN	I
of	O	ADP	O
methyl	O	NOUN	B
parathion	O	NOUN	I
on	O	ADP	O
nuthatches	O	NOUN	B
:	O	PUNCT	O
cholinesterase	B-GENE	NOUN	B
and	O	CCONJ	O
ptilochronology	O	NOUN	B
.	O	PUNCT	O


Similarly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
sequence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
U2	B-GENE	NOUN	B
RNA	I-GENE	NOUN	I
region	I-GENE	NOUN	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
pre	O	ADJ	B
-	O	PUNCT	O
mRNA	O	NOUN	B
branchpoint	O	ADJ	B
recognition	O	NOUN	I
in	O	ADP	O
yeast	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
exactly	O	ADV	O
conserved	O	VERB	O
in	O	ADP	O
metazoan	B-GENE	ADJ	B
U2	I-GENE	NOUN	I
RNAs	I-GENE	NOUN	I
,	O	PUNCT	O
was	O	AUX	O
totally	O	ADV	O
divergent	O	ADJ	B
in	O	ADP	O
trypanosomes	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
striking	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
active	O	ADJ	B
CHO	O	NOUN	B
spacer	O	NOUN	O
promoter	O	NOUN	B
violated	O	VERB	O
the	O	DET	O
otherwise	O	ADV	O
universal	O	ADJ	O
rule	O	NOUN	O
that	O	SCONJ	O
metazoan	B-GENE	ADJ	B
RNA	I-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
I	I-GENE	NUM	I
promoters	I-GENE	NOUN	I
all	O	DET	O
have	O	AUX	O
a	O	DET	O
G	O	NOUN	B
residue	O	NOUN	B
at	O	ADP	O
position	O	NOUN	B
-	O	PUNCT	O
16	O	NUM	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
final	O	ADJ	O
model	O	NOUN	B
,	O	PUNCT	O
grade	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
0002	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
peritoneal	O	ADJ	B
cytologic	O	ADJ	O
results	O	NOUN	O
(	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
0002	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
progesterone	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
status	O	NOUN	I
(	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
004	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
age	O	NOUN	B
as	O	ADP	O
a	O	DET	O
continuous	O	ADJ	B
variable	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
008	O	NUM	O
)	O	PUNCT	O
were	O	AUX	O
most	O	ADV	O
closely	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
disease	O	NOUN	B
-	O	PUNCT	O
free	O	ADJ	B
survival	O	NOUN	B
.	O	PUNCT	O


Transcripts	O	NOUN	B
characterized	O	VERB	B
include	O	VERB	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
abundant	O	ADJ	O
monocistronic	O	ADJ	B
L11e	B-GENE	NOUN	B
and	O	CCONJ	O
tricistronic	O	ADJ	B
L1e	B-GENE	NOUN	I
-	O	PUNCT	O
L10e	B-GENE	PROPN	B
-	O	PUNCT	O
L12e	B-GENE	NOUN	B
transcripts	O	NOUN	B
;	O	PUNCT	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
less	O	ADV	O
abundant	O	ADJ	B
bicistronic	O	ADJ	B
NAB	B-GENE	PROPN	B
-	O	PUNCT	O
L11e	B-GENE	PROPN	B
and	O	CCONJ	O
monocistronic	O	ADJ	B
NAB	B-GENE	NOUN	B
transcripts	I-GENE	NOUN	B
and	O	CCONJ	O
(	O	PUNCT	O
iii	O	X	O
)	O	PUNCT	O
a	O	DET	O
very	O	ADV	O
rare	O	ADJ	O
ORF	O	NOUN	B
monocistronic	O	ADJ	B
transcript	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
suggested	O	VERB	O
that	O	SCONJ	O
baboon	B-GENE	NOUN	B
liver	I-GENE	NOUN	B
class	I-GENE	NOUN	I
I	I-GENE	NUM	I
ADH	I-GENE	NOUN	B
is	O	AUX	O
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
ancestral	O	ADJ	B
lineage	O	NOUN	O
as	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
ADH	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
beta	I-GENE	NOUN	B
.	O	PUNCT	O


Brain	B-GENE	NOUN	B
cholinesterase	I-GENE	NOUN	I
activity	O	NOUN	B
of	O	ADP	O
nestling	O	VERB	B
great	O	ADJ	O
egrets	O	NOUN	B
,	O	PUNCT	O
snowy	O	ADJ	B
egrets	O	NOUN	I
and	O	CCONJ	O
black	O	ADJ	B
-	O	PUNCT	O
crowned	O	VERB	B
night	O	NOUN	B
-	O	PUNCT	O
herons	O	NOUN	B
.	O	PUNCT	O
inhibition	O	NOUN	B
of	O	ADP	O
brain	B-GENE	NOUN	B
cholinesterase	I-GENE	NOUN	I
(	O	PUNCT	O
ChE	B-GENE	NOUN	B
)	O	PUNCT	O
activity	O	NOUN	B
in	O	ADP	O
birds	O	NOUN	B
is	O	AUX	O
often	O	ADV	O
used	O	VERB	O
to	O	PART	O
diagnose	O	VERB	B
exposure	O	NOUN	B
or	O	CCONJ	I
death	O	NOUN	B
from	O	ADP	O
organophosphorus	O	NOUN	B
or	O	CCONJ	O
carbamate	O	ADJ	B
pesticides	O	NOUN	I
.	O	PUNCT	O


Heating	O	NOUN	B
cells	O	NOUN	I
to	O	ADP	O
43	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	O
decreased	O	VERB	B
the	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
newly	O	ADV	O
synthesized	O	VERB	B
rRNA	O	NOUN	B
to	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
5	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
control	O	NOUN	B
level	O	NOUN	O
and	O	CCONJ	O
led	O	VERB	O
to	O	PART	O
greater	O	ADJ	O
than	O	ADP	O
95	O	NUM	O
%	O	NOUN	O
inhibition	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
termination	O	NOUN	I
at	O	ADP	O
a	O	DET	O
region	O	NOUN	B
355	O	NUM	O
to	O	PART	O
362	O	NUM	O
nucleotides	O	NOUN	B
downstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
end	O	NOUN	O
of	O	ADP	O
28S	B-GENE	ADJ	B
rRNA	I-GENE	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
readthrough	O	NOUN	B
continuing	O	VERB	O
into	O	ADP	O
the	O	DET	O
next	O	ADJ	B
transcription	O	NOUN	I
unit	O	NOUN	I
.	O	PUNCT	O


